syndrome	score	normalized_score
+173470 INTEGRIN, BETA-3; ITGB3;;PLATELET GLYCOPROTEIN IIIa; GP3A;;GP IIIa;;PLATELET FIBRINOGEN RECEPTOR, BETA SUBUNIT;;CD61THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE, INCLUDED; NAIT, INCLUDED;;POSTTRANSFUSION PURPURA, INCLUDED; PTP, INCLUDED	2.0	100.0
MYOCLONIC EPILEPSY OF LAFORA	1.5181308000000002	75.90654
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	1.5025640999999998	75.128205
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	1.492658882	74.6329441
#604004 MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1; MLC1;;VACUOLATING MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS;;LVM;;VL;;LEUKOENCEPHALOPATHY WITH SWELLING AND CYSTS;;VAN DER KNAAP DISEASE	1.336812851	66.84064255
D-2-HYDROXYGLUTARIC ACIDURIA 1	1.3112836330000002	65.56418165000001
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.3055556	65.27777999999999
3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	1.1	55.00000000000001
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	1.0858974	54.294869999999996
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	1.0833333	54.166665
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	1.0819398	54.09699
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	1.0683441530000002	53.41720765000001
#257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME	1.0566039500000002	52.83019750000001
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	1.054812582	52.7406291
ABLEPHARON-MACROSTOMIA SYNDROME	1.0434783	52.173915
#609242 KANZAKI DISEASE;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, TYPE II;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, ADULT-ONSET;;NAGA DEFICIENCY, TYPE II;;SCHINDLER DISEASE, TYPE II	1.02276726	51.138363
TRANSSEXUALITY	1.0188679	50.943395
MOWAT-WILSON SYNDROME; MOWS	1.018788611	50.93943055
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	1.0182538529999998	50.91269264999999
#133540 COCKAYNE SYNDROME, TYPE B; CSB;;CKN2	1.014687861	50.73439305
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	1.014527833	50.726391650000004
MEVALONIC ACIDURIA; MEVA	1.013772082	50.6886041
HAMAMY SYNDROME; HMMS	1.00970874	50.485437
WOLMAN DISEASE WITH HYPOLIPOPROTEINEMIA AND ACANTHOCYTOSIS	1.00724638	50.362319
FRONTONASAL DYSPLASIA 1; FND1	1.00704225	50.352112500000004
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	1.004428112	50.221405600000004
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	1.00440529	50.2202645
SPLENOPORTAL VASCULAR ANOMALIES	1.00440529	50.2202645
WILSON DISEASE	1.00280899	50.140449499999995
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	1.00280899	50.140449499999995
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	1.0025641	50.128205
PERIPHERAL NEUROPATHY, ATAXIA, FOCAL NECROTIZING ENCEPHALOPATHY, AND	1.0025641	50.128205
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	1.001759633	50.08798165
HYDROXYKYNURENINURIA	1.000843882	50.0421941
PORTAL VEIN, CAVERNOUS TRANSFORMATION OF	1.0	50.0
HEPATOCELLULAR CARCINOMA	1.0	50.0
#615207 IL21R IMMUNODEFICIENCY	1.0	50.0
DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION; DFNA34	1.0	50.0
PHEOCHROMOCYTOMA	1.0	50.0
AGENESIS OF CEREBRAL WHITE MATTER	1.0	50.0
PHEOCHROMOCYTOMA--ISLET CELL TUMOR SYNDROME	1.0	50.0
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.9484125999999999	47.420629999999996
#225750 AICARDI-GOUTIERES SYNDROME 1; AGS1;;AGS;;ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATIONAND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS;;CREE ENCEPHALITIS;;PSEUDOTOXOPLASMOSIS SYNDROMEAICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT, INCLUDED	0.883141443	44.15707215
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1	0.8600871099999999	43.004355499999996
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.765549782	38.277489100000004
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.6388886	31.94443
HALOTHANE HEPATITIS	0.6147059	30.735295
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.614527833	30.72639165
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.6119618900000001	30.598094500000006
#307200 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III; IGHD3;;IGHD III;;GROWTH HORMONE DEFICIENCY WITH HYPOGAMMAGLOBULINEMIA;;HYPOGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;AGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;FLEISHER SYNDROME	0.6	30.0
#300755 AGAMMAGLOBULINEMIA, X-LINKED; XLA;;BRUTON-TYPE AGAMMAGLOBULINEMIA;;AGAMMAGLOBULINEMIA, X-LINKED, TYPE 1; AGMX1;;IMMUNODEFICIENCY 1; IMD1HYPOGAMMAGLOBULINEMIA, X-LINKED, INCLUDED	0.6	30.0
BARE LYMPHOCYTE SYNDROME, TYPE II	0.6	30.0
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.5896218409999999	29.481092049999997
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.5864633810000001	29.323169050000004
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.58425917	29.212958500000003
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.583333	29.16665
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.583333	29.16665
THROMBOCYTOPENIA 1	0.583333	29.16665
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.5689316000000001	28.446580000000004
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.56498956	28.249478
COMBINED SAPOSIN DEFICIENCY	0.54645102	27.322551
#612951 LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	0.545966451	27.298322549999998
TRICHOHEPATOENTERIC SYNDROME 1	0.54276726	27.138363
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.539231002	26.961550099999997
#121200 SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1EPILEPSY, BENIGN NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED;;SEIZURES, BENIGN FAMILIAL NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED	0.537771982	26.8885991
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.5357143	26.785715
Congenital disorder of glycosylation, type IIh	0.535096382	26.7548191
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	0.533438773	26.671938649999998
AICARDI-GOUTIERES SYNDROME 5	0.529781502	26.489075099999997
EPILEPSY, BENIGN NEONATAL, 2	0.5147059	25.735295
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 1	0.51008711	25.5043555
#614265 COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA	0.508090262	25.4045131
MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	0.50680272	25.340136
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.5045686229999999	25.22843115
IMMUNODEFICIENCY 36; IMD36	0.50440529	25.2202645
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.50280899	25.1404495
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.5017596329999999	25.087981649999996
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	0.5017596329999999	25.087981649999996
#603285 CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3	0.500915751	25.04578755
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.500915751	25.04578755
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.500915751	25.04578755
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.500843882	25.0421941
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.5	25.0
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	25.0
BRANCHIOOTORENAL SYNDROME 1	0.5	25.0
247150 LIP PRINTS	0.5	25.0
PHLEBECTASIA OF LIPS	0.5	25.0
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.5	25.0
IMMUNE DEFICIENCY DISEASE	0.5	25.0
PYLORIC STENOSIS, INFANTILE HYPERTROPHIC 1	0.5	25.0
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.49956068200000003	24.978034100000002
#604403 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2; GEFSP2;;GEFS+, TYPE 2; GEFS+2FEBRILE SEIZURES, FAMILIAL, 3A, INCLUDED; FEB3A, INCLUDED	0.46636890000000003	23.318445
CENTRALOPATHIC EPILEPSY	0.4484126	22.42063
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.44841259999999994	22.420629999999996
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.44841259999999994	22.420629999999996
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.42204009000000003	21.102004500000003
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.39772848199999994	19.886424099999996
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.39640542100000004	19.820271050000002
#230600 GM1-GANGLIOSIDOSIS, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, JUVENILE TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 2GANGLIOSIDOSIS, GENERALIZED GM1, LATE-INFANTILE TYPE, INCLUDED	0.38940120000000006	19.470060000000004
PSEUDOXANTHOMA ELASTICUM; PXE	0.38361402	19.180701
#605751 SEIZURES, BENIGN FAMILIAL INFANTILE, 2; BFIS2;;CONVULSIONS, BENIGN FAMILIAL INFANTILE, 2; BFIC2	0.3824787	19.123935
#602066 CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS;ICCA;;INFANTILE CONVULSIONS AND PAROXYSMAL CHOREOATHETOSIS, FAMILIAL;;ICCA SYNDROME;;PAROXYSMAL KINESIGENIC DYSKINESIA WITH INFANTILE CONVULSIONS; PKD/IC	0.3824787	19.123935
#267000 PERLMAN SYNDROME; PRLMNS;;RENAL HAMARTOMAS, NEPHROBLASTOMATOSIS, AND FETAL GIGANTISM;;NEPHROBLASTOMATOSIS, FETAL ASCITES, MACROSOMIA, AND WILMS TUMOR	0.379680632	18.9840316
EPILEPSY, JUVENILE ABSENCE	0.3752738	18.76369
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.3752738	18.76369
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.37227752199999997	18.6138761
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.372024453	18.60122265
AICARDI SYNDROME; AIC	0.3704545	18.522725
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.36383518	18.191758999999998
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.3613516	18.06758
#607682 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 9; EIG9EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 6, INCLUDED; EJM6,INCLUDED	0.3596488	17.98244
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.349801882	17.4900941
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.3480389	17.401944999999998
PROPIONIC ACIDEMIA	0.34802083300000003	17.40104165
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.346419832	17.3209916
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.34557594999999997	17.2787975
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.341619382	17.0809691
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.341495131	17.07475655
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.341495131	17.07475655
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.3407851720000001	17.039258600000004
AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL	0.33901482	16.950741
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.33509263300000003	16.75463165
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.33509263300000003	16.75463165
ALSTROM SYNDROME; ALMS	0.334569702	16.7284851
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.334248751	16.71243755
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.334248751	16.71243755
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.334248751	16.71243755
#300860 MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 30; MRXS30	0.334248751	16.71243755
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.333333	16.66665
GRANGE SYNDROME; GRNG	0.333333	16.66665
DANDY-WALKER SYNDROME	0.333333	16.66665
#163950 NOONAN SYNDROME 1; NS1;;NOONAN SYNDROME;;MALE TURNER SYNDROME;;FEMALE PSEUDO-TURNER SYNDROME;;TURNER PHENOTYPE WITH NORMAL KARYOTYPEPTERYGIUM COLLI SYNDROME, INCLUDED	0.333333	16.66665
PARAGANGLIOMAS 3	0.333333	16.66665
PARAGANGLIOMAS 1	0.333333	16.66665
#608709 LIPODYSTROPHY, PARTIAL, ACQUIRED, SUSCEPTIBILITY TO; APLD;;APLD, SUSCEPTIBILITY TO;;BARRAQUER-SIMONS SYNDROME;;LIPODYSTROPHY, CEPHALOTHORACIC TYPE;;LIPODYSTROPHY, PARTIAL, PROGRESSIVE	0.333333	16.66665
PSEUDO-VON WILLEBRAND DISEASE	0.333333	16.66665
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6	0.333333	16.66665
PARAGANGLIOMAS 4	0.333333	16.66665
Microangiopathy and leukoencephalopathy, pontine, autosomal dominant	0.333333	16.66665
IMMUNODEFICIENCY 46; IMD46	0.333333	16.66665
DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY	0.333333	16.66665
FIBROMUSCULAR DYSPLASIA OF ARTERIES	0.333333	16.66665
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.333333	16.66665
#607208 DRAVET SYNDROME;;EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6;;SEVERE MYOCLONIC EPILEPSY OF INFANCY; SMEI	0.330641882	16.5320941
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.326571951	16.32859755
TUBEROUS SCLEROSIS	0.32591575100000003	16.29578755
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.30439123300000004	15.219561650000003
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.30378898200000004	15.189449100000003
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.290631452	14.5315726
GLUTAMINE DEFICIENCY, CONGENITAL	0.28655128100000005	14.327564050000003
MYASTHENIA GRAVIS; MG	0.28614229	14.3071145
#602398 DESMOSTEROLOSIS	0.285309733	14.26548665
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.27413986	13.706993
#252011 MITOCHONDRIAL COMPLEX II DEFICIENCY;;SUCCINATE CoQ REDUCTASE DEFICIENCY	0.27262255100000005	13.631127550000002
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.269005983	13.45029915
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.26196373300000003	13.098186650000002
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.26093099200000003	13.046549600000002
INFANTILE LIVER FAILURE SYNDROME 2	0.258162131	12.908106550000001
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2	0.25568182	12.784091
Pontine tegmental cap dysplasia	0.255343863	12.76719315
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.254499981	12.72499905
CEPHALIN LIPIDOSIS	0.25408163	12.704081500000001
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.25280899	12.6404495
DYSTONIA 6, TORSION	0.25280899	12.6404495
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.250915751	12.545787550000002
LOWE OCULOCEREBRORENAL SYNDROME	0.250915751	12.545787550000002
#614379 COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD ;;C4B DEFICIENCY	0.25	12.5
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	12.5
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.25	12.5
HYPEREKPLEXIA 1; HKPX1	0.25	12.5
118900 CIRRHOSIS, FAMILIAL	0.25	12.5
#300367 THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA;XLTDA	0.25	12.5
#215400 CHORDOMA, SUSCEPTIBILITY TO; CHDM	0.25	12.5
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.25	12.5
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.25	12.5
PATENT DUCTUS VENOSUS	0.25	12.5
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	12.5
CEROID STORAGE DISEASE	0.25	12.5
HYPERPARATHYROIDISM 2	0.25	12.5
TUFTSIN DEFICIENCY	0.25	12.5
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.25	12.5
#604364 EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI; FFEVF;;EPILEPSY, PARTIAL, WITH VARIABLE FOCI; FPEVF	0.25	12.5
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.23552298200000002	11.776149100000001
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.2244281	11.221404999999999
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.2244281	11.221404999999999
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.2244281	11.221404999999999
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.2244281	11.221404999999999
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.2244281	11.221404999999999
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.221422222	11.0711111
LATHOSTEROLOSIS	0.21758275100000002	10.879137550000001
PHELAN-MCDERMID SYNDROME; PHMDS	0.216988633	10.84943165
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.20860835100000003	10.430417550000001
#603387 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME;MPPH;;MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME;;MEG-PMG-MEGACC SYNDROME;;MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT	0.20534386300000002	10.26719315
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1	0.20440529000000002	10.2202645
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.20412282199999998	10.2061411
CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE	0.20256410000000002	10.128205000000001
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.20213734099999997	10.106867049999998
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.20175963300000002	10.087981650000001
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.200915751	10.04578755
COHEN SYNDROME	0.200915751	10.04578755
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.200843882	10.0421941
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.200843882	10.0421941
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4	0.2	10.0
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	0.192302043	9.61510215
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.19133394299999998	9.56669715
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.190895181	9.54475905
PEHO-LIKE SYNDROME; PEHOL	0.189963012	9.498150599999999
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.18266586	9.133293
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.182143382	9.1071691
#613863 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 7; GEFSP7;;GEFS+, TYPE 7; GEFS+7FEBRILE SEIZURES, FAMILIAL, 3B, INCLUDED; FEB3B, INCLUDED	0.1812995	9.064975
ADAMS-OLIVER SYNDROME 1; AOS1	0.17881358300000003	8.940679150000001
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.178205013	8.91025065
NIEMANN-PICK DISEASE, TYPE C2	0.178205013	8.91025065
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.17718612	8.859306
#615369 EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC	0.177157222	8.857861100000001
PEHO SYNDROME; PEHO	0.17201086299999999	8.60054315
PYRUVATE CARBOXYLASE DEFICIENCY	0.168426633	8.421331649999999
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.168426633	8.421331649999999
GLUTARIC ACIDEMIA I; GA1	0.167582751	8.37913755
COFFIN-SIRIS SYNDROME 6; CSS6	0.167510882	8.3755441
#613112 MACROTHROMBOCYTOPENIA, AUTOSOMAL DOMINANT, TUBB1-RELATED	0.166667	8.333350000000001
#215140 GREENBERG DYSPLASIA; GRBGD;;HYDROPS-ECTOPIC CALCIFICATION-MOTH-EATEN SKELETAL DYSPLASIA;;HEM SKELETAL DYSPLASIA;;MOTH-EATEN SKELETAL DYSPLASIA;;CHONDRODYSTROPHY, HYDROPIC AND PRENATALLY LETHAL TYPE	0.166667	8.333350000000001
#600208 MACROTHROMBOCYTOPENIA AND PROGRESSIVE SENSORINEURAL DEAFNESS	0.166667	8.333350000000001
BLEEDING DISORDER, PLATELET-TYPE, 16; BDPLT16	0.166667	8.333350000000001
BLEEDING DISORDER, PLATELET-TYPE, 19; BDPLT19	0.166667	8.333350000000001
CHROMOSOME 1P36 DELETION SYNDROME	0.160641913	8.03209565
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.15390498199999997	7.695249099999998
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.152868172	7.6434086
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.14852299	7.426149499999999
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.147006533	7.3503266499999995
GLYCEROL KINASE DEFICIENCY; GKD	0.14461663299999997	7.230831649999998
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.14394119	7.1970595
#613722 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 12; EIEE12	0.1433483	7.167415000000001
DUBOWITZ SYNDROME	0.14285699999999998	7.142849999999999
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.14175584100000002	7.087792050000001
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.1405258	7.02629
#615473 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17; EIEE17	0.140297712	7.0148855999999995
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.14006922	7.003461
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.13952911199999998	6.9764555999999995
219400 CYANOSIS AND HEPATIC DISEASE	0.1357143	6.785715000000001
#613060 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 10; EIG10GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 5, SUSCEPTIBILITYTO, INCLUDED; GEFS5, INCLUDED;;GEFS+, TYPE 5, SUSCEPTIBILITY TO, INCLUDED;;GEFS+5, SUSCEPTIBILITY TO, INCLUDED;;GEFSP5, SUSCEPTIBILITY TO, INCLUDED;;EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 7, INCLUDED; EJM7,INCLUDED	0.1344245	6.7212250000000004
#604213 CHUDLEY-MCCULLOUGH SYNDROME; CMCS;;DEAFNESS, SENSORINEURAL, WITH PARTIAL AGENESIS OF THE CORPUS CALLOSUMAND ARACHNOID CYSTS;;DEAFNESS, AUTOSOMAL RECESSIVE 82; DFNB82	0.13328778100000002	6.664389050000001
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIx;;CDG-x	0.129997381	6.49986905
TUBEROUS SCLEROSIS 2; TSC2	0.125915751	6.29578755
#604233 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1; GEFSP1;;GEFS+, TYPE 1; GEFS+1	0.1257439	6.287195
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.124621051	6.23105255
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.12164170300000003	6.082085150000002
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.12029108200000001	6.014554100000001
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.12025952200000001	6.0129761
KRABBE DISEASE	0.11998677099999999	5.999338549999999
MUCOLIPIDOSIS IV; ML4	0.11989148200000002	5.994574100000001
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.119875613	5.993780650000001
#222448 DONNAI-BARROW SYNDROME;;FACIOOCULOACOUSTICORENAL SYNDROME;;DBS/FOAR SYNDROME;;DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM,MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA	0.11864273300000001	5.93213665
#236792 L-2-HYDROXYGLUTARIC ACIDURIA;;L-2-HYDROXYGLUTARIC ACIDEMIA	0.117213591	5.86067955
COFFIN-SIRIS SYNDROME 2; CSS2	0.11509293300000001	5.754646650000001
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.11441084300000001	5.720542150000001
#604367 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3; FPLD3;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PPARG MUTATIONS	0.11402882	5.701441
HEART AND BRAIN MALFORMATION SYNDROME	0.113915263	5.69576315
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.1130708	5.65354
WITTEVEEN-KOLK SYNDROME	0.11171920300000002	5.585960150000001
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.11091769	5.5458845
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.10920595100000001	5.460297550000001
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.10818720000000001	5.40936
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.10690448200000001	5.3452241
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	0.10652570200000001	5.326285100000001
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.10568182000000001	5.284091
WHITE-SUTTON SYNDROME; WHSUS	0.104428112	5.2214056
DEHYDRATED HEREDITARY STOMATOCYTOSIS 1 WITH OR WITHOUT PSEUDOHYPERKALEMIA AND/OR PERINATAL EDEMA; DHS1	0.10440529000000001	5.220264500000001
#613812 BILE ACID SYNTHESIS DEFECT, CONGENITAL, 3; CBAS3	0.10440529000000001	5.220264500000001
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.10430439100000001	5.2152195500000005
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.10347985100000001	5.17399255
JOUBERT SYNDROME 2	0.10340798200000001	5.170399100000001
JOUBERT SYNDROME 7	0.10340798200000001	5.170399100000001
#611943 RIDDLE SYNDROME;;RADIOSENSITIVITY, IMMUNODEFICIENCY, DYSMORPHIC FEATURES, AND LEARNINGDIFFICULTIES	0.1025641	5.128205
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.10177925100000002	5.088962550000001
COFFIN-SIRIS SYNDROME 4; CSS4	0.10175963300000002	5.087981650000001
COFFIN-SIRIS SYNDROME 3; CSS3	0.10175963300000002	5.087981650000001
#262600 PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2;;PANHYPOPITUITARISM;;ATELIOTIC DWARFISM WITH HYPOGONADISM;;PITUITARY DWARFISM III;;HANHART DWARFISM	0.10091575100000001	5.045787550000001
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.10091575100000001	5.045787550000001
IMMUNODEFICIENCY 37; IMD37	0.10091575100000001	5.045787550000001
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.10091575100000001	5.045787550000001
TARP SYNDROME; TARPS	0.10084388200000001	5.042194100000001
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.10084388200000001	5.042194100000001
#609528 CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMASYNDROME;;CEDNIK SYNDROME	0.10084388200000001	5.042194100000001
DYSTONIA, JUVENILE-ONSET	0.1	5.0
PANENCEPHALITIS, SUBACUTE SCLEROSING	0.1	5.0
HEPATITIS B VACCINE, RESPONSE TO	0.1	5.0
#613783 COMPLEMENT COMPONENT C1s DEFICIENCY; C1SD;;C1s DEFICIENCY	0.1	5.0
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.1	5.0
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.1	5.0
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.1	5.0
TRICHOHEPATOENTERIC SYNDROME 2	0.1	5.0
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.1	5.0
SECKEL SYNDROME 2; SCKL2	0.1	5.0
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.1	5.0
#256450 HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1;;PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PHHI;;HYPOGLYCEMIA, HYPERINSULINEMIC, OF INFANCY;;HYPERINSULINEMIC HYPOGLYCEMIA DUE TO FOCAL ADENOMATOUS HYPERPLASIA;;NESIDIOBLASTOSIS OF PANCREAS;;HYPERINSULINISM, FAMILIAL, WITH PANCREATIC NESIDIOBLASTOSIS;;HYPERINSULINISM, CONGENITAL	0.1	5.0
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.1	5.0
#614921 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It; CDG1T;;CDG It; CDGIt;;PHOSPHOGLUCOMUTASE 1 DEFICIENCY;;PGM1 DEFICIENCY;;GLYCOGEN STORAGE DISEASE XIV; GSD14;;GSD XIV	0.1	5.0
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.1	5.0
MEIER-GORLIN SYNDROME 5; MGORS5	0.1	5.0
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.1	5.0
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.1	5.0
COACH SYNDROME	0.098865043	4.94325215
#193300 VON HIPPEL-LINDAU SYNDROME; VHLVON HIPPEL-LINDAU SYNDROME, MODIFIERS OF, INCLUDED	0.09771182	4.885591
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.09761066300000001	4.880533150000001
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.096634882	4.8317441
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.09642013200000002	4.821006600000001
SITOSTEROLEMIA	0.09531439000000001	4.7657195
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.09499073000000001	4.7495365000000005
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.094246682	4.7123341
#614018 EPILEPSY, PROGRESSIVE MYOCLONIC, 6; EPM6	0.09418889	4.7094445
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.09409702100000002	4.704851050000001
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.09361114200000002	4.6805571000000015
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.093208312	4.6604156
#276710 TYROSINEMIA, TYPE III; TYRSN3;;4-@HYDROXYPHENYLPYRUVIC ACID OXIDASE DEFICIENCY;;4-@HYDROXYPHENYLPYRUVATE DIOXYGENASE DEFICIENCY	0.09182485100000001	4.5912425500000005
EVEN-PLUS SYNDROME	0.09121943200000002	4.560971600000001
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.0909091	4.5454550000000005
ATRANSFERRINEMIA	0.0909091	4.5454550000000005
RCAD (renal cysts and diabetes)	0.0909091	4.5454550000000005
FIBROSCLEROSIS, MULTIFOCAL	0.0909091	4.5454550000000005
HYPERVITAMINOSIS A, SUSCEPTIBILITY TO	0.0909091	4.5454550000000005
MENTAL RETARDATION, X-LINKED 98; MRX98	0.088941933	4.44709665
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.08867716300000002	4.433858150000001
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.08867716300000002	4.433858150000001
RHEUMATOID ARTHRITIS	0.08791550000000001	4.395775
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.08701021	4.3505105
#613162 SPASTIC PARAPLEGIA 45, AUTOSOMAL RECESSIVE; SPG45	0.08691753	4.3458765
CANAVAN DISEASE	0.08663184000000002	4.3315920000000006
#615268 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME4; CAMRQ4;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 4	0.08614229000000001	4.307114500000001
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.085598651	4.27993255
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.08541391000000001	4.2706955
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.08509293300000002	4.2546466500000015
CAROLI DISEASE, ISOLATED	0.08427718	4.213858999999999
JOUBERT SYNDROME 23; JBTS23	0.08417718200000002	4.208859100000001
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.08385746	4.192873
#615703 MORBID OBESITY AND SPERMATOGENIC FAILURE; MOSPGF	0.08372582	4.186291000000001
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.08372582	4.186291000000001
601016 MIDLINE MALFORMATIONS, MULTIPLE, WITH LIMB ABNORMALITIES AND HYPOPITUITARISM;;DINCSOY SYNDROME	0.08333330000000001	4.166665000000001
TANGIER DISEASE; TGD	0.08132839000000001	4.0664195
NIEMANN-PICK DISEASE, TYPE B	0.08132839000000001	4.0664195
#612437 EPILEPSY, PROGRESSIVE MYOCLONIC 1B; EPM1B	0.08093399	4.0466995
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.0804656	4.02328
260570 PELGER-HUET-LIKE ANOMALY AND EPISODIC FEVER WITH ABDOMINAL PAIN	0.079832	3.9916
LISSENCEPHALY, X-LINKED, 2	0.079820401	3.99102005
MCLEOD SYNDROME; MCLDS	0.07973209	3.9866045000000003
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.07971867099999999	3.9859335499999995
MYOCLONUS AND ATAXIA	0.07948720000000001	3.9743600000000003
ACROCALLOSAL SYNDROME; ACLS	0.07938660100000001	3.969330050000001
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.0788689	3.943445
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.078688741	3.9344370500000005
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.07837063	3.9185315
POTOCKI-LUPSKI SYNDROME	0.077818963	3.8909481500000003
LISSENCEPHALY 2; LIS2	0.07776698200000001	3.8883491000000006
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.07746378200000001	3.8731891000000003
HYPOALPHALIPOPROTEINEMIA, PRIMARY	0.07692310000000001	3.8461550000000004
LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY	0.07692310000000001	3.8461550000000004
ATHEROSCLEROSIS SUSCEPTIBILITY	0.07692310000000001	3.8461550000000004
#605814 CITRULLINEMIA, TYPE II, NEONATAL-ONSET;;CHOLESTASIS, NEONATAL INTRAHEPATIC, CAUSED BY CITRIN DEFICIENCY; NICCD	0.07692310000000001	3.8461550000000004
#615604 L-FERRITIN DEFICIENCY; LFTD	0.07692310000000001	3.8461550000000004
HYPERLIPOPROTEINEMIA, TYPE V	0.07692310000000001	3.8461550000000004
FISH-EYE DISEASE	0.07692310000000001	3.8461550000000004
Polyarteritis nodosa, childhood-onset	0.07609700999999999	3.8048504999999997
MICROHYDRANENCEPHALY; MHAC	0.07529885	3.7649425
LISSENCEPHALY 5; LIS5	0.074652351	3.7326175500000005
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.0744235	3.721175
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.07405635100000002	3.702817550000001
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.07318823300000002	3.659411650000001
MYELOPEROXIDASE DEFICIENCY	0.07312923000000002	3.6564615000000007
#191900 MUCKLE-WELLS SYNDROME; MWS;;URTICARIA-DEAFNESS-AMYLOIDOSIS SYNDROME;;UDA SYNDROME;;CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME 2; CAPS2	0.0728901	3.644505
#613150 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 2; MDDGA2;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED	0.07234435100000002	3.617217550000001
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.07234435100000002	3.617217550000001
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.07227248200000001	3.6136241000000004
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.07186239999999999	3.59312
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.07142860000000001	3.5714300000000003
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.07142860000000001	3.5714300000000003
#201000 CARPENTER SYNDROME 1; CRPT1;;CARPENTER SYNDROME;;ACROCEPHALOPOLYSYNDACTYLY TYPE II;;ACPS II	0.07142860000000001	3.5714300000000003
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.07079194200000001	3.5395971000000004
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.070277153	3.51385765
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.0702615	3.513075
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.069952081	3.49760405
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.06946939	3.4734695
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.06938421200000001	3.4692106000000007
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.068845063	3.44225315
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.068367151	3.41835755
WILLIAMS-BEUREN SYNDROME; WBS	0.06775502	3.3877509999999997
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA	0.06690529	3.3452645000000003
RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD	0.06690529	3.3452645000000003
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V; ALPS5	0.06690529	3.3452645000000003
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS3	0.06690529	3.3452645000000003
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.06690529	3.3452645000000003
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.06690529	3.3452645000000003
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.06683997	3.3419985
#230650 GM1-GANGLIOSIDOSIS, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, ADULT TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, CHRONIC TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 3	0.0660173	3.300865
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.065874981	3.2937490499999997
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	0.065166013	3.25830065
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.065092933	3.25464665
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.064505471	3.22527355
KABUKI SYNDROME 1	0.06425963300000001	3.2129816500000006
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.06424905100000002	3.212452550000001
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.064177182	3.2088590999999997
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.064163	3.20815
COFFIN-SIRIS SYNDROME 1; CSS1	0.06413166299999999	3.2065831499999997
Growth hormone deficiency, isolated, type IA	0.0636363	3.1818150000000003
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.063343882	3.1671941
#154780 MARSHALL SYNDROME; MRSHS	0.06333330000000001	3.1666650000000005
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.06333330000000001	3.1666650000000005
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.06333330000000001	3.1666650000000005
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.06324389999999999	3.1621949999999996
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.06324389999999999	3.1621949999999996
ANTIPHOSPHOLIPID SYNDROME, FAMILIAL	0.0625	3.125
SPASTIC PARAPLEGIA AND EVANS SYNDROME	0.0625	3.125
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 4	0.0625	3.125
CERVICAL RIBS, SPRENGEL ANOMALY, ANAL ATRESIA, AND URETHRAL OBSTRUCTION	0.0625	3.125
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.0625	3.125
IMMUNODEFICIENCY 62; IMD62	0.0625	3.125
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.0625	3.125
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.062260922999999996	3.1130461499999997
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.062152282999999996	3.10761415
YUNIS-VARON SYNDROME	0.061987350000000004	3.0993675
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.061128932000000004	3.0564466
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.060547433	3.02737165
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.060232323	3.01161615
#254770 EPILEPSY, MYOCLONIC JUVENILE; EJM;;MYOCLONIC EPILEPSY, JUVENILE; JME;;PETIT MAL, IMPULSIVE;;JANZ SYNDROMEMYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 1, INCLUDED; EJM1,INCLUDED	0.0598896	2.9944800000000003
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.059703551	2.98517755
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.059139830000000004	2.9569915
POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4	0.05882701	2.9413505
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.058608051	2.93040255
CYCLIC NEUTROPENIA	0.058184200000000005	2.9092100000000003
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.057975112	2.8987556000000003
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0573294	2.86647
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.057209731	2.86048655
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.057131581	2.85657905
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.056955333	2.8477666499999996
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.056715352999999996	2.8357676499999998
EPILEPSY, IDIOPATHIC GENERALIZED	0.0566467	2.832335
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.056399482	2.8199741
YOU-HOOVER-FONG SYNDROME; YHFS	0.056039582	2.8019791
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.055788572	2.7894286
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.055781131	2.7890565499999997
#300491 EPILEPSY, X-LINKED, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIORDISORDERS	0.055555600000000004	2.7777800000000004
#300643 ROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, X-LINKED;RESDX	0.055555600000000004	2.7777800000000004
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.055555600000000004	2.7777800000000004
CHROMOSOME 17q12 DELETION SYNDROME	0.055555600000000004	2.7777800000000004
APNEA, OBSTRUCTIVE SLEEP	0.055555600000000004	2.7777800000000004
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.055555600000000004	2.7777800000000004
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.055343863	2.76719315
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.055343863	2.76719315
#616341 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30; EIEE30	0.054864882000000004	2.7432441
ATYPICAL MYCOBACTERIOSIS, FAMILIAL	0.054825490000000004	2.7412745000000003
#601277 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A;;ICHTHYOSIS CONGENITA IIB; ICR2B;;ICHTHYOSIS, LAMELLAR, 2, FORMERLY; LI2, FORMERLY	0.054582200000000004	2.7291100000000004
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.054568623000000004	2.72843115
#221820 LEUKOENCEPHALOPATHY, DIFFUSE HEREDITARY, WITH SPHEROIDS; HDLS;;LEUKOENCEPHALOPATHY WITH NEUROAXONAL SPHEROIDS, AUTOSOMAL DOMINANT;;GLIOSIS, FAMILIAL PROGRESSIVE SUBCORTICAL; GPSC;;DEMENTIA, FAMILIAL, NEUMANN TYPE;;SUBCORTICAL GLIOSIS OF NEUMANN	0.0545058	2.72529
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.0545058	2.72529
#604360 SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, WITH MENTAL IMPAIRMENT ANDTHIN CORPUS CALLOSUM;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, COMPLICATED, WITH THIN CORPUSCALLOSUM;;HSP-TCC	0.05446107	2.7230535
EPILEPSY, PYRIDOXINE-DEPENDENT	0.054124312	2.7062156
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0535793	2.6789650000000003
#275350 TRANSCOBALAMIN II DEFICIENCY;;TC II DEFICIENCY;;TCN2 DEFICIENCY	0.05328878000000001	2.6644390000000002
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.052738863	2.63694315
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.052636472999999996	2.63182365
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.0526316	2.63158
PORTAL HYPERTENSION, NONCIRRHOTIC	0.05202429	2.6012145
SCLEROSING CHOLANGITIS, NEONATAL	0.05202429	2.6012145
HARDIKAR SYNDROME	0.05202429	2.6012145
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.051395181	2.56975905
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.051372801999999995	2.5686400999999996
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.050843882	2.5421941
OGDEN SYNDROME; OGDNS	0.050843882	2.5421941
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.050601781	2.53008905
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.050297633	2.51488165
CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2	0.0501831	2.5091550000000002
NASODIGITOACOUSTIC SYNDROME	0.05	2.5
DIAMOND-BLACKFAN ANEMIA 8	0.05	2.5
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.05	2.5
226440 EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTALRETARDATION	0.05	2.5
KEIPERT SYNDROME; KPTS	0.05	2.5
#186500 MULTIPLE SYNOSTOSES SYNDROME 1; SYNS1;;SYNOSTOSES, MULTIPLE, WITH BRACHYDACTYLY;;SYMPHALANGISM-BRACHYDACTYLY SYNDROME;;WL SYNDROME;;DEAFNESS-SYMPHALANGISM SYNDROME OF HERRMANN;;FACIOAUDIOSYMPHALANGISM SYNDROME	0.05	2.5
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.049778233	2.48891165
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.049718041000000004	2.4859020500000004
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.049378633000000005	2.46893165
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.049264891000000005	2.46324455
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.04903873	2.4519365
FEBRILE CONVULSIONS, FAMILIAL, 9	0.048538	2.4269
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.048538	2.4269
RETT SYNDROME, CONGENITAL VARIANT	0.048222321	2.41111605
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.048039200000000004	2.4019600000000003
RAGWEED SENSITIVITY	0.048039200000000004	2.4019600000000003
#604901 NORTH AMERICAN INDIAN CHILDHOOD CIRRHOSIS; NAIC	0.047619	2.38095
#267010 MECKEL SYNDROME, TYPE 7; MKS7;;RENAL-HEPATIC-PANCREATIC DYSPLASIA WITH DANDY-WALKER CYST;;GOLDSTON SYNDROME	0.047619	2.38095
#615506 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 5; HHT5	0.047619	2.38095
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 4	0.047619	2.38095
GLYCOGEN STORAGE DISEASE IV	0.047619	2.38095
ADAMS-OLIVER SYNDROME 6; AOS6	0.047619	2.38095
#610829 HOLOPROSENCEPHALY 9; HPE9;;PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;;HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES	0.047214133	2.36070665
#117550 SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5q35 DELETION SYNDROME	0.047214133	2.36070665
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.04720275299999999	2.3601376499999995
HYPOADRENOCORTICISM, FAMILIAL	0.046623631	2.33118155
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.046394790000000005	2.3197395000000003
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.046370251	2.31851255
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.046370251	2.31851255
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.046298382	2.3149191
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.046298382	2.3149191
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.046298382	2.3149191
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.04628729	2.3143645
#272200 MULTIPLE SULFATASE DEFICIENCY; MSD;;MUCOSULFATIDOSIS;;SULFATIDOSIS, JUVENILE, AUSTIN TYPE	0.046274772	2.3137385999999998
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.045770471	2.28852355
#615033 SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54	0.045698602000000005	2.2849301000000004
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.045593773	2.2796886499999998
MENTAL RETARDATION, BUENOS AIRES TYPE	0.0454545	2.272725
#607196 MICROCEPHALY, AMISH TYPE; MCPHA;;AMISH LETHAL MICROCEPHALY;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 3 (MICROCEPHALY TYPE); THMD3	0.0454545	2.272725
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.0454545	2.272725
GABRIELE-DE VRIES SYNDROME; GADEVS	0.045427181999999997	2.2713590999999997
SMITH-MAGENIS SYNDROME; SMS	0.045297033	2.26485165
#613721 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11	0.045287282	2.2643641
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.045007692999999994	2.2503846499999995
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.04494029	2.2470145
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.044914382	2.2457191
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.044851432999999996	2.24257165
ADENYLOSUCCINASE DEFICIENCY	0.04479993299999999	2.2399966499999997
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.04476559	2.2382795
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.044534652999999993	2.2267326499999998
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.044526903	2.2263451499999998
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.044322182	2.2161091
NAVAJO NEUROHEPATOPATHY	0.043987662	2.1993831
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.043956051	2.19780255
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.043805363	2.19026815
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.043771743	2.18858715
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.043478300000000004	2.173915
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.043478300000000004	2.173915
SHPRINTZEN OMPHALOCELE SYNDROME	0.043478300000000004	2.173915
MAL DE MELEDA	0.043478300000000004	2.173915
BLEPHAROCHALASIS AND DOUBLE LIP	0.043478300000000004	2.173915
LIP, HAMARTOMATOUS	0.043478300000000004	2.173915
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.043478300000000004	2.173915
LIP, MEDIAN NODULE OF UPPER	0.043478300000000004	2.173915
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.043478300000000004	2.173915
BAZEX SYNDROME; BZX	0.043478300000000004	2.173915
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.043478300000000004	2.173915
#148500 TYLOSIS WITH ESOPHAGEAL CANCER; TOC;;KERATOSIS PALMARIS ET PLANTARIS WITH ESOPHAGEAL CANCER	0.043478300000000004	2.173915
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.043478300000000004	2.173915
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.0434609	2.1730449999999997
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.043401881999999996	2.1700940999999996
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.042889612	2.1444806
MISMATCH REPAIR CANCER SYNDROME; MMRCS	0.042756550000000004	2.1378275
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.042573849999999996	2.1286924999999997
%123550 CRYOGLOBULINEMIA, FAMILIAL MIXED;;MELTZER SYNDROME	0.04251702	2.125851
MYELOCEREBELLAR DISORDER	0.04230491	2.1152455
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.042241022	2.1120511
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.042194881999999996	2.1097441
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.042186241	2.1093120499999998
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.042063353	2.10316765
SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63	0.04204573	2.1022865
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.041973863	2.09869315
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.041869482	2.0934741
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.041865582	2.0932790999999997
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.041865582	2.0932790999999997
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.04131735	2.0658675
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.041129981	2.05649905
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.040351572	2.0175786
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.040290122	2.0145060999999997
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.040290122	2.0145060999999997
GITELMAN SYNDROME	0.040138031000000005	2.0069015500000003
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.040022963	2.00114815
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.040022963	2.00114815
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.040022963	2.00114815
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.039998730999999996	1.9999365499999997
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.039959263	1.9979631500000001
FLOOD FACTOR DEFICIENCY	0.03979593000000001	1.9897965000000004
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.03979593000000001	1.9897965000000004
MACROCYTOSIS, FAMILIAL	0.03979593000000001	1.9897965000000004
COUMARIN RESISTANCE	0.03979593000000001	1.9897965000000004
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.03979593000000001	1.9897965000000004
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.03979593000000001	1.9897965000000004
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.03979593000000001	1.9897965000000004
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.03979593000000001	1.9897965000000004
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.03979593000000001	1.9897965000000004
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.03949891	1.9749455
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.039493481999999996	1.9746740999999999
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.03944624	1.972312
COWDEN SYNDROME 6; CWS6	0.039377251	1.96886255
COWDEN SYNDROME 5; CWS5	0.039377251	1.96886255
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.039359281999999995	1.9679640999999997
SILVER-RUSSELL SYNDROME; SRS	0.039305382	1.9652691
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.039305382	1.9652691
ARTERIES, ANOMALIES OF	0.0384615	1.923075
#608358 MYOPATHY, MYOSIN STORAGE;;MYOPATHY, HYALINE BODY, AUTOSOMAL DOMINANT	0.0384615	1.923075
WATSON SYNDROME	0.0384615	1.923075
THUMB DEFORMITY	0.0384615	1.923075
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0384615	1.923075
#206920 MICROPHTHALMIA WITH LIMB ANOMALIES;;WAARDENBURG ANOPHTHALMIA SYNDROME;;ANOPHTHALMIA-SYNDACTYLY;;OPHTHALMOACROMELIC SYNDROME; OAS	0.0384615	1.923075
ATROPHODERMA VERMICULATA; AVA	0.0384615	1.923075
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0384615	1.923075
ACRORENAL-MANDIBULAR SYNDROME	0.0384615	1.923075
PREPAPILLARY VASCULAR LOOPS	0.0384615	1.923075
VENULAR INSUFFICIENCY, SYSTEMIC	0.0384615	1.923075
#214700 DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1;;CHLORIDE DIARRHEA, CONGENITAL, FINNISH TYPE;;CHLORIDORRHEA, CONGENITAL	0.0384615	1.923075
MUSCULAR HYPERTONIA, LETHAL	0.0384615	1.923075
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.0384615	1.923075
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0384615	1.923075
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0384615	1.923075
HEMANGIOPERICYTOMA, MALIGNANT	0.0384615	1.923075
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0384615	1.923075
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.0384615	1.923075
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.0384615	1.923075
BETHLEM MYOPATHY 1	0.0384615	1.923075
#615182 COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD	0.038389633000000006	1.9194816500000003
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.038331972000000006	1.9165986000000004
CHANARIN-DORFMAN SYNDROME	0.038278400000000004	1.9139200000000003
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.038062849999999995	1.9031424999999997
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.037986682	1.8993341000000001
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.037971841	1.89859205
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.037959881	1.89799405
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.037835933	1.89179665
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.037545751	1.8772875500000001
#235400 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1;;AHUS, SUSCEPTIBILITY TO, 1HEMOLYTIC UREMIC SYNDROME, TYPICAL, INCLUDED	0.037540150999999994	1.8770075499999996
OCULODENTODIGITAL DYSPLASIA; ODDD	0.037538840999999996	1.8769420499999998
METACHROMATIC LEUKODYSTROPHY	0.037538840999999996	1.8769420499999998
PEROXISOME BIOGENESIS DISORDER 6B	0.037466971999999994	1.8733485999999997
#261000 INTRINSIC FACTOR DEFICIENCY; IFD;;PERNICIOUS ANEMIA, CONGENITAL, DUE TO DEFECT OF INTRINSIC FACTOR	0.037414930000000006	1.8707465000000003
BLOOD GROUP, DUFFY SYSTEM; FY	0.037414930000000006	1.8707465000000003
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.037414930000000006	1.8707465000000003
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.037320041	1.8660020499999999
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	0.037248711999999996	1.8624355999999997
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.03708468299999999	1.8542341499999997
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.0369281	1.8464049999999999
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.0369281	1.8464049999999999
#203400 CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY;;CMO I DEFICIENCY;;ALDOSTERONE DEFICIENCY I;;HYPERRENINEMIC HYPOALDOSTERONISM, FAMILIAL, 1; FHHA1A;;ALDOSTERONE DEFICIENCY DUE TO DEFECT IN STEROID 18-HYDROXYLASE;;18-@HYDROXYLASE DEFICIENCY;;STEROID 18-@HYDROXYLASE DEFICIENCY	0.03665818	1.832909
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.036630051000000004	1.8315025500000002
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.03662309	1.8311544999999998
CHROMOSOME Xp11.23-p11.22 DUPLICATION SYNDROME	0.0365199	1.825995
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.03649898099999999	1.8249490499999996
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.036438733	1.82193665
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.03621452	1.810726
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.03614229	1.8071145
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.03614229	1.8071145
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.035773232999999995	1.7886616499999997
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.035771620000000004	1.7885810000000002
ACETOPHENETIDIN SENSITIVITY	0.035714300000000004	1.7857150000000002
HEMOPOIETIC PROLIFERATION	0.035714300000000004	1.7857150000000002
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.035714300000000004	1.7857150000000002
METHANE PRODUCTION	0.035714300000000004	1.7857150000000002
BLUE DIAPER SYNDROME	0.035714300000000004	1.7857150000000002
ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS; ILVASC	0.035714300000000004	1.7857150000000002
MESOMELIA-SYNOSTOSES SYNDROME	0.035714300000000004	1.7857150000000002
%243600 JEJUNAL ATRESIA;;APPLE PEEL SYNDROME;;APPLE PEEL SMALL BOWEL SYNDROME; APSB	0.035714300000000004	1.7857150000000002
MYELOMA, MULTIPLE	0.035714300000000004	1.7857150000000002
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.035714300000000004	1.7857150000000002
AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION	0.035714300000000004	1.7857150000000002
AMYLOIDOSIS, FINNISH TYPE	0.035714300000000004	1.7857150000000002
TERATOMA, PINEAL	0.035714300000000004	1.7857150000000002
CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL RECESSIVE	0.035714300000000004	1.7857150000000002
EOSINOPHILOPENIA	0.035714300000000004	1.7857150000000002
HEMOGLOBIN, HIGH OXYGEN SATURATION OF	0.035714300000000004	1.7857150000000002
POLYPOSIS SYNDROME, HEREDITARY MIXED, 1	0.035714300000000004	1.7857150000000002
PARANA HARD-SKIN SYNDROME	0.035714300000000004	1.7857150000000002
GASTRIC SNEEZING	0.035714300000000004	1.7857150000000002
GALLBLADDER, AGENESIS OF	0.035714300000000004	1.7857150000000002
SULFHEMOGLOBINEMIA, CONGENITAL	0.035714300000000004	1.7857150000000002
FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 3	0.035714300000000004	1.7857150000000002
GIANT NEUTROPHIL LEUKOCYTES	0.035714300000000004	1.7857150000000002
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.035714300000000004	1.7857150000000002
LEUKOCYTE NUCLEAR APPENDAGES, HEREDITARY PREVALENCE OF	0.035714300000000004	1.7857150000000002
BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD	0.035714300000000004	1.7857150000000002
FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 2	0.035714300000000004	1.7857150000000002
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.035714300000000004	1.7857150000000002
PANCREATIC BETA CELL AGENESIS WITH NEONATAL DIABETES MELLITUS	0.035714300000000004	1.7857150000000002
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.035714300000000004	1.7857150000000002
SCLERODERMA, FAMILIAL PROGRESSIVE	0.035714300000000004	1.7857150000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.035655900000000004	1.7827950000000001
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.035573732999999996	1.7786866499999998
#611390 SPASTIC ATAXIA 3, AUTOSOMAL RECESSIVE; SPAX3;;AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY; ARSAL	0.035498749999999996	1.7749374999999998
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.035405602	1.7702801000000001
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.035398032999999995	1.7699016499999998
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.035279861999999995	1.7639930999999998
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.03527616299999999	1.7638081499999996
#612199 CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS; CRMCC;;COATS PLUS SYNDROME	0.035226461	1.7613230500000001
IMMUNODEFICIENCY 10; IMD10	0.03509362	1.754681
AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE	0.03509362	1.754681
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.035092933	1.75464665
#156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	0.0348873	1.7443650000000002
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.034763502	1.7381751
MEGALENCEPHALY WITH DYSMYELINATION	0.034729851	1.73649255
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.034395262999999995	1.7197631499999997
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M	0.034395262999999995	1.7197631499999997
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.034165612	1.7082806
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.03405899	1.7029495
#302800 CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1; CMTX1;;CMTX;;CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY, X-LINKED;;HEREDITARY MOTOR AND SENSORY NEUROPATHY, X-LINKED;;HMSN, X-LINKED;;CHARCOT-MARIE-TOOTH NEUROPATHY, X-LINKED, 1;;CMT2, FORMERLY	0.03405899	1.7029495
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.03381709	1.6908545000000001
FAMILIAL MEDITERRANEAN FEVER; FMF	0.03381709	1.6908545000000001
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.033735533	1.6867766499999999
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.033735533	1.6867766499999999
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.033626662999999994	1.6813331499999997
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.0335738	1.67869
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.033533642	1.6766821
HYPERPROLINEMIA, TYPE I	0.033395733	1.6697866499999998
SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS	0.0333333	1.666665
IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW	0.0333333	1.666665
#250460 METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS;;CARTILAGE-HAIR HYPOPLASIA-LIKE SKELETAL DYSPLASIA WITHOUT HYPOTRICHOSISOR IMMUNODEFICIENCY;;CARTILAGE-HAIR HYPOPLASIA VARIANT, SKELETAL MANIFESTATIONS ONLY; CHHV	0.0333333	1.666665
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.0333333	1.666665
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.0333333	1.666665
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.0333333	1.666665
ECHO VIRUS 11 SENSITIVITY	0.0333333	1.666665
#246300 LEPROSY, SUSCEPTIBILITY TO, 3; LPRS3	0.0333333	1.666665
RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY	0.0333333	1.666665
SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO	0.0333333	1.666665
GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN	0.0333333	1.666665
SHORT SYNDROME	0.0333333	1.666665
DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF	0.0333333	1.666665
IMMUNE SUPPRESSION	0.0333333	1.666665
#254300 MYASTHENIA, LIMB-GIRDLE, FAMILIAL;;LGM;;CONGENITAL MYASTHENIC SYNDROME TYPE Ib; CMS1B;;CMS Ib;;MYASTHENIC MYOPATHY, FORMERLY	0.0333333	1.666665
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.03332173	1.6660865
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.033241703	1.6620851499999998
LETTERER-SIWE DISEASE	0.03320822	1.6604109999999999
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.033145482000000004	1.6572741000000002
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.033009633	1.65048165
LISSENCEPHALY 1; LIS1	0.033009633	1.65048165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.033004752	1.6502375999999999
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.0328877	1.644385
GOLDBERG-SHPRINTZEN SYNDROME	0.032710911999999995	1.6355455999999997
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.032542073	1.6271036499999998
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.032532282	1.6266141
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.032479982	1.6239990999999998
ZUNICH NEUROECTODERMAL SYNDROME	0.032430851	1.6215425499999998
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.032214272999999995	1.6107136499999997
Adrenoleukodystrophy	0.032165751	1.60828755
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.032165751	1.60828755
CHROMOSOME 18Q DELETION SYNDROME	0.032165751	1.60828755
#222748 DIHYDROPYRIMIDINASE DEFICIENCY;;DIHYDROPYRIMIDINURIA;;DPYS DEFICIENCY;;DPH DEFICIENCY	0.032165751	1.60828755
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.032148453	1.60742265
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.03209502299999999	1.6047511499999996
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.032093882	1.6046941
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.032093882	1.6046941
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.032093882	1.6046941
MENTAL RETARDATION, X-LINKED 104; MRX104	0.031717463	1.58587315
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.03125	1.5625
#606612 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUTMENTAL RETARDATION), TYPE B, 5; MDDGB5;;MUSCULAR DYSTROPHY, CONGENITAL, 1C; MDC1C;;MUSCULAR DYSTROPHY, CONGENITAL, FKRP-RELATED	0.03125	1.5625
MENKES DISEASE	0.031218750999999996	1.5609375499999998
#128200 EPISODIC KINESIGENIC DYSKINESIA 1; EKD1;;PAROXYSMAL KINESIGENIC CHOREOATHETOSIS; PKC;;PAROXYSMAL KINESIGENIC DYSKINESIA; PKD;;DYSTONIA, FAMILIAL PAROXYSMAL;;DYSTONIA 10; DYT10	0.031218750999999996	1.5609375499999998
15q13.3 microdeletion syndrome	0.031218750999999996	1.5609375499999998
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.031171433	1.55857165
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.031171433	1.55857165
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.031146881999999997	1.5573441
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.031146881999999997	1.5573441
#300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	0.030922712	1.5461356000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.030581382	1.5290691
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.030388523	1.5194261500000001
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.030388523	1.5194261500000001
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.0303309	1.516545
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.0303309	1.516545
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.030327550999999998	1.5163775499999999
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.030302999999999997	1.5151499999999998
NASAL ALAR COLLAPSE, BILATERAL	0.030302999999999997	1.5151499999999998
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.030302999999999997	1.5151499999999998
15q24 recurrent microdeletion syndrome	0.030302999999999997	1.5151499999999998
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.030302999999999997	1.5151499999999998
#219100 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA; ARCL1A;;ARCL1;;CUTIS LAXA, AUTOSOMAL RECESSIVE	0.030302999999999997	1.5151499999999998
WAARDENBURG SYNDROME, TYPE IIB	0.030302999999999997	1.5151499999999998
NASAL BONES, ABSENCE OF	0.030302999999999997	1.5151499999999998
NASAL GROOVE, FAMILIAL TRANSVERSE	0.030302999999999997	1.5151499999999998
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.030302999999999997	1.5151499999999998
SPEECH-LANGUAGE DISORDER 1	0.030302999999999997	1.5151499999999998
DIMPLES, FACIAL	0.030302999999999997	1.5151499999999998
EDINBURGH MALFORMATION SYNDROME	0.030302999999999997	1.5151499999999998
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.030302999999999997	1.5151499999999998
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.030302999999999997	1.5151499999999998
22q11.2 distal deletion syndrome	0.030302999999999997	1.5151499999999998
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.030302999999999997	1.5151499999999998
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.030302999999999997	1.5151499999999998
CLEFT CHIN	0.030302999999999997	1.5151499999999998
CYANIDE, INABILITY TO SMELL	0.030302999999999997	1.5151499999999998
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.030302999999999997	1.5151499999999998
DWARFISM, LEVI TYPE	0.030302999999999997	1.5151499999999998
OSTEOPENIA AND SPARSE HAIR	0.030302999999999997	1.5151499999999998
OROFACIAL CLEFT 3	0.030302999999999997	1.5151499999999998
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.030255682	1.5127841
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.030233661	1.51168305
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.030175682000000002	1.5087841000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.0301004	1.50502
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.029967150999999997	1.49835755
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.029915881999999998	1.4957941
#264470 PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY;;STRAIGHT-CHAIN ACYL-CoA OXIDASE DEFICIENCY;;PSEUDONEONATAL ADRENOLEUKODYSTROPHY	0.029855291	1.49276455
HAREL-YOON SYNDROME; HAYOS	0.029723782	1.4861891
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V	0.0294118	1.4705899999999998
STUVE-WIEDEMANN SYNDROME	0.0294118	1.4705899999999998
Yao syndrome	0.0294118	1.4705899999999998
MAJEED SYNDROME	0.0294118	1.4705899999999998
IMMUNODEFICIENCY 9; IMD9	0.0294118	1.4705899999999998
MARSILI SYNDROME; MARSIS	0.0294118	1.4705899999999998
#134610 FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT;;FMF, AUTOSOMAL DOMINANT	0.0294118	1.4705899999999998
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1	0.0294118	1.4705899999999998
DOHLE BODIES AND LEUKEMIA	0.0294118	1.4705899999999998
IMMUNODEFICIENCY 61; IMD61	0.0294118	1.4705899999999998
PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	0.0294118	1.4705899999999998
#613101 HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5; FHL5	0.0294118	1.4705899999999998
#610951 CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7	0.029237081999999998	1.4618540999999998
CHROMOSOME 14q11-q22 DELETION SYNDROME	0.029153363	1.4576681500000002
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.029153363	1.4576681500000002
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.029112792	1.4556396
MYOCLONIC-ATONIC EPILEPSY	0.0288799	1.443995
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.028818081000000002	1.44090405
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.028815753	1.4407876499999999
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.02857664	1.428832
GAPO SYNDROME; GAPOS	0.028534781	1.42673905
NOONAN SYNDROME 7; NS7	0.028531510999999996	1.4265755499999997
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.028486302999999998	1.42431515
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.028442151	1.42210755
#614706 CEROID LIPOFUSCINOSIS, NEURONAL, 11; CLN11	0.0283932	1.41966
#609060 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1;;HEPATOENCEPHALOPATHY, EARLY FATAL PROGRESSIVE	0.028309481	1.41547405
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.028282799999999997	1.4141399999999997
#231000 GAUCHER DISEASE, TYPE III;;GD III;;GAUCHER DISEASE, SUBACUTE NEURONOPATHIC TYPE;;GAUCHER DISEASE, CHRONIC NEURONOPATHIC TYPE;;GAUCHER DISEASE, JUVENILE AND ADULT, CEREBRALGAUCHER DISEASE, TYPE IIIA, INCLUDED;;GAUCHER DISEASE, TYPE IIIB, INCLUDED;;GAUCHER DISEASE, NORRBOTTNIAN TYPE, INCLUDED	0.02827621	1.4138105
ASPARTYLGLUCOSAMINURIA; AGU	0.028039421	1.40197105
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.028002923000000002	1.40014615
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.027934281	1.39671405
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.027873103000000003	1.39365515
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.027755781	1.38778905
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.027579533	1.37897665
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.027338482	1.3669241
MENTAL RETARDATION, X-LINKED 41	0.027159682	1.3579841000000001
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.027050663	1.35253315
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.026852973000000002	1.34264865
#615281 HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEGSPASTICITY; HBSL;;ASPARTYL-tRNA SYNTHETASE DEFICIENCY	0.02684003	1.3420015
FUMARASE DEFICIENCY; FMRD	0.026754032	1.3377016
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.026735651	1.33678255
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.02662627	1.3313135
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.026578193000000003	1.3289096500000002
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.026552643	1.3276321500000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.0264946	1.32473
#609304 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 3; EIEE3	0.0264946	1.32473
#612269 EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5; ECA5	0.0263158	1.31579
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.026294881	1.31474405
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.02606479	1.3032395
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.026009091	1.30045455
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.025922203	1.29611015
POPOV-CHANG SYNDROME; POPCHAS	0.025828402	1.2914201
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.025753882	1.2876941
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.025648963	1.28244815
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.025569133	1.27845665
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.025569133	1.27845665
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.025569133	1.27845665
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.025569133	1.27845665
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.025569133	1.27845665
#610127 CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10;;CEROID LIPOFUSCINOSIS, NEURONAL, CATHEPSIN D-DEFICIENT;;NEURONAL CEROID LIPOFUSCINOSIS DUE TO CATHEPSIN D DEFICIENCYNEURONAL CEROID LIPOFUSCINOSIS, CONGENITAL, INCLUDED	0.02551363	1.2756815
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.025449733000000002	1.27248665
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.025397432999999997	1.2698716499999998
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.025397432999999997	1.2698716499999998
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.025084872	1.2542436000000001
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.025015433	1.25077165
#226750 KOHLSCHUTTER-TONZ SYNDROME; KTZS;;EPILEPSY AND YELLOW TEETH;;EPILEPSY, DEMENTIA, AND AMELOGENESIS IMPERFECTA;;KOHLSCHUTTER SYNDROME	0.024902073	1.2451036500000001
#300673 ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	0.024784233000000003	1.23921165
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.024733212	1.2366606
FRAGILE X MENTAL RETARDATION SYNDROME	0.024725251	1.23626255
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.024653382	1.2326691
ALLAN-HERNDON-DUDLEY SYNDROME	0.02460389	1.2301945
WEBB-DATTANI SYNDROME; WEDAS	0.024574663	1.22873315
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.024574662999999997	1.2287331499999998
#252500 MUCOLIPIDOSIS II ALPHA/BETA;;MUCOLIPIDOSIS II; ML II;;ML II ALPHA/BETA;;I-CELL DISEASE; ICD	0.024479972	1.2239986
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.024336161	1.21680805
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.024288873000000002	1.2144436500000002
ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY; AMACRD	0.02424099	1.2120495
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.024236573	1.21182865
#125310 CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTSAND LEUKOENCEPHALOPATHY; CADASIL;;DEMENTIA, HEREDITARY MULTI-INFARCT TYPE;;CASIL	0.024171551	1.20857755
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.024171551	1.20857755
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.024171551	1.20857755
#607876 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2; FAME2;;BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY 2; BAFME2;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 2; FCMTE2;;CORTICAL MYOCLONUS AND EPILEPSY, AUTOSOMAL DOMINANT; ADCME	0.02413986	1.206993
OPTIC ATROPHY 11; OPA11	0.024099682	1.2049841000000001
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.024099682	1.2049841000000001
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.02407272	1.203636
#615516 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38	0.023981833	1.19909165
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.023730781	1.18653905
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.023730781	1.18653905
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.023711912999999998	1.1855956499999998
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.023711912999999998	1.1855956499999998
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.023604391	1.18021955
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.023537453	1.17687265
XQ25 DUPLICATION SYNDROME	0.023525662999999995	1.1762831499999997
ACROMICRIC DYSPLASIA	0.023434299999999998	1.1717149999999998
MENTAL RETARDATION, X-LINKED, SYNDROMIC 11; MRXS11	0.023434299999999998	1.1717149999999998
#612713 KAHRIZI SYNDROME; KHRZ;;MENTAL RETARDATION, CATARACT, COLOBOMA, AND KYPHOSIS, AUTOSOMAL RECESSIVE	0.023434299999999998	1.1717149999999998
HURLER SYNDROME	0.023430971999999998	1.1715486
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.023392691	1.16963455
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.023296012	1.1648006
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.023296011999999998	1.1648006
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.02327319	1.1636595
ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	0.0232558	1.16279
#615651 LEUKOENCEPHALOPATHY WITH ATAXIA; LKPAT	0.0232558	1.16279
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	0.0232558	1.16279
DYSTONIA 28, CHILDHOOD-ONSET	0.023187832	1.1593916
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.023066082	1.1533041000000002
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.023066082	1.1533041000000002
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.023066082	1.1533041000000002
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.023066082	1.1533041000000002
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.023046042	1.1523021
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02294953	1.1474765
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.02294953	1.1474765
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.02294953	1.1474765
GRANULOMAS, CONGENITAL CEREBRAL	0.02294953	1.1474765
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02294953	1.1474765
HYPOPHOSPHATASIA, INFANTILE	0.022868030999999997	1.1434015499999999
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.022868030999999997	1.1434015499999999
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.022833332999999997	1.14166665
WARBURG MICRO SYNDROME 2; WARBM2	0.02281503	1.1407515
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.022681780999999998	1.1340890499999998
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.022681780999999998	1.1340890499999998
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.022681780999999998	1.1340890499999998
HURLER-SCHEIE SYNDROME	0.022587089999999997	1.1293544999999998
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.02258554	1.129277
#121300 COPROPORPHYRIA, HEREDITARY; HCP;;COPROPORPHYRINOGEN OXIDASE DEFICIENCY;;CPOX DEFICIENCY;;CPO DEFICIENCY;;CPX DEFICIENCYHARDEROPORPHYRIA, INCLUDED	0.02253602	1.126801
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.022529240000000002	1.126462
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.022529240000000002	1.126462
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.022505532999999998	1.12527665
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.022424371	1.12121855
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.022352502	1.1176251
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.022337973	1.11689865
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.022337973	1.11689865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.022337973	1.11689865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.022337973	1.11689865
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.022263429999999997	1.1131714999999998
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.0222222	1.11111
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.0222222	1.11111
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.0222222	1.11111
MENTAL RETARDATION, X-LINKED 77	0.0222222	1.11111
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.0222222	1.11111
EPILEPSY, HOT WATER, 1	0.0222222	1.11111
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.022018219999999998	1.100911
HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA	0.021952279999999998	1.0976139999999999
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.021820073	1.09100365
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.0217068	1.08534
AICARDI-GOUTIERES SYNDROME 7	0.021555483	1.07777415
HALLERMANN-STREIFF SYNDROME; HSS	0.02150862	1.075431
STIFF-PERSON SYNDROME; SPS	0.02150862	1.075431
CIRRHOSIS, FAMILIAL	0.02150862	1.075431
#252940 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY	0.021463331	1.0731665499999998
#606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIERGLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	0.021418453	1.07092265
CORNELIA DE LANGE SYNDROME 3	0.021294593	1.06472965
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.021278853	1.06394265
PELGER-HUET ANOMALY; PHA	0.021231602	1.0615801
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.021229783	1.0614891499999999
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.020990433	1.04952165
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.020990433	1.04952165
RETT SYNDROME; RTT	0.020828591	1.04142955
GLYCINE ENCEPHALOPATHY; GCE	0.020778501	1.03892505
HYPERCALCEMIA, INFANTILE, 1	0.02057968	1.028984
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.02057834	1.028917
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.020397381	1.01986905
#274150 THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL; TTP;;MICROANGIOPATHIC HEMOLYTIC ANEMIA;;THROMBOTIC MICROANGIOPATHY, FAMILIAL;;UPSHAW-SCHULMAN SYNDROME; USS;;SCHULMAN-UPSHAW SYNDROME;;UPSHAW FACTOR, DEFICIENCY OF;;MICROANGIOPATHIC HEMOLYTIC ANEMIA, CONGENITAL;;THROMBOTIC THROMBOCYTOPENIC PURPURA, FAMILIAL	0.020387719999999998	1.019386
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.020387719999999998	1.019386
#256520 NEU-LAXOVA SYNDROME; NLS	0.02037555	1.0187775
CYCLIC VOMITING SYNDROME	0.020160191	1.0080095500000001
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.020146551	1.0073275499999998
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.020146551	1.0073275499999998
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.020146551	1.0073275499999998
SECKEL SYNDROME 7; SCKL7	0.020146551	1.0073275499999998
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.020146551	1.0073275499999998
#600072 FATAL FAMILIAL INSOMNIA; FFI;;INSOMNIA, FATAL FAMILIAL	0.02007899	1.0039495
300270 ADRENOMYODYSTROPHY	0.020074682	1.0037341
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.020074682	1.0037341
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.020066880000000002	1.003344
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.020053112	1.0026556
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.020053111999999998	1.0026556
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.019941432999999998	0.9970716499999999
TEMPLE-BARAITSER SYNDROME; TMBTS	0.019941432999999998	0.9970716499999999
PETTIGREW SYNDROME	0.019941432999999998	0.9970716499999999
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.019941432999999998	0.9970716499999999
BETA-UREIDOPROPIONASE DEFICIENCY	0.019711782	0.9855891
RING CHROMOSOME 14 SYNDROME	0.019711782	0.9855891
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.019711782	0.9855891
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.019711782	0.9855891
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.019550272	0.9775136
OSTEOCHONDRODYSPLASIA, RHIZOMELIC, WITH CALLOSAL AGENESIS, THROMBOCYTOPENIA,HYDROCEPHALUS, AND HYPERTENSION	0.01952679	0.9763394999999999
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.01951922	0.975961
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.0192308	0.96154
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.0192308	0.96154
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.019174563	0.9587281499999999
AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC	0.01911119	0.9555595
T-CELL LYMPHOMA, SUBCUTANEOUS PANNICULITIS-LIKE; SPTCL	0.01911119	0.9555595
IMMUNODEFICIENCY 32B; IMD32B	0.01911119	0.9555595
GLYCOGEN STORAGE DISEASE II	0.01911119	0.9555595
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	0.01911119	0.9555595
MYELOFIBROSISMYELOFIBROSIS WITH MYELOID METAPLASIA, INCLUDED	0.01911119	0.9555595
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.01911119	0.9555595
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.01911119	0.9555595
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.01911119	0.9555595
LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2	0.01911119	0.9555595
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.019109341000000002	0.9554670500000001
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.019107013	0.95535065
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.019104851	0.9552425499999999
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.019104851	0.9552425499999999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.019097550999999997	0.9548775499999999
NOONAN SYNDROME 5; NS5	0.019025682	0.9512841
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.019025682	0.9512841
JOUBERT SYNDROME 10	0.019025682	0.9512841
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.019025682	0.9512841
THAUVIN-ROBINET-FAIVRE SYNDROME	0.019025682	0.9512841
ALAZAMI SYNDROME; ALAZS	0.019025682	0.9512841
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.019025682	0.9512841
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.019025682	0.9512841
Retinitis pigmentosa with or without skeletal anomalies	0.019025682	0.9512841
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.019025682	0.9512841
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.018902883	0.94514415
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0188679	0.943395
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0188679	0.943395
MYOPATHY, CONGENITAL	0.0188679	0.943395
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0188679	0.943395
THUMBS, CONGENITAL CLASPED	0.0188679	0.943395
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0188679	0.943395
SPATIAL VISUALIZATION, APTITUDE FOR	0.0188679	0.943395
#259420 OSTEOGENESIS IMPERFECTA, TYPE III;;OI, TYPE III;;OI3;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE	0.0188679	0.943395
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0188679	0.943395
#220100 CYSTINURIA;;CSNU;;CYSTINURIA, TYPE I, FORMERLY; CSNU1, FORMERLY;;CYSTINURIA, TYPE II, FORMERLY;;CYSTINURIA, TYPE III, FORMERLY; CSNU3, FORMERLY;;CYSTINURIA, TYPE NON-I, FORMERLYCYSTINURIA, TYPE A, INCLUDED;;CYSTINURIA, TYPE B, INCLUDED;;CYSTINURIA, TYPE A/B, INCLUDED	0.0188679	0.943395
PALMOMENTAL REFLEX	0.0188679	0.943395
DIASTEMATOMYELIA	0.0188679	0.943395
ANDROSTENONE, ABILITY TO SMELL	0.0188679	0.943395
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0188679	0.943395
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0188679	0.943395
CARDIAC ARRHYTHMIA	0.0188679	0.943395
ALCOHOL DEPENDENCE	0.0188679	0.943395
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0188679	0.943395
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0188679	0.943395
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0188679	0.943395
CERVICAL RIB	0.0188679	0.943395
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0188679	0.943395
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0188679	0.943395
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0188679	0.943395
269800 SENILE PLAQUE FORMATION	0.0188679	0.943395
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0188679	0.943395
NOVELTY SEEKING PERSONALITY TRAIT	0.0188679	0.943395
141405 HEMIFACIAL SPASM, FAMILIAL	0.0188679	0.943395
ENDOCARDIAL FIBROELASTOSIS	0.0188679	0.943395
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0188679	0.943395
MOTION SICKNESS	0.0188679	0.943395
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0188679	0.943395
#610189 SENIOR-LOKEN SYNDROME 6; SLSN6	0.0188679	0.943395
ERYTHERMALGIA, PRIMARY	0.0188679	0.943395
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0188679	0.943395
MERALGIA PARAESTHETICA, FAMILIAL	0.0188679	0.943395
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0188679	0.943395
JUMPING FRENCHMAN OF MAINE	0.0188679	0.943395
#614652 COENZYME Q10 DEFICIENCY, PRIMARY, 3; COQ10D3	0.0188679	0.943395
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0188679	0.943395
COGNITIVE FUNCTION 1, SOCIAL	0.0188679	0.943395
PERONEAL NERVE, ACCESSORY DEEP	0.0188679	0.943395
SPASTIC PSEUDOSCLEROSIS	0.0188679	0.943395
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0188679	0.943395
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.01878753	0.9393765000000001
COFFIN-SIRIS SYNDROME 5	0.018677163	0.93385815
ZIMMERMANN-LABAND SYNDROME 1	0.018654340999999998	0.9327170499999999
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	0.018654340999999998	0.9327170499999999
MUCOPOLYSACCHARIDOSIS, TYPE II	0.018654340999999998	0.9327170499999999
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.018609463	0.93047315
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.018510623	0.92553115
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.018502320000000003	0.9251160000000002
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.01843399	0.9216995
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.018430640999999998	0.9215320499999999
#300337 HYPOMELANOSIS OF ITO; HMI;;INCONTINENTIA PIGMENTI ACHROMIANS; IPA;;ITO HYPOMELANOSIS; ITO;;INCONTINENTIA PIGMENTI, TYPE I, FORMERLY; IP1, FORMERLY	0.018330680999999998	0.9165340499999999
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.018290129999999998	0.9145064999999999
#141500 MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1;;FHM;;MHP1MIGRAINE, FAMILIAL HEMIPLEGIC 1, WITH PROGRESSIVE CEREBELLAR ATAXIA,INCLUDED;;MIGRAINE, SPORADIC HEMIPLEGIC, INCLUDED	0.018185751	0.9092875499999999
ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD10B	0.018181799999999998	0.90909
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.018181799999999998	0.90909
601957 ODONTOTRICHOUNGUAL-DIGITAL-PALMAR SYNDROME;;OTUDP SYNDROME	0.018181799999999998	0.90909
#225410 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE;;EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE;;DERMATOSPARAXIS;;EDS VIIC;;EDS7C	0.018181799999999998	0.90909
MEIER-GORLIN SYNDROME 6; MGORS6	0.018181799999999998	0.90909
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.018181799999999998	0.90909
ECTODERMAL DYSPLASIA 14, HAIR/TOOTH TYPE WITH OR WITHOUT HYPOHIDROSIS; ECTD14	0.018181799999999998	0.90909
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.018181799999999998	0.90909
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.018181799999999998	0.90909
MEIER-GORLIN SYNDROME 8; MGORS8	0.018181799999999998	0.90909
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.018181799999999998	0.90909
FEINGOLD SYNDROME 1; FGLDS1	0.018181799999999998	0.90909
THREE M SYNDROME 2; 3M2	0.018181799999999998	0.90909
CHITAYAT SYNDROME	0.018181799999999998	0.90909
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.018181799999999998	0.90909
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.018164363000000003	0.9082181500000002
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.018162101	0.90810505
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.018114103000000003	0.9057051500000002
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.018113882	0.9056941000000001
#608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;;CPT II DEFICIENCY, LETHAL NEONATAL;;CPT2 DEFICIENCY, LETHAL NEONATAL	0.018059000999999998	0.90295005
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.018008963	0.90044815
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.017987132	0.8993566
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.017933681	0.89668405
HADZISELIMOVIC SYNDROME	0.017761412	0.8880706
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.017616703	0.88083515
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.017596091	0.87980455
DYSTONIA 12; DYT12	0.017514889999999998	0.8757444999999999
COCKAYNE SYNDROME A; CSA	0.017496851	0.87484255
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.017336822999999998	0.8668411499999998
LYSINURIC PROTEIN INTOLERANCE; LPI	0.01733349	0.8666745
PITT-HOPKINS SYNDROME	0.017320481000000002	0.8660240500000002
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.017248612000000003	0.8624306000000002
#245400 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITHMETHYLMALONIC ACIDURIA); MTDPS9;;LACTIC ACIDOSIS, FATAL INFANTILE, FORMERLY	0.017144233000000002	0.8572116500000001
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.017144233000000002	0.8572116500000001
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.01714325	0.8571624999999999
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.017058041	0.85290205
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.016945842	0.8472921
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.01691753	0.8458765
PRIMROSE SYNDROME; PRIMS	0.01691753	0.8458765
GAUCHER DISEASE, TYPE I	0.01688983	0.8444915000000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.016841463	0.84207315
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.016671873	0.83359365
#608804 LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2;;PELIZAEUS-MERZBACHER-LIKE DISEASE, 1; PMLD1	0.016566683	0.8283341499999999
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.016545241000000002	0.8272620500000001
#614457 ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR	0.016468882	0.8234441
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.016468882	0.8234441
ROIFMAN-CHITAYAT SYNDROME	0.016468882	0.8234441
#300848 MENTAL RETARDATION, X-LINKED 89; MRX89	0.016468882	0.8234441
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.016468882	0.8234441
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.016468882	0.8234441
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.016465532999999997	0.8232766499999998
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.016317972	0.8158986
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.016213463	0.8106731500000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.016213463	0.8106731500000001
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.016213463	0.8106731500000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.016213463	0.8106731500000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.016213463	0.8106731500000001
#256731 CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5;;CEROID LIPOFUSCINOSIS, NEURONAL, 5, VARIABLE AGE AT ONSETNEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE, FINNISH VARIANT, INCLUDED;;FINNISH vLINCL, INCLUDED	0.015997581	0.79987905
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.015975403	0.79877015
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.015925712	0.7962856
IMMUNODEFICIENCY 23; IMD23	0.015650932	0.7825466
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.015625	0.78125
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.015625	0.78125
CARNOSINEMIA	0.015625	0.78125
HYDROXYLYSINURIA	0.015625	0.78125
PAINE SYNDROME	0.015625	0.78125
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.015625	0.78125
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.015625	0.78125
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.015625	0.78125
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.015621650999999999	0.7810825499999999
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.015621650999999999	0.7810825499999999
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.015621650999999999	0.7810825499999999
#616351 MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34	0.015549782	0.7774891
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.015444863000000001	0.7722431500000001
DESANTO-SHINAWI SYNDROME	0.015444863000000001	0.7722431500000001
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.015444863000000001	0.7722431500000001
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.015444863000000001	0.7722431500000001
#612936 SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3, FORMERLY; CPSQ3, FORMERLY	0.015444863000000001	0.7722431500000001
KOOLEN-DE VRIES SYNDROME; KDVS	0.015444863000000001	0.7722431500000001
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.015384600000000002	0.7692300000000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.015369581	0.76847905
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.015193333	0.75966665
RECOMBINANT CHROMOSOME 8 SYNDROME	0.015092933	0.75464665
MENTAL RETARDATION, X-LINKED 9	0.015092933	0.75464665
Helsmoortel-van der Aa syndrome	0.015092933	0.75464665
ZTTK SYNDROME; ZTTKS	0.015052603000000001	0.7526301500000001
#170100 PROLIDASE DEFICIENCY	0.015012622	0.7506311
#176000 PORPHYRIA, ACUTE INTERMITTENT;;AIP;;PORPHYRIA, SWEDISH TYPE;;PORPHOBILINOGEN DEAMINASE DEFICIENCY;;PBGD DEFICIENCY;;UROPORPHYRINOGEN SYNTHASE DEFICIENCY;;UPS DEFICIENCYPORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT, INCLUDED;;PORPHYRIA, CHESTER TYPE, INCLUDED; PORC, INCLUDED	0.014964851000000001	0.7482425500000001
Fabry disease	0.014964851000000001	0.7482425500000001
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.014807049999999999	0.7403525
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.014807049999999999	0.7403525
#258501 3-@METHYLGLUTACONIC ACIDURIA, TYPE III; MGCA3;;MGA, TYPE III; MGA3;;OPTIC ATROPHY PLUS SYNDROME;;OPTIC ATROPHY, INFANTILE, WITH CHOREA AND SPASTIC PARAPLEGIA;;IRAQI-JEWISH 'OPTIC ATROPHY PLUS';;COSTEFF SYNDROME;;OPTIC ATROPHY 3, AUTOSOMAL RECESSIVE;;OPA3, AUTOSOMAL RECESSIVE	0.014807049999999999	0.7403525
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.014807049999999999	0.7403525
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.014772722999999998	0.7386361499999999
OROFACIODIGITAL SYNDROME I; OFD1	0.014760721	0.7380360499999999
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 4; FCAS4	0.0147059	0.7352949999999999
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.0147059	0.7352949999999999
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.0147059	0.7352949999999999
EPILEPSY, BENIGN NEONATAL, 3	0.0147059	0.7352949999999999
#608898 HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3; FHL3;;HPLH3;;HLH3	0.0147059	0.7352949999999999
RHABDOMYOLYSIS, ACUTE RECURRENT	0.0147059	0.7352949999999999
#117000 CENTRAL CORE DISEASE OF MUSCLE;;CCD;;CCOMINICORE MYOPATHY, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;MULTICORE MYOPATHY, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;MULTIMINICORE DISEASE, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;NEUROMUSCULAR DISEASE, CONGENITAL, WITH UNIFORM TYPE 1 FIBER, INCLUDED;CNMDU1, INCLUDED	0.0147059	0.7352949999999999
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.0147059	0.7352949999999999
NEUROPATHY, HEREDITARY THERMOSENSITIVE	0.0147059	0.7352949999999999
MYOCLONIC EPILEPSY, JUVENILE, 2	0.0147059	0.7352949999999999
PSEUDODIASTROPHIC DYSPLASIA	0.0147059	0.7352949999999999
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2	0.0147059	0.7352949999999999
NEUROPATHY, PAINFUL	0.0147059	0.7352949999999999
#104290 ALTERNATING HEMIPLEGIA OF CHILDHOOD 1; AHC1	0.0147059	0.7352949999999999
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.0147059	0.7352949999999999
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3	0.0147059	0.7352949999999999
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5	0.0147059	0.7352949999999999
#614653 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI; HSAN6;;HSAN VI	0.0147059	0.7352949999999999
PANCREATITIS, HEREDITARY	0.0147059	0.7352949999999999
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.0147059	0.7352949999999999
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.0147059	0.7352949999999999
#145600 MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1; MHS1;;MHS;;HYPERTHERMIA OF ANESTHESIA;;HYPERPYREXIA, MALIGNANT; MHKING SYNDROME, INCLUDED;;KING-DENBOROUGH SYNDROME, INCLUDED	0.0147059	0.7352949999999999
PSORIASIS 14, PUSTULAR	0.0147059	0.7352949999999999
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.0147059	0.7352949999999999
CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.0147059	0.7352949999999999
HYPOHIDROSIS WITH ABNORMAL PALMAR DERMAL RIDGES	0.0147059	0.7352949999999999
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.0147059	0.7352949999999999
CINCA SYNDROME; CINCA	0.0147059	0.7352949999999999
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.0147059	0.7352949999999999
FEVER, FAMILIAL LIFELONG PERSISTENT	0.0147059	0.7352949999999999
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.0147059	0.7352949999999999
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.0147059	0.7352949999999999
CAFFEY DISEASE	0.0147059	0.7352949999999999
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.014704080999999997	0.7352040499999999
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.014688852	0.7344426000000001
METHYLMALONIC ACIDURIA, CBLA TYPE	0.014687833	0.7343916500000001
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.014687833	0.7343916500000001
#243500 ISOVALERIC ACIDEMIA; IVA;;ISOVALERIC ACID CoA DEHYDROGENASE DEFICIENCY;;IVD DEFICIENCY	0.014687833	0.7343916500000001
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.014600981	0.7300490500000001
HYPEREKPLEXIA 4; HKPX4	0.014580133000000002	0.7290066500000001
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.014580133000000002	0.7290066500000001
2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD	0.014580133000000002	0.7290066500000001
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.014580133000000002	0.7290066500000001
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.014580133000000002	0.7290066500000001
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.014580133000000002	0.7290066500000001
#220120 D-GLYCERIC ACIDURIA;;D-GLYCERIC ACIDEMIA;;GLYCERATE KINASE DEFICIENCY	0.014580133000000002	0.7290066500000001
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.014529112	0.7264556
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.014529112	0.7264556
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.014527832999999999	0.7263916499999999
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.01445383	0.7226915
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.014424733000000002	0.7212366500000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.014349451	0.71747255
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.01428573	0.7142865
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.014277363000000001	0.71386815
COFFIN-SIRIS SYNDROME 8; CSS8	0.014249050999999999	0.71245255
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.014249050999999999	0.71245255
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.014249050999999999	0.71245255
CLARK-BARAITSER SYNDROME	0.014249050999999999	0.71245255
ATKIN-FLAITZ SYNDROME	0.014249050999999999	0.71245255
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.014249050999999999	0.71245255
FOUNTAIN SYNDROME	0.014249050999999999	0.71245255
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.014182630000000002	0.7091315
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.014177182	0.7088591
ELSAHY-WATERS SYNDROME; ESWS	0.014177182	0.7088591
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.014177182	0.7088591
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.014177182	0.7088591
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.014177182	0.7088591
COSTELLO SYNDROME; CSTLO	0.014177182	0.7088591
LISSENCEPHALY 3; LIS3	0.014106331	0.70531655
#231690 GLUTARIC ACIDURIA III;;GA III;;GLUTARYL-CoA OXIDASE DEFICIENCY	0.0140491	0.702455
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.0140491	0.702455
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.014032473	0.70162365
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.014032473	0.70162365
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.014032473	0.70162365
#309510 PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS;;PARTINGTON SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 1; MRXS1;;MENTAL RETARDATION, X-LINKED, WITH DYSTONIC MOVEMENTS, ATAXIA, ANDSEIZURES;;MENTAL RETARDATION, X-LINKED 36; MRX36	0.013928840999999997	0.6964420499999999
SUPRABULBAR PARESIS, CONGENITAL	0.013928840999999997	0.6964420499999999
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.013862072	0.6931035999999999
JOUBERT SYNDROME 31; JBTS31	0.013862072	0.6931035999999999
MARSHALL-SMITH SYNDROME; MRSHSS	0.01384497	0.6922485
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.013843951	0.69219755
METHYLMALONIC ACIDURIA, CBLB TYPE	0.013772082	0.6886040999999999
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.013772082	0.6886040999999999
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.013736251000000001	0.6868125500000001
CROME SYNDROME	0.013736251000000001	0.6868125500000001
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.013736251000000001	0.6868125500000001
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.013736251000000001	0.6868125500000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.013736251000000001	0.6868125500000001
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.013736251000000001	0.6868125500000001
#608033 ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3; IIAE3;;ENCEPHALOPATHY, ACUTE NECROTIZING, SUSCEPTIBILITY TO; ANE	0.013736251000000001	0.6868125500000001
CHROMOSOME 13q14 DELETION SYNDROME	0.01368523	0.6842615
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.013664382000000003	0.6832191000000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.013664382000000003	0.6832191000000001
BAKER-GORDON SYNDROME; BAGOS	0.013612082	0.6806040999999999
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.013515590000000001	0.6757795000000001
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.013508982000000001	0.6754491
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.013433481	0.67167405
PREECLAMPSIA/ECLAMPSIA 1	0.013400291	0.67001455
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.013361612	0.6680806
MACS SYNDROME	0.0133333	0.666665
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.0133333	0.666665
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.0133333	0.666665
MEIER-GORLIN SYNDROME 3; MGORS3	0.0133333	0.666665
MEIER-GORLIN SYNDROME 1; MGORS1	0.0133333	0.666665
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.0133333	0.666665
#611554 LEOPARD SYNDROME 2	0.0133333	0.666665
PROGNATHISM, MANDIBULAR	0.0133333	0.666665
#246200 DONOHUE SYNDROME;;LEPRECHAUNISMINSULIN RECEPTOR, DEFECT IN, INCLUDED	0.0133333	0.666665
CRI-DU-CHAT SYNDROME	0.0133333	0.666665
#273750 THREE M SYNDROME 1; 3M1;;3@M SYNDROME;;LE MERRER SYNDROME;;DOLICHOSPONDYLIC DYSPLASIA;;GLOOMY FACE SYNDROMEYAKUT SHORT STATURE SYNDROME, INCLUDED	0.0133333	0.666665
MENTAL RETARDATION, X-LINKED 19	0.0133333	0.666665
NOONAN SYNDROME 4; NS4	0.0133333	0.666665
#613804 MEIER-GORLIN SYNDROME 4; MGORS4	0.0133333	0.666665
LISSENCEPHALY, X-LINKED, 1; LISX1	0.013331091	0.66655455
ALEXANDER DISEASE	0.013188591	0.65942955
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.013188591	0.65942955
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.013158700999999998	0.65793505
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.013158700999999998	0.65793505
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.013091560999999998	0.6545780499999999
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.013086832	0.6543416
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.013086832	0.6543416
SPINOCEREBELLAR ATAXIA 5; SCA5	0.013086832	0.6543416
#607454 SPINOCEREBELLAR ATAXIA 21; SCA21	0.013086832	0.6543416
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.013086832	0.6543416
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.013086832	0.6543416
#615030 SPASTIC PARAPLEGIA 56, AUTOSOMAL RECESSIVE; SPG56	0.013018189999999999	0.6509094999999999
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.013018189999999999	0.6509094999999999
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.013013089999999998	0.6506544999999999
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H	0.0129282	0.64641
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.012913810999999999	0.64569055
BARAITSER-WINTER SYNDROME 1; BRWS1	0.012883513000000001	0.6441756500000001
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.012883513	0.64417565
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.012841942	0.6420971
#218800 CRIGLER-NAJJAR SYNDROME, TYPE I;;HYPERBILIRUBINEMIA, CRIGLER-NAJJAR TYPE I; HBLRCN1;;CRIGLER-NAJJAR SYNDROME	0.012820500000000002	0.6410250000000001
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6; MC3DN6	0.012820500000000002	0.6410250000000001
IMMUNODEFICIENCY 44	0.012820500000000002	0.6410250000000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.012820500000000002	0.6410250000000001
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 2; CEMCOX2	0.012820500000000002	0.6410250000000001
#606688 SPONGIFORM ENCEPHALOPATHY WITH NEUROPSYCHIATRIC FEATURES	0.012820500000000002	0.6410250000000001
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.012820500000000002	0.6410250000000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.012629233	0.63146165
RAYNAUD-CLAES SYNDROME; MRXSRC	0.012629233	0.63146165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.012629233	0.63146165
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.012629233	0.63146165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.012629233	0.63146165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.012629233	0.63146165
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.012629233	0.63146165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.012629233	0.63146165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.012629233	0.63146165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.012629233	0.63146165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.012629233	0.63146165
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.01261947	0.6309735000000001
NIEMANN-PICK DISEASE, TYPE A	0.012495552	0.6247776
GALACTOSE EPIMERASE DEFICIENCY	0.012495552	0.6247776
ALPORT SYNDROME, X-LINKED; ATS	0.012484539999999999	0.624227
#612923 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 3; AHUS3;;AHUS, SUSCEPTIBILITY TO, 3	0.012484539999999999	0.624227
#612922 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 2; AHUS2;;AHUS, SUSCEPTIBILITY TO, 2	0.012484539999999999	0.624227
#612924 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 4; AHUS4;;AHUS, SUSCEPTIBILITY TO, 4	0.012484539999999999	0.624227
#612926 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 6; AHUS6;;AHUS, SUSCEPTIBILITY TO, 6	0.012484539999999999	0.624227
#612925 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5; AHUS5;;AHUS, SUSCEPTIBILITY TO, 5	0.012484539999999999	0.624227
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.012386113	0.61930565
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.012386113	0.61930565
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.012386113	0.61930565
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.012386113	0.61930565
BOHRING-OPITZ SYNDROME	0.012386113	0.61930565
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.012386113	0.61930565
#607346 SPINOCEREBELLAR ATAXIA 19; SCA19;;SPINOCEREBELLAR ATAXIA 22; SCA22	0.012242949999999999	0.6121475
SPINOCEREBELLAR ATAXIA 42	0.012242949999999999	0.6121475
SPINOCEREBELLAR ATAXIA 1	0.012242949999999999	0.6121475
#117360 SPINOCEREBELLAR ATAXIA 29; SCA29;;CEREBELLAR ATAXIA, CONGENITAL NONPROGRESSIVE, AUTOSOMAL DOMINANT;CNPCA;;CEREBELLAR VERMIS APLASIA;;APLASIA OF CEREBELLAR VERMIS; ACV	0.012242949999999999	0.6121475
#601042 DYSTONIA 9; DYT9;;CHOREOATHETOSIS/SPASTICITY, EPISODIC;;CSE CHOREOATHETOSIS, PAROXYSMAL, WITH EPISODIC ATAXIA;;CHOREOATHETOSIS, KINESIGENIC, WITH EPISODIC ATAXIA AND SPASTICITY	0.012242949999999999	0.6121475
#233400 PERRAULT SYNDROME 1; PRLTS1;;OVARIAN DYSGENESIS WITH SENSORINEURAL DEAFNESS;;GONADAL DYSGENESIS, XX TYPE, WITH DEAFNESS	0.012242949999999999	0.6121475
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.012242949999999999	0.6121475
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.012242949999999999	0.6121475
DYSTONIA 16; DYT16	0.012242949999999999	0.6121475
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.012146582999999999	0.60732915
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.012051892	0.6025946
#309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME	0.012039631	0.60198155
ATAXIA-OCULOMOTOR APRAXIA 4; AOA4	0.01199806	0.599903
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.01199806	0.599903
SPINOCEREBELLAR ATAXIA 32; SCA32	0.01199806	0.599903
JOUBERT SYNDROME 4	0.01199806	0.599903
#222300 WOLFRAM SYNDROME 1; WFS1;;WFS;;DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD	0.011970660999999999	0.5985330499999999
ANGELMAN SYNDROME	0.011963732999999999	0.5981866499999999
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.011963732999999999	0.5981866499999999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.011963732999999999	0.5981866499999999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.011963732999999999	0.5981866499999999
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.011963732999999999	0.5981866499999999
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	0.011860633	0.59303165
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.011860633	0.59303165
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.011860633	0.59303165
GLASS SYNDROME	0.011860633	0.59303165
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.011860633	0.59303165
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.011860633	0.59303165
ADAMS-OLIVER SYNDROME 2; AOS2	0.011860633	0.59303165
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	0.011846743	0.59233715
#251290 BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;BLCPMG;;PSEUDO-TORCH SYNDROME	0.011846743	0.59233715
GAUCHER DISEASE, TYPE II	0.011846743	0.59233715
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.011785351	0.58926755
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.011785351	0.58926755
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.011785351	0.58926755
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.011785351	0.58926755
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.011785351	0.58926755
#300607 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 8; EIEE8;;HYPEREKPLEXIA AND EPILEPSY	0.011785351	0.58926755
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.011785351	0.58926755
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.011746361	0.58731805
HYPER-IGD SYNDROME	0.01165167	0.5825834999999999
LYSOSOMAL ACID LIPASE DEFICIENCY	0.01165167	0.5825834999999999
HYPERLIPOPROTEINEMIA, TYPE I	0.01165167	0.5825834999999999
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.011610873	0.5805436500000001
CITRULLINEMIA, CLASSIC	0.011570113	0.57850565
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	0.011570113	0.57850565
#311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO;;ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY;;OTC DEFICIENCYVALPROATE SENSITIVITY, INCLUDED	0.011570113	0.57850565
#237300 CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO;;CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY;;CPS I DEFICIENCY	0.011570113	0.57850565
ARGININOSUCCINIC ACIDURIA	0.011570113	0.57850565
OCULOCEREBROCUTANEOUS SYNDROME	0.011542231	0.57711155
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.011542231	0.57711155
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.011542231	0.57711155
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.011542231	0.57711155
CRANIOFRONTONASAL SYNDROME; CFNS	0.011470362000000001	0.5735181
MICROPHTHALMIA, SYNDROMIC 3	0.011470362000000001	0.5735181
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.011470362000000001	0.5735181
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	0.011469370999999999	0.57346855
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.011468373	0.57341865
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.011468373	0.57341865
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.011468373	0.57341865
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.011468373	0.57341865
SCHINDLER DISEASE, TYPE I	0.011468373	0.57341865
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.011468373	0.57341865
MECKEL SYNDROME, TYPE 1; MKS1	0.011447539999999999	0.5723769999999999
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.011447539999999999	0.5723769999999999
SALLA DISEASE	0.011214353	0.56071765
AMYLOIDOSIS, FAMILIAL VISCERAL	0.011208010000000001	0.5604005000000001
TRIMETHYLAMINURIA	0.011208010000000001	0.5604005000000001
SICKLE CELL ANEMIA	0.011208010000000001	0.5604005000000001
#133100 ERYTHROCYTOSIS, FAMILIAL, 1; ECYT1;;POLYCYTHEMIA, PRIMARY FAMILIAL AND CONGENITAL; PFCP;;ERYTHROCYTOSIS, AUTOSOMAL DOMINANT BENIGN	0.011208010000000001	0.5604005000000001
THROMBOCYTHEMIA, ESSENTIAL	0.011208010000000001	0.5604005000000001
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.011193593	0.55967965
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.011193593	0.55967965
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.011193593	0.55967965
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.011193593	0.55967965
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.011193593	0.55967965
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.01112388	0.556194
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.01112388	0.556194
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.01112388	0.556194
MENTAL RETARDATION, X-LINKED 82	0.011119850999999998	0.5559925499999999
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.011119850999999998	0.5559925499999999
Angelman syndrome (Type 2)	0.011119850999999998	0.5559925499999999
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.011119850999999998	0.5559925499999999
Angelman syndrome (Type 1)	0.011119850999999998	0.5559925499999999
EPILEPSY, READING	0.011119850999999998	0.5559925499999999
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.011119850999999998	0.5559925499999999
AUTISM	0.011119850999999998	0.5559925499999999
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.011119850999999998	0.5559925499999999
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.011119850999999998	0.5559925499999999
EPILEPSY, BENIGN OCCIPITAL	0.011119850999999998	0.5559925499999999
CHROMOSOME 15q11-q13 DUPLICATION SYNDROME	0.011119850999999998	0.5559925499999999
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.011119850999999998	0.5559925499999999
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.011119850999999998	0.5559925499999999
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.011119850999999998	0.5559925499999999
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.011119850999999998	0.5559925499999999
#610758 CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4	0.011047982	0.5523991
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.011016751	0.55083755
KAPUR-TORIELLO SYNDROME	0.011016751	0.55083755
RENPENNING SYNDROME 1; RENS1	0.011016751	0.55083755
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.011016751	0.55083755
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.011016751	0.55083755
GAUCHER DISEASE, PERINATAL LETHAL	0.011002861	0.55014305
#214500 CHEDIAK-HIGASHI SYNDROME; CHS	0.011002861	0.55014305
EPISODIC ATAXIA, TYPE 6	0.010971121	0.54855605
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.010944882000000001	0.5472441
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.010944882000000001	0.5472441
LAMB-SHAFFER SYNDROME	0.010944882000000001	0.5472441
NOONAN SYNDROME 11; NS11	0.010944882000000001	0.5472441
CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME	0.010944882000000001	0.5472441
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.010944882000000001	0.5472441
#611936 CHROMOSOME 3q29 DUPLICATION SYNDROME;;MICRODUPLICATION 3q29 SYNDROME	0.010944882000000001	0.5472441
#300895 OHDO SYNDROME, X-LINKED; OHDOX;;BLEPHAROPHIMOSIS-MENTAL RETARDATION SYNDROME, MAAT-KIEVIT-BRUNNERTYPE	0.010944882000000001	0.5472441
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.010930992	0.5465496000000001
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.010930992	0.5465496000000001
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.010884350000000001	0.5442175
MAPLE SYRUP URINE DISEASE; MSUD	0.010726231	0.53631155
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.010726231	0.53631155
WARBURG MICRO SYNDROME 1	0.01062648	0.531324
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.010624491	0.53122455
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.010624491	0.53122455
DYSOSTEOSCLEROSIS	0.010624491	0.53122455
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.010624491	0.53122455
HYPERMANGANESEMIA WITH DYSTONIA 2	0.010552622000000001	0.5276311
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.010552622000000001	0.5276311
AICARDI-GOUTIERES SYNDROME 6	0.010552622000000001	0.5276311
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.010552622000000001	0.5276311
SNEDDON SYNDROME	0.010527460999999998	0.5263730499999999
#612462 PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C;;PHP IC	0.010349711	0.51748555
#613707 LEOPARD SYNDROME 3; LPRD3	0.010349711	0.51748555
#103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A;;PHP IA;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITH MULTIPLE HORMONE RESISTANCE	0.010349711	0.51748555
HYPERLYSINEMIA, TYPE I	0.010349711	0.51748555
Myhre syndrome	0.010282571	0.51412855
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.010277842	0.5138921000000001
BARDET-BIEDL SYNDROME 8; BBS8	0.010277842	0.5138921000000001
BARDET-BIEDL SYNDROME 17; BBS17	0.010277842	0.5138921000000001
BARDET-BIEDL SYNDROME 16; BBS16	0.010277842	0.5138921000000001
#300257 DANON DISEASE;;VACUOLAR CARDIOMYOPATHY AND MYOPATHY, X-LINKED;;PSEUDOGLYCOGENOSIS II;;ANTOPOL DISEASE;;LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY,FORMERLY;;GLYCOGEN STORAGE DISEASE IIb; GSD2B, FORMERLY;;GSD IIb, FORMERLY	0.010277842	0.5138921000000001
#300555 DENT DISEASE 2	0.010277842	0.5138921000000001
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.010277842	0.5138921000000001
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.010277842	0.5138921000000001
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.010246553	0.51232765
BARDET-BIEDL SYNDROME 1; BBS1	0.010210701999999999	0.5105350999999999
JOUBERT SYNDROME 14	0.010210701999999999	0.5105350999999999
ELECTROENCEPHALOGRAPHIC PATTERNS	0.010204099999999999	0.5102049999999999
MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION	0.010204099999999999	0.5102049999999999
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.010204099999999999	0.5102049999999999
#614096 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 8; COXPD8;;CARDIOMYOPATHY, HYPERTROPHIC MITOCHONDRIAL, FATAL INFANTILE	0.010204099999999999	0.5102049999999999
ELECTROENCEPHALOGRAPHIC PECULIARITY: 14 AND 6 PER SEC. POSITIVE SPIKEPHENOMENON	0.010204099999999999	0.5102049999999999
SACCHAROPINURIA	0.010204099999999999	0.5102049999999999
SCHIZOPHRENIA	0.010204099999999999	0.5102049999999999
ELECTROENCEPHALOGRAPHIC PECULIARITY: FRONTO-PRECENTRAL BETA WAVE GROUPS	0.010204099999999999	0.5102049999999999
ELECTROENCEPHALOGRAPHIC PECULIARITY: OCCIPITAL SLOW BETA WAVES	0.010204099999999999	0.5102049999999999
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.010101	0.50505
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.010101	0.50505
NOSE, ANOMALOUS SHAPE OF	0.010101	0.50505
OROFACIAL CLEFT 15	0.010101	0.50505
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.010101	0.50505
260150 PALANT CLEFT PALATE SYNDROME	0.010101	0.50505
15q26 overgrowth syndrome	0.010101	0.50505
BARBER-SAY SYNDROME; BBRSAY	0.010101	0.50505
#215150 OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA; OSMED;;CHONDRODYSTROPHY WITH SENSORINEURAL DEAFNESS;;NANCE-INSLEY SYNDROME;;NANCE-SWEENEY CHONDRODYSPLASIA	0.010101	0.50505
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.010101	0.50505
VELOCARDIOFACIAL SYNDROME	0.010101	0.50505
#608980 BIFID NOSE WITH OR WITHOUT ANORECTAL AND RENAL ANOMALIES; BNAR	0.010101	0.50505
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.010101	0.50505
FACIAL ECTODERMAL DYSPLASIA	0.010101	0.50505
RUIJS-AALFS SYNDROME; RJALS	0.010101	0.50505
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.010101	0.50505
OROFACIODIGITAL SYNDROME III	0.010101	0.50505
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.010101	0.50505
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.010101	0.50505
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.010101	0.50505
CHROMOSOME 1q21.1 DELETION SYNDROME, 1.35-MB	0.010101	0.50505
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.010101	0.50505
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.010101	0.50505
#603554 OMENN SYNDROME;;RETICULOENDOTHELIOSIS, FAMILIAL, WITH EOSINOPHILIA;;SEVERE COMBINED IMMUNODEFICIENCY WITH HYPEREOSINOPHILIA	0.01008711	0.5043555
#615085 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 8; OPTB8	0.01008711	0.5043555
ERYTHROLEUKEMIA, FAMILIAL, SUSCEPTIBILITY TO; FERLK	0.01008711	0.5043555
SEA-BLUE HISTIOCYTE DISEASE	0.01008711	0.5043555
THROMBOCYTOPENIA, ANEMIA, AND MYELOFIBROSIS; THAMY	0.01008711	0.5043555
#608233 HERMANSKY-PUDLAK SYNDROME 2; HPS2	0.01008711	0.5043555
#314050 THROMBOCYTOPENIA WITH BETA-THALASSEMIA, X-LINKED; XLTT;;THROMBOCYTOPENIA, PLATELET DYSFUNCTION, HEMOLYSIS, AND IMBALANCEDGLOBIN SYNTHESIS	0.01008711	0.5043555
IMMUNODEFICIENCY 52; IMD52	0.01008711	0.5043555
#263300 POLYCYTHEMIA VERA;;PV;;POLYCYTHEMIA RUBRA VERA; PRV	0.01008711	0.5043555
#613011 LYMPHOPROLIFERATIVE SYNDROME 1; LPFS1	0.01008711	0.5043555
#139090 GRAY PLATELET SYNDROME; GPS;;BLEEDING DISORDER, PLATELET-TYPE, 4; BDPLT4;;PLATELET ALPHA-GRANULE DEFICIENCY	0.01008711	0.5043555
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.01008711	0.5043555
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.01008711	0.5043555
TRANSALDOLASE DEFICIENCY	0.01008711	0.5043555
VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE	0.010055370000000001	0.5027685000000001
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.010055370000000001	0.5027685000000001
LESCH-NYHAN SYNDROME; LNS	0.010055370000000001	0.5027685000000001
FOLATE MALABSORPTION, HEREDITARY	0.010005553	0.50027765
#249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA,DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUSAND SENSORINEURAL DEAFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA	0.010005553	0.50027765
SPINOCEREBELLAR ATAXIA 23; SCA23	0.00985124	0.49256200000000006
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00970874	0.485437
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.00970874	0.485437
#271930 STRIATONIGRAL DEGENERATION, INFANTILE; SNDI;;INFANTILE BILATERAL STRIATAL NECROSIS; IBSN;;BILATERAL STRIATAL NECROSIS, INFANTILE;;STRIATAL DEGENERATION, FAMILIAL	0.00970874	0.485437
CHIARI MALFORMATION TYPE II	0.00960635	0.48031749999999995
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00945472	0.472736
#212840 CEREBELLAR ATAXIA AND HYPOGONADOTROPIC HYPOGONADISM; CAHH;;GORDON HOLMES SYNDROME;;LUTEINIZING HORMONE-RELEASING HORMONE, DEFICIENCY OF, WITH ATAXIA;;LHRH DEFICIENCY AND ATAXIA	0.00945472	0.472736
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.00943396	0.471698
SECKEL SYNDROME 4	0.00943396	0.471698
BARDET-BIEDL SYNDROME 18; BBS18	0.00943396	0.471698
FLOATING-HARBOR SYNDROME	0.00943396	0.471698
COWCHOCK SYNDROME; COWCK	0.00943396	0.471698
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.00943396	0.471698
SCLEROSTEOSIS 1; SOST1	0.00943396	0.471698
TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE	0.00943396	0.471698
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	0.00943396	0.471698
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.00943396	0.471698
#615418 MITOCHONDRIAL DNA DEPLETION SYNDROME 12 (CARDIOMYOPATHIC TYPE); MTDPS12	0.00943396	0.471698
BARDET-BIEDL SYNDROME 10; BBS10	0.00943396	0.471698
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5	0.00943396	0.471698
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.00943396	0.471698
BARDET-BIEDL SYNDROME 12; BBS12	0.00943396	0.471698
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00943396	0.471698
BARDET-BIEDL SYNDROME 5; BBS5	0.00943396	0.471698
#612463 PSEUDOPSEUDOHYPOPARATHYROIDISM; PPHP;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITHOUT MULTIPLE HORMONE RESISTANCE	0.00943396	0.471698
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12	0.00943396	0.471698
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.00943396	0.471698
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00943396	0.471698
SCHIZOPHRENIA 19; SCZD19	0.00943396	0.471698
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.009425493	0.47127465
EMANUEL SYNDROME	0.009425493	0.47127465
THYROCEREBRORETINAL SYNDROME	0.009161671	0.45808355
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.009089802000000001	0.45449010000000006
CHROMOSOME 19p13.13 DELETION SYNDROME	0.009006013	0.45030065
#207800 ARGININEMIA;;ARGINASE DEFICIENCY;;HYPERARGININEMIA;;ARG1 DEFICIENCY	0.009006013	0.45030065
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	0.009006013	0.45030065
3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.009006013	0.45030065
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.009006013	0.45030065
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.009006013	0.45030065
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.009006013	0.45030065
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.009006013	0.45030065
#270700 SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE; SPG15;;SPASTIC PARAPLEGIA AND RETINAL DEGENERATION;;KJELLIN SYNDROME	0.00895732	0.447866
HOLOPROSENCEPHALY 2; HPE2	0.008801883	0.44009415
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.008801883	0.44009415
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.008801883	0.44009415
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.008801883	0.44009415
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.008801883	0.44009415
HOLOPROSENCEPHALY 7	0.008801883	0.44009415
LISSENCEPHALY 4	0.008801883	0.44009415
PETERS-PLUS SYNDROME; PTRPLS	0.008801883	0.44009415
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.008801883	0.44009415
TEMTAMY SYNDROME; TEMTYS	0.008801883	0.44009415
#218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN;;CHARLEVOIX DISEASE;;ANDERMANN SYNDROME;;POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUSCALLOSUM;;CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY	0.008801883	0.44009415
VICI SYNDROME; VICIS	0.008801883	0.44009415
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.008801883	0.44009415
BAND HETEROTOPIA; BH	0.008801883	0.44009415
GABA-TRANSAMINASE DEFICIENCY	0.008801883	0.44009415
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.008801883	0.44009415
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.008801883	0.44009415
JABERI-ELAHI SYNDROME; JABELS	0.008801883	0.44009415
HOLOPROSENCEPHALY 1; HPE1	0.008801883	0.44009415
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.008729022999999999	0.43645114999999995
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.008650253	0.43251265
#235700 HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY	0.00848692	0.424346
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.00848692	0.424346
#185020 CRYOHYDROCYTOSIS; CHC;;STOMATOCYTOSIS, COLD-SENSITIVE	0.00848692	0.424346
#127550 DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 1; DKCA1;;DYSKERATOSIS CONGENITA, SCOGGINS TYPE	0.00824592	0.412296
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00824592	0.412296
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.008162131	0.40810654999999996
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.008162131	0.40810654999999996
PAPILLOMA OF CHOROID PLEXUS	0.008162131	0.40810654999999996
#229600 FRUCTOSE INTOLERANCE, HEREDITARY;;FRUCTOSEMIA;;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;;ALDOLASE B DEFICIENCY;;ALDOB DEFICIENCY	0.008162131	0.40810654999999996
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.008152853	0.40764265
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.008090262	0.40451310000000007
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.008058162	0.40290810000000005
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.007958001	0.39790004999999995
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.007958001	0.39790004999999995
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.007958001	0.39790004999999995
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.007958001	0.39790004999999995
FRYNS SYNDROME; FRNS	0.007958001	0.39790004999999995
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.007958001	0.39790004999999995
BARAITSER-WINTER SYNDROME 2; BRWS2	0.007958001	0.39790004999999995
MARDEN-WALKER SYNDROME	0.007958001	0.39790004999999995
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.007958001	0.39790004999999995
#309520 LUJAN-FRYNS SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS	0.007958001	0.39790004999999995
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.007958001	0.39790004999999995
#218600 BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	0.007958001	0.39790004999999995
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.007907963	0.39539815
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.007907963	0.39539815
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.007907962999999999	0.39539814999999995
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.007907962999999999	0.39539814999999995
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.007886132	0.3943066
#614402 MICROPHTHALMIA, SYNDROMIC 11; MCOPS11	0.007886132	0.3943066
CRANIOSYNOSTOSIS 6; CRS6	0.007886132	0.3943066
SEPTOOPTIC DYSPLASIA	0.007886132	0.3943066
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.007886132	0.3943066
CURRY-JONES SYNDROME	0.007886132	0.3943066
GENITOPATELLAR SYNDROME; GTPTS	0.007886132	0.3943066
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.007886132	0.3943066
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.007886132	0.3943066
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.007886132	0.3943066
HOLOPROSENCEPHALY 11	0.007886132	0.3943066
CRANIOTELENCEPHALIC DYSPLASIA	0.007886132	0.3943066
#600638 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULARINVOLVEMENT; CFEOM3A;;FEOM3 LOCUS	0.007886132	0.3943066
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.007886132	0.3943066
HARTSFIELD SYNDROME; HRTFDS	0.007886132	0.3943066
KEUTEL SYNDROME; KTLS	0.007718471	0.38592355
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.007718471	0.38592355
NEUROFIBROMATOSIS, TYPE I	0.007718471	0.38592355
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.007718471	0.38592355
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.007718471	0.38592355
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.007646602	0.3823301
CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME	0.007646602	0.3823301
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.007646602	0.3823301
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.007646602	0.3823301
REVESZ SYNDROME	0.007489612	0.3744806
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.007441453	0.37207265
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	0.007441453	0.37207265
MIRAGE SYNDROME; MIRAGE	0.007441453	0.37207265
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X	0.007441453	0.37207265
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	0.007441453	0.37207265
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.007308971	0.36544855
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.007308971	0.36544855
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.007308971	0.36544855
ALPHA-METHYLACETOACETIC ACIDURIA	0.00724638	0.362319
ESOPHAGITIS, EOSINOPHILIC, 1; EOE1	0.00724638	0.362319
#177735 PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT; PHA1A;;PHA I, AUTOSOMAL DOMINANT	0.00724638	0.362319
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.00724638	0.362319
SUCCINYL-COA:3-OXOACID COA TRANSFERASE DEFICIENCY	0.00724638	0.362319
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib; CDG1B	0.00724638	0.362319
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.00724638	0.362319
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.00724638	0.362319
#264350 PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B;;PHA I, AUTOSOMAL RECESSIVE	0.00724638	0.362319
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	0.00724638	0.362319
PORPHYRIA, ACUTE HEPATIC	0.00724638	0.362319
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00724638	0.362319
LIVER FAILURE, INFANTILE, TRANSIENT	0.00724638	0.362319
EPISODIC ATAXIA, TYPE 3	0.00724638	0.362319
118301 CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM	0.00724638	0.362319
CHYLOMICRON RETENTION DISEASE	0.00724638	0.362319
MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD	0.00724638	0.362319
#602722 RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE; RTADR;;RTA, DISTAL, AUTOSOMAL RECESSIVE;;RENAL TUBULAR ACIDOSIS, AUTOSOMAL RECESSIVE, WITH PRESERVED HEARINGRENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE, WITH LATE-ONSETSENSORINEURAL HEARING LOSS, INCLUDED	0.00724638	0.362319
CONGENITAL SHORT BOWEL SYNDROME	0.00724638	0.362319
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.00724638	0.362319
VISCERAL MYOPATHY; VSCM	0.00724638	0.362319
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	0.00724638	0.362319
VALINEMIA	0.00724638	0.362319
%241150 HYPOKALEMIC ALKALOSIS, FAMILIAL, WITH SPECIFIC RENAL TUBULOPATHY;;HYPOKALEMIA, FAMILIAL;;GULLNER SYNDROME	0.00724638	0.362319
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.00724638	0.362319
#308940 LEIOMYOMATOSIS, DIFFUSE, WITH ALPORT SYNDROME; DL-ATS;;LEIOMYOMATOSIS, ESOPHAGEAL AND VULVAL, WITH NEPHROPATHY;;ALPORT SYNDROME AND DIFFUSE LEIOMYOMATOSIS; ATS-DL;;CHROMOSOME Xq22.3 CENTROMERIC DELETION SYNDROME	0.00724638	0.362319
ACID PHOSPHATASE DEFICIENCY	0.00724638	0.362319
DIARRHEA 4, MALABSORPTIVE, CONGENITAL	0.00724638	0.362319
ANGIOEDEMA, HEREDITARY, TYPE I; HAE1	0.00724638	0.362319
HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	0.00724638	0.362319
MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	0.00724638	0.362319
ENTEROPATHY, FAMILIAL, WITH VILLOUS EDEMA AND IMMUNOGLOBULIN G2 DEFICIENCY	0.00724638	0.362319
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	0.00724638	0.362319
ESOPHAGITIS, EOSINOPHILIC, 2; EOE2	0.00724638	0.362319
PORPHYRIA VARIEGATA	0.00724638	0.362319
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	0.00724638	0.362319
MEDIUM CHAIN 3-KETOACYL-COA THIOLASE DEFICIENCY	0.00724638	0.362319
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE-2 DEFICIENCY	0.00724638	0.362319
GALACTOSEMIA	0.00724638	0.362319
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.00724638	0.362319
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.00724638	0.362319
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.00724638	0.362319
ANGIOEDEMA, HEREDITARY, TYPE III	0.00724638	0.362319
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.00724638	0.362319
DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR7	0.00724638	0.362319
SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT	0.00724638	0.362319
5-@OXOPROLINASE DEFICIENCY; OPLAHD	0.00724638	0.362319
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	0.00724638	0.362319
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	0.00724638	0.362319
175500 POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES;;CRONKHITE-CANADA SYNDROME	0.00724638	0.362319
#607694 LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/ORHYPOGONADOTROPIC HYPOGONADISM; HLD7;;LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION;;ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION; ADDH;;LEUKODYSTROPHY, HYPOMYELINATING, WITH HYPODONTIA AND HYPOGONADOTROPICHYPOGONADISM;;4H SYNDROME	0.007237102	0.3618551
TURNPENNY-FRY SYNDROME; TPFS	0.007237102	0.3618551
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.007237102	0.3618551
#610185 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME2; CAMRQ2;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 2	0.007237102	0.3618551
CHROMOSOME 1p35 DELETION SYNDROME	0.007132723	0.35663615
LEIGH SYNDROME; LS	0.007132723	0.35663615
PELIZAEUS-MERZBACHER DISEASE	0.007132723	0.35663615
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.007132723	0.35663615
#612716 DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY;;SEPIAPTERIN REDUCTASE DEFICIENCY;;SPR DEFICIENCY	0.007132723	0.35663615
OROFACIODIGITAL SYNDROME XV; OFD15	0.00704225	0.3521125
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00704225	0.3521125
MASA SYNDROME	0.00704225	0.3521125
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00704225	0.3521125
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.00704225	0.3521125
FOCAL DERMAL HYPOPLASIA; FDH	0.00704225	0.3521125
SCHIZENCEPHALY	0.00704225	0.3521125
CHROMOSOME 3q13.31 DELETION SYNDROME	0.00704225	0.3521125
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00704225	0.3521125
PSEUDOTRISOMY 13 SYNDROME	0.00704225	0.3521125
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00704225	0.3521125
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00704225	0.3521125
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00704225	0.3521125
HYDROLETHALUS SYNDROME 1	0.00704225	0.3521125
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00704225	0.3521125
HEMIFACIAL MICROSOMIA	0.00704225	0.3521125
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.00704225	0.3521125
#101200 APERT SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE I; ACS1;;ACS IAPERT-CROUZON DISEASE, INCLUDED;;ACROCEPHALOSYNDACTYLY, TYPE II, INCLUDED;;ACS II, INCLUDED;;VOGT CEPHALODACTYLY, INCLUDED	0.00704225	0.3521125
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00704225	0.3521125
STROMME SYNDROME; STROMS	0.00704225	0.3521125
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.00704225	0.3521125
ASPLENIA WITH CARDIOVASCULAR ANOMALIES	0.00704225	0.3521125
AGNATHIA-OTOCEPHALY COMPLEX	0.00704225	0.3521125
MIRROR MOVEMENTS 1; MRMV1	0.00704225	0.3521125
OROFACIODIGITAL SYNDROME V; OFD5	0.00704225	0.3521125
#613091 ASPHYXIATING THORACIC DYSTROPHY 3; ATD3	0.00704225	0.3521125
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00704225	0.3521125
FETAL AKINESIA SYNDROME, X-LINKED	0.00704225	0.3521125
HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS	0.00704225	0.3521125
#614120 HYDROLETHALUS SYNDROME 2; HLS2	0.00704225	0.3521125
MECKEL SYNDROME 12; MKS12	0.00704225	0.3521125
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00704225	0.3521125
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.006992211999999999	0.3496106
JOUBERT SYNDROME 21	0.006992211999999999	0.3496106
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.00696939	0.3484695
#613470 HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASEDEFICIENCY	0.00696939	0.3484695
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00689062	0.34453100000000003
PERRY SYNDROME	0.00689062	0.34453100000000003
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.00689062	0.34453100000000003
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00689062	0.34453100000000003
PSEUDOHYPOALDOSTERONISM, TYPE II	0.00680272	0.340136
IGA NEPHROPATHY, SUSCEPTIBILITY TO, 3	0.00680272	0.340136
#191830 RENAL HYPODYSPLASIA/APLASIA 1; RHDA1;;RENAL ADYSPLASIA;;RENAL AGENESIS;;RENAL APLASIA;;HEREDITARY RENAL APLASIA; HRA	0.00680272	0.340136
%161900 RENAL FAILURE, PROGRESSIVE, WITH HYPERTENSION; RFH1;;NEPHROPATHY, FAMILIAL;;NEPHRITIS, FAMILIAL, WITHOUT DEAFNESS OR OCULAR DEFECT;;RENAL FAILURE, ADULT-ONSET; AORF	0.00680272	0.340136
#614491 PSEUDOHYPOALDOSTERONISM, TYPE IIB; PHA2B	0.00680272	0.340136
LIDDLE SYNDROME 3; LIDLS3	0.00680272	0.340136
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.00680272	0.340136
ABDOMINAL OBESITY-METABOLIC SYNDROME QUANTITATIVE TRAIT LOCUS 2	0.00680272	0.340136
ARTERIAL TORTUOSITY SYNDROME	0.00680272	0.340136
%613944 IgA NEPHROPATHY, SUSCEPTIBILITY TO, 2; IGAN2	0.00680272	0.340136
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1	0.00680272	0.340136
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.00680272	0.340136
LIDDLE SYNDROME 1; LIDLS1	0.00680272	0.340136
ABDOMINAL OBESITY-METABOLIC SYNDROME 1	0.00680272	0.340136
GLYCOGEN STORAGE DISEASE IB	0.00680272	0.340136
GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM	0.00680272	0.340136
GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1; GFND1	0.00680272	0.340136
SCALP-EAR-NIPPLE SYNDROME; SENS	0.00680272	0.340136
#615378 ATRIAL FIBRILLATION, FAMILIAL, 14; ATFB14	0.00680272	0.340136
MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME; MCTO	0.00680272	0.340136
HYPERALDOSTERONISM, FAMILIAL, TYPE IV	0.00680272	0.340136
#614495 PSEUDOHYPOALDOSTERONISM, TYPE IID; PHA2D;;FAMILIAL HYPERKALEMIC HYPERTENSION; FHHT	0.00680272	0.340136
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.00680272	0.340136
#602088 NEPHRONOPHTHISIS 2; NPHP2;;NPH2	0.00680272	0.340136
POLYCYSTIC KIDNEY DISEASE 2	0.00680272	0.340136
POLYCYSTIC KIDNEY DISEASE 3	0.00680272	0.340136
LONG QT SYNDROME 13; LQT13	0.00680272	0.340136
POLYCYSTIC KIDNEY DISEASE 6 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD6	0.00680272	0.340136
#178600 PULMONARY HYPERTENSION, PRIMARY, 1; PPH1;;PHT;;PULMONARY ARTERIAL HYPERTENSION; PAHPULMONARY HYPERTENSION, PRIMARY, DEXFENFLURAMINE-ASSOCIATED, INCLUDED;;PULMONARY HYPERTENSION, PRIMARY, FENFLURAMINE-ASSOCIATED, INCLUDED;;PULMONARY HYPERTENSION, PRIMARY, 1, WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA,INCLUDED;;PPH1 WITH HHT, INCLUDED	0.00680272	0.340136
SECKEL SYNDROME 10; SCKL10	0.00680272	0.340136
HUNTER-MACDONALD SYNDROME	0.00680272	0.340136
ALAGILLE SYNDROME 2	0.00680272	0.340136
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASEDEFICIENCY	0.00680272	0.340136
PITUITARY ADENOMA, GROWTH HORMONE-SECRETING, 1	0.00680272	0.340136
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.00680272	0.340136
IgA NEPHROPATHY, SUSCEPTIBILITY TO, 1; IGAN1	0.00680272	0.340136
#607832 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 3, SUSCEPTIBILITY TO; FSGS3;;GLOMERULOSCLEROSIS, FOCAL SEGMENTAL, 3, SUSCEPTIBILITY TO	0.00680272	0.340136
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.00680272	0.340136
#112410 HYPERTENSION AND BRACHYDACTYLY SYNDROME; HTNB;;BRACHYDACTYLY WITH HYPERTENSION;;BRACHYDACTYLY, TYPE E, WITH SHORT STATURE AND HYPERTENSION;;BILGINTURAN SYNDROME	0.00680272	0.340136
#614473 ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2; GACI2	0.00680272	0.340136
#605115 HYPERTENSION, EARLY-ONSET, AUTOSOMAL DOMINANT, WITH SEVERE EXACERBATIONIN PREGNANCY	0.00680272	0.340136
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.00680272	0.340136
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00680272	0.340136
#194080 DENYS-DRASH SYNDROME; DDS;;DRASH SYNDROME;;WILMS TUMOR AND PSEUDO- OR TRUE HERMAPHRODITISM;;NEPHROPATHY, WILMS TUMOR, AND GENITAL ANOMALIES	0.00680272	0.340136
ATRIOVENTRICULAR SEPTAL DEFECT 3; AVSD3	0.00680272	0.340136
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00680272	0.340136
XFE PROGEROID SYNDROME; XFEPS	0.00680272	0.340136
#218030 APPARENT MINERALOCORTICOID EXCESS; AME;;AME1;;CORTISOL 11-BETA-KETOREDUCTASE DEFICIENCY	0.00680272	0.340136
#601894 GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 2; GFND2;;GLOMERULAR NEPHRITIS, FAMILIAL, WITH FIBRONECTIN DEPOSITS;;FIBRONECTIN GLOMERULOPATHY	0.00680272	0.340136
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.00680272	0.340136
#613677 HYPERALDOSTERONISM, FAMILIAL, TYPE III;;FH III	0.00680272	0.340136
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.00680272	0.340136
POLYCYSTIC KIDNEYS	0.00680272	0.340136
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.00680272	0.340136
ROWLEY-ROSENBERG SYNDROME	0.00680272	0.340136
ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	0.00680272	0.340136
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2	0.00680272	0.340136
GLYCOGEN STORAGE DISEASE Ic; GSD1C	0.00680272	0.340136
LIDDLE SYNDROME 2; LIDLS2	0.00680272	0.340136
GLYCOGEN STORAGE DISEASE IA	0.00680272	0.340136
Paragangliomas 6	0.00680272	0.340136
PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E	0.00680272	0.340136
#104200 ALPORT SYNDROME, AUTOSOMAL DOMINANT	0.00680272	0.340136
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.00680272	0.340136
NEPHRONOPHTHISIS 1	0.00680272	0.340136
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.00680272	0.340136
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2; FSGS2	0.00680272	0.340136
INTRACRANIAL HYPERTENSION, IDIOPATHIC	0.00680272	0.340136
MEDULLARY CYSTIC KIDNEY DISEASE 1; MCKD1	0.00680272	0.340136
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.00680272	0.340136
ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS; ACDMPV	0.00680272	0.340136
PSEUDOHYPOALDOSTERONISM, TYPE IIC	0.00680272	0.340136
HYPERALDOSTERONISM, FAMILIAL, TYPE II; HALD2	0.00680272	0.340136
#613877 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 4; FPLD4;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PLIN1 MUTATIONS	0.00680272	0.340136
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	0.00680272	0.340136
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.00680272	0.340136
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1; ADCAD1	0.00680272	0.340136
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.00680272	0.340136
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.00664573	0.3322865
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.00664573	0.3322865
CEREBELLOPARENCHYMAL DISORDER V	0.00664573	0.3322865
SMITH-KINGSMORE SYNDROME; SKS	0.006597571	0.32987855
PSEUDO-TORCH SYNDROME 2	0.006597571	0.32987855
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.006597571	0.32987855
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.006597571	0.32987855
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.006597571	0.32987855
#610539 GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY	0.006597571	0.32987855
CORNELIA DE LANGE SYNDROME 1	0.006597571	0.32987855
FORSYTHE-WAKELING SYNDROME; FWS	0.0065257019999999995	0.3262851
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.0065257019999999995	0.3262851
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.0065257019999999995	0.3262851
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.0065257019999999995	0.3262851
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.0065257019999999995	0.3262851
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.0065257019999999995	0.3262851
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.0065257019999999995	0.3262851
LIG4 SYNDROME	0.0065257019999999995	0.3262851
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.0065257019999999995	0.3262851
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.0065257019999999995	0.3262851
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.00639322	0.319661
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.00639322	0.319661
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.00639322	0.319661
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.00639322	0.319661
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.006288841	0.31444205
KUFOR-RAKEB SYNDROME	0.006288841	0.31444205
#612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6;;LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIAAND CEREBELLUM; HABC	0.006288841	0.31444205
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.006288841	0.31444205
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.006288841	0.31444205
CEREBELLOPARENCHYMAL DISORDER II	0.006288841	0.31444205
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.006288841	0.31444205
#208900 ATAXIA-TELANGIECTASIA; AT;;AT1;;LOUIS-BAR SYNDROMEAT, COMPLEMENTATION GROUP A, INCLUDED; ATA, INCLUDED;;AT, COMPLEMENTATION GROUP C, INCLUDED; ATC, INCLUDED;;AT, COMPLEMENTATION GROUP D, INCLUDED; ATD, INCLUDED;;AT, COMPLEMENTATION GROUP E, INCLUDED; ATE, INCLUDED;;ATAXIA-TELANGIECTASIA VARIANT, INCLUDED	0.006288841	0.31444205
GLUTATHIONE SYNTHETASE DEFICIENCY	0.006288841	0.31444205
#615705 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15; SCAR15;;SALIH ATAXIA	0.006288841	0.31444205
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.006216971999999999	0.3108486
MARINESCO-SJOGREN SYNDROME; MSS	0.006216971999999999	0.3108486
PELLAGRA-LIKE SYNDROME	0.006216971999999999	0.3108486
#231550 ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS;;TRIPLE-A SYNDROME;;ALACRIMA-ACHALASIA-ADRENAL INSUFFICIENCY NEUROLOGIC DISORDER;;GLUCOCORTICOID DEFICIENCY AND ACHALASIA;;ALLGROVE SYNDROME;;ADDISONIAN-ACHALASIA SYNDROME;;HYPOADRENALISM WITH ACHALASIA;;ALACRIMA-ACHALASIA-ADDISONIANISM;;ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMAACHALASIA-ALACRIMA SYNDROME, INCLUDED	0.006216971999999999	0.3108486
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.006216971999999999	0.3108486
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.006216971999999999	0.3108486
JOUBERT SYNDROME 32; JBTS32	0.006216971999999999	0.3108486
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.006216971999999999	0.3108486
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.006216971999999999	0.3108486
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.006216971999999999	0.3108486
KAGAMI-OGATA SYNDROME	0.006164923	0.30824615
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.006164923	0.30824615
INFANTILE SIALIC ACID STORAGE DISEASE	0.006164923	0.30824615
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.006164923	0.30824615
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.006164923	0.30824615
CHROMOSOME 10Q26 DELETION SYNDROME	0.005841263	0.29206315
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.005841263	0.29206315
600903 WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT FORM	0.00568182	0.284091
%614200 BLEEDING DISORDER, PLATELET-TYPE, 9; BDPLT9;;GLYCOPROTEIN Ia DEFICIENCY;;GP Ia DEFICIENCY;;COLLAGEN PLATELET RECEPTOR DEFICIENCY	0.00568182	0.284091
IMMUNODEFICIENCY, COMMON VARIABLE, 12; CVID12	0.00568182	0.284091
HERMANSKY-PUDLAK SYNDROME 9	0.00568182	0.284091
THROMBOCYTOPENIA 2	0.00568182	0.284091
BLEEDING DISORDER, PLATELET-TYPE, 17; BDPLT17	0.00568182	0.284091
VON WILLEBRAND DISEASE, TYPE 3; VWD3	0.00568182	0.284091
NEPHROTIC SYNDROME, TYPE 7; NPHS7	0.00568182	0.284091
167850 PANCYTOPENIA AND OCCLUSIVE VASCULAR DISEASE	0.00568182	0.284091
IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX	0.00568182	0.284091
THROMBOCYTOPENIA 5; THC5	0.00568182	0.284091
EOSINOPHILIA, FAMILIAL	0.00568182	0.284091
HEMANGIOMA-THROMBOCYTOPENIA SYNDROME	0.00568182	0.284091
#188025 THROMBOCYTOPENIA, PARIS-TROUSSEAU TYPE; TCPT;;CHROMOSOME 11q23 DELETION SYNDROME	0.00568182	0.284091
IMMUNODEFICIENCY, COMMON VARIABLE, 6; CVID6	0.00568182	0.284091
Bernard-Soulier syndrome	0.00568182	0.284091
#614493 WISKOTT-ALDRICH SYNDROME 2; WAS2;;WIPF1 DEFICIENCY	0.00568182	0.284091
#259710 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 2; OPTB2;;OSTEOPETROSIS, OSTEOCLAST-POOR;;OSTEOPETROSIS, MILD AUTOSOMAL RECESSIVE FORM	0.00568182	0.284091
DEAFNESS, AUTOSOMAL DOMINANT 1	0.00568182	0.284091
Diamond-Blackfan anemia 1	0.00568182	0.284091
THROMBOCYTOPENIA, CYCLIC	0.00568182	0.284091
THROMBOCYTOPENIA WITH ELEVATED SERUM IGA AND RENAL DISEASE	0.00568182	0.284091
BLEEDING DISORDER, PLATELET-TYPE, 21; BDPLT21	0.00568182	0.284091
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.00568182	0.284091
VON WILLEBRAND DISEASE, TYPE 2; VWD2	0.00568182	0.284091
THROMBOCYTOPENIA 6	0.00568182	0.284091
#601709 QUEBEC PLATELET DISORDER; QPD;;BLEEDING DISORDER, PLATELET-TYPE, 5; BDPLT5;;FACTOR V QUEBEC	0.00568182	0.284091
DK PHOCOMELIA SYNDROME	0.00568182	0.284091
BEEMER LETHAL MALFORMATION SYNDROME	0.00568182	0.284091
GIANT PLATELET SYNDROME WITH THROMBOCYTOPENIA	0.00568182	0.284091
FECHTNER SYNDROME	0.00568182	0.284091
THROMBOCYTOPENIA 3	0.00568182	0.284091
PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY	0.00568182	0.284091
BLEEDING DISORDER, PLATELET-TYPE, 15; BDPLT15	0.00568182	0.284091
#227646 FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2;;FAD2;;FANCONI ANEMIA, COMPLEMENTATION GROUP D; FANCD; FACD;;FANCONI PANCYTOPENIA, TYPE 4; FA4	0.00568182	0.284091
#614082 FANCONI ANEMIA, COMPLEMENTATION GROUP G; FANCG	0.00568182	0.284091
#227645 FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC;;FACC; FAC;;FANCONI PANCYTOPENIA, TYPE 3; FA3	0.00568182	0.284091
IVIC SYNDROME	0.00568182	0.284091
PLATELET SIGNAL PROCESSING DEFECT	0.00568182	0.284091
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.00568182	0.284091
BLEEDING DISORDER, PLATELET-TYPE, 20	0.00568182	0.284091
#615715 BONE MARROW FAILURE SYNDROME 2; BMFS2	0.00568182	0.284091
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.00568182	0.284091
FANCONI ANEMIA	0.00568182	0.284091
#612004 THROMBOCYTOPENIA 4; THC4;;THROMBOCYTOPENIA, AUTOSOMAL DOMINANT, 4	0.00568182	0.284091
SEBASTIAN SYNDROME	0.00568182	0.284091
#301000 WISKOTT-ALDRICH SYNDROME; WAS;;WISKOTT-ALDRICH SYNDROME 1; WAS1;;ALDRICH SYNDROME;;ECZEMA-THROMBOCYTOPENIA-IMMUNODEFICIENCY SYNDROME;;IMMUNODEFICIENCY 2; IMD2	0.00568182	0.284091
PLATELET DISORDER, UNDEFINED	0.00568182	0.284091
FANCONI ANEMIA, COMPLEMENTATION GROUP T; FANCT	0.00568182	0.284091
NIJMEGEN BREAKAGE SYNDROME	0.00568182	0.284091
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.00568182	0.284091
WT LIMB-BLOOD SYNDROME	0.00568182	0.284091
JACOBSEN SYNDROME	0.00568182	0.284091
MONOSOMY 7 OF BONE MARROW	0.00568182	0.284091
PLATELET ABNORMALITIES WITH EOSINOPHILIA AND IMMUNE-MEDIATED INFLAMMATORY DISEASE; PLTEID	0.00568182	0.284091
#300835 ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES;XLANP	0.00568182	0.284091
STORMORKEN SYNDROME; STRMK	0.00568182	0.284091
188030 THROMBOCYTOPENIC PURPURA, AUTOIMMUNE; AITP;;IMMUNE THROMBOCYTOPENIC PURPURA; ITP;;IDIOPATHIC THROMBOCYTOPENIC PURPURA	0.00568182	0.284091
#231095 GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD;;GHOSAL SYNDROME	0.00568182	0.284091
#614700 IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY; CVID8	0.00568182	0.284091
SENGERS SYNDROME	0.00568182	0.284091
MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS; MATINS	0.00568182	0.284091
#608404 PLATELET GLYCOPROTEIN IV DEFICIENCY;;BLEEDING DISORDER, PLATELET-TYPE, 10; BDPLT10;;CD36 DEFICIENCY	0.00568182	0.284091
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00568182	0.284091
#613987 DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 2; DKCB2	0.00568182	0.284091
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.00537309	0.26865449999999996
#609270 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 7; SCAR7	0.00537309	0.26865449999999996
SPINOCEREBELLAR ATAXIA 31	0.00537309	0.26865449999999996
MACHADO-JOSEPH DISEASE; MJD	0.00537309	0.26865449999999996
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.00537309	0.26865449999999996
EPISODIC ATAXIA, TYPE 8	0.00537309	0.26865449999999996
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.00537309	0.26865449999999996
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.00537309	0.26865449999999996
ACERULOPLASMINEMIA	0.00537309	0.26865449999999996
#613227 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME3; CAMRQ3;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 3	0.00537309	0.26865449999999996
165200 OPTIC ATROPHY WITH DEMYELINATING DISEASE OF CNS	0.00537309	0.26865449999999996
SPINOCEREBELLAR ATAXIA 37; SCA37	0.00537309	0.26865449999999996
LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK	0.00537309	0.26865449999999996
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.00537309	0.26865449999999996
ICHTHYOSIS, HEPATOSPLENOMEGALY, AND CEREBELLAR DEGENERATION	0.00537309	0.26865449999999996
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00537309	0.26865449999999996
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.00537309	0.26865449999999996
#612674 POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT;PHARC	0.00537309	0.26865449999999996
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.00537309	0.26865449999999996
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.00537309	0.26865449999999996
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.00537309	0.26865449999999996
SPINOCEREBELLAR ATAXIA WITH RIGIDITY AND PERIPHERAL NEUROPATHY	0.00537309	0.26865449999999996
OLIVOPONTOCEREBELLAR ATROPHY II, AUTOSOMAL RECESSIVE	0.00537309	0.26865449999999996
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00537309	0.26865449999999996
SPINOCEREBELLAR ATAXIA 30; SCA30	0.00537309	0.26865449999999996
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.00537309	0.26865449999999996
SANDHOFF DISEASE	0.00537309	0.26865449999999996
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.005343863	0.26719315
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.005343863	0.26719315
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.005343863	0.26719315
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.005343863	0.26719315
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.005343863	0.26719315
#604317 MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICALMALFORMATIONS; MCPH2	0.005343863	0.26719315
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.005343863	0.26719315
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.005343863	0.26719315
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.005343863	0.26719315
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.005343863	0.26719315
CODAS SYNDROME	0.005343863	0.26719315
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.005343863	0.26719315
AL KAISSI SYNDROME; ALKAS	0.005343863	0.26719315
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.005343863	0.26719315
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.005343863	0.26719315
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.005343863	0.26719315
611961 STEVENSON-CAREY SYNDROME	0.005343863	0.26719315
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.005343863	0.26719315
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y	0.005343863	0.26719315
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.005343863	0.26719315
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q	0.005343863	0.26719315
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.005343863	0.26719315
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.005343863	0.26719315
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.005343863	0.26719315
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.005343863	0.26719315
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.005343863	0.26719315
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.005343863	0.26719315
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.005343863	0.26719315
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.005343863	0.26719315
LISSENCEPHALY 8; LIS8	0.005343863	0.26719315
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.005343863	0.26719315
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.005343863	0.26719315
MEHMO SYNDROME; MEHMO	0.005343863	0.26719315
Xq28 (MECP2) duplication	0.005343863	0.26719315
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.005343863	0.26719315
ADAMS-OLIVER SYNDROME 5; AOS5	0.005321041	0.26605205000000004
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.005321041	0.26605205000000004
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.005321041	0.26605205000000004
#252930 MUCOPOLYSACCHARIDOSIS TYPE IIIC;;MPS IIIC; MPS3C;;SANFILIPPO SYNDROME C;;ACETYL-CoA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY	0.005321041	0.26605205000000004
GAUCHER DISEASE, TYPE IIIC	0.005321041	0.26605205000000004
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.005321041	0.26605205000000004
IMMUNODEFICIENCY 47	0.005321041	0.26605205000000004
NEURAMINIDASE DEFICIENCY	0.005321041	0.26605205000000004
MACROCEPHALY/AUTISM SYNDROME	0.005249172	0.2624586
#612714 EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIALHYPEROSTOSIS	0.005249172	0.2624586
OCULOSKELETODENTAL SYNDROME; OCSKD	0.005249172	0.2624586
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.005249172	0.2624586
ROIFMAN SYNDROME; RFMN	0.005249172	0.2624586
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.005249172	0.2624586
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.005249172	0.2624586
LYMPHEDEMA, HEREDITARY, III	0.005249172	0.2624586
ICHTHYOSIS AND MALE HYPOGONADISM	0.004997381	0.24986905
EPILEPSY-TELANGIECTASIA	0.004997381	0.24986905
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.004997381	0.24986905
XYLOSIDASE DEFICIENCY	0.004997381	0.24986905
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.004997381	0.24986905
#215100 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1;;PEROXISOME BIOGENESIS DISORDER 9; PBD9;;CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC FORM; CDPR;;CHONDRODYSTROPHIA CALCIFICANS PUNCTATA	0.004997381	0.24986905
HYPERLEUCINE-ISOLEUCINEMIA	0.004997381	0.24986905
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.004997381	0.24986905
LARSEN-LIKE SYNDROME	0.004925512	0.24627559999999998
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.004925512	0.24627559999999998
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.004568623	0.22843115
#614322 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12;;SPINOCEREBELLAR ATAXIA WITH MENTAL RETARDATION AND EPILEPSY	0.004568623	0.22843115
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.004568623	0.22843115
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.004568623	0.22843115
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.004568623	0.22843115
WEAVER SYNDROME	0.004568623	0.22843115
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.004568623	0.22843115
WAISMAN SYNDROME; WSMN	0.004568623	0.22843115
#177980 PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES;;HASPESLAGH SYNDROME	0.004499981	0.22499905
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.004499981	0.22499905
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.004499981	0.22499905
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.004499981	0.22499905
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.004499981	0.22499905
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.004499981	0.22499905
#615937 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2;MPPH2	0.004499981	0.22499905
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.004499981	0.22499905
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.004499981	0.22499905
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.004499981	0.22499905
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.004499981	0.22499905
#612475 CHROMOSOME 1q21.1 DUPLICATION SYNDROME	0.004499981	0.22499905
#615663 WARBURG MICRO SYNDROME 4; WARBM4	0.004499981	0.22499905
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.004499981	0.22499905
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.004499981	0.22499905
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.004499981	0.22499905
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.004499981	0.22499905
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.004499981	0.22499905
MENTAL RETARDATION, X-LINKED 102	0.004499981	0.22499905
WARBURG MICRO SYNDROME 3; WARBM3	0.004499981	0.22499905
TYSHCHENKO SYNDROME	0.004428112	0.22140559999999998
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.004428112	0.22140559999999998
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.004428112	0.22140559999999998
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.004428112	0.22140559999999998
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.004428112	0.22140559999999998
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.004428112	0.22140559999999998
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.004428112	0.22140559999999998
XIA-GIBBS SYNDROME	0.004428112	0.22140559999999998
OROFACIODIGITAL SYNDROME XIV; OFD14	0.004428112	0.22140559999999998
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.004428112	0.22140559999999998
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.004428112	0.22140559999999998
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.004428112	0.22140559999999998
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.004428112	0.22140559999999998
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.004428112	0.22140559999999998
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.004428112	0.22140559999999998
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.004428112	0.22140559999999998
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.004428112	0.22140559999999998
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.004428112	0.22140559999999998
#615280 CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4	0.004428112	0.22140559999999998
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00440529	0.2202645
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2	0.00440529	0.2202645
OSTEOPETROSIS, AUTOSOMAL DOMINANT 3; OPTA3	0.00440529	0.2202645
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00440529	0.2202645
#612690 SPHEROCYTOSIS, TYPE 5; SPH5;;SPHEROCYTOSIS, HEREDITARY, 5; HS5	0.00440529	0.2202645
CASPASE 8 DEFICIENCY	0.00440529	0.2202645
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00440529	0.2202645
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1	0.00440529	0.2202645
SPHEROCYTOSIS, TYPE 1; SPH1	0.00440529	0.2202645
CHYLOMICRONEMIA, FAMILIAL, DUE TO CIRCULATING INHIBITOR OF LIPOPROTEINLIPASE	0.00440529	0.2202645
THROMBOCYTOSIS, FAMILIAL X-LINKED	0.00440529	0.2202645
#607594 IMMUNODEFICIENCY, COMMON VARIABLE, 1; CVID1;;ANTIBODY DEFICIENCY DUE TO ICOS DEFECTIMMUNODEFICIENCY, COMMON VARIABLE, INCLUDED; CVID, INCLUDED	0.00440529	0.2202645
SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 1; SLC4A1	0.00440529	0.2202645
RED CELL PHOSPHOLIPID DEFECT WITH HEMOLYSIS	0.00440529	0.2202645
#612653 SPHEROCYTOSIS, TYPE 4; SPH4;;SPHEROCYTOSIS, HEREDITARY, 4; HS4	0.00440529	0.2202645
HEMOGLOBIN--BETA LOCUS	0.00440529	0.2202645
Lipodystrophy, congenital generalized, type 2	0.00440529	0.2202645
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	0.00440529	0.2202645
DEHYDRATED HEREDITARY STOMATOCYTOSIS 2; DHS2	0.00440529	0.2202645
#614480 HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE; HTGTI	0.00440529	0.2202645
#228000 FARBER LIPOGRANULOMATOSIS;;FARBER DISEASE;;CERAMIDASE DEFICIENCY;;ACID CERAMIDASE DEFICIENCY;;AC DEFICIENCY;;N-LAURYLSPHINGOSINE DEACYLASE DEFICIENCY	0.00440529	0.2202645
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.00440529	0.2202645
HYPERBILIRUBINEMIA, SHUNT, PRIMARY; PSHB	0.00440529	0.2202645
#604173 POIKILODERMA WITH NEUTROPENIA; PN;;POIKILODERMA WITH NEUTROPENIA, CLERICUZIO-TYPE	0.00440529	0.2202645
HEMOCHROMATOSIS, TYPE 2A	0.00440529	0.2202645
#613978 HEMOGLOBIN H DISEASE; HBH;;ALPHA-THALASSEMIA, HEMOGLOBIN H TYPE;;HEMOGLOBIN H DISEASE, DELETIONALHEMOGLOBIN H DISEASE, NONDELETIONAL, INCLUDED	0.00440529	0.2202645
#611881 GLYCOGEN STORAGE DISEASE XII; GSD12;;GSD XII;;ALDOLASE A DEFICIENCY;;ALDOA DEFICIENCY;;ALDOLASE DEFICIENCY, RED CELL;;RED CELL ALDOLASE DEFICIENCY	0.00440529	0.2202645
SPLENOMEGALY, CYTOPENIA, AND VISION LOSS	0.00440529	0.2202645
#230500 GM1-GANGLIOSIDOSIS, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, INFANTILE FORM;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 1;;BETA-GALACTOSIDASE-1 DEFICIENCY;;GLB1 DEFICIENCYGM1-GANGLIOSIDOSIS, TYPE I, WITH CARDIAC INVOLVEMENT, INCLUDED;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I, WITH CARDIAC INVOLVEMENT,INCLUDED	0.00440529	0.2202645
#616278 BILE ACID SYNTHESIS DEFECT, CONGENITAL, 5; CBAS5	0.00440529	0.2202645
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I; CDG1	0.00440529	0.2202645
CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI	0.00440529	0.2202645
HEMOCHROMATOSIS, TYPE 1	0.00440529	0.2202645
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00440529	0.2202645
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2	0.00440529	0.2202645
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, POSSIBLY DUE TO DEFECT IN PORPHYRINMETABOLISM	0.00440529	0.2202645
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00440529	0.2202645
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH	0.00440529	0.2202645
#613673 ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE IV; CDAN4	0.00440529	0.2202645
NEPHRONOPHTHISIS 19; NPHP19	0.00440529	0.2202645
#224120 ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ia; CDAN1A;;DYSERYTHROPOIETIC ANEMIA, CONGENITAL, TYPE Ia;;CDA Ia;;ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE I	0.00440529	0.2202645
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.00440529	0.2202645
PROTEUS SYNDROME	0.00440529	0.2202645
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.00440529	0.2202645
IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD63	0.00440529	0.2202645
FELTY SYNDROME	0.00440529	0.2202645
SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2	0.00440529	0.2202645
SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX	0.00440529	0.2202645
REYNOLDS SYNDROME	0.00440529	0.2202645
TYROSINEMIA, TYPE I; TYRSN1	0.00440529	0.2202645
OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS; OMPP	0.00440529	0.2202645
CYSTINOSIS, NEPHROPATHIC; CTNS	0.00440529	0.2202645
GLYCOPROTEIN STORAGE DISEASE	0.00440529	0.2202645
GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CDGX	0.00440529	0.2202645
#615513 IMMUNODEFICIENCY 14; IMD14;;ACTIVATED PI3K-DELTA SYNDROME; APDS;;P110-DELTA-ACTIVATING MUTATION CAUSING SENESCENT T CELLS, LYMPHADENOPATHY,AND IMMUNODEFICIENCY; PASLI	0.00440529	0.2202645
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.00440529	0.2202645
#615631 ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ib; CDAN1B;;CDA, TYPE Ib	0.00440529	0.2202645
HYPERLIPOPROTEINEMIA, TYPE ID	0.00440529	0.2202645
BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT; BSSA2	0.00440529	0.2202645
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00440529	0.2202645
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE	0.00440529	0.2202645
#269840 SELECTIVE T-CELL DEFECT; STCD	0.00440529	0.2202645
Lipodystrophy, congenital generalized, type 1	0.00440529	0.2202645
IMMUNODEFICIENCY 60; IMD60	0.00440529	0.2202645
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.00440529	0.2202645
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.00440529	0.2202645
HEMOCHROMATOSIS, TYPE 2B	0.00440529	0.2202645
SPLENOMEGALY SYNDROME WITH SPLENIC GERMINAL CENTER HYPOPLASIA ANDREDUCED CIRCULATING T-HELPER CELLS	0.00440529	0.2202645
ELLIPTOCYTOSIS 1; EL1	0.00440529	0.2202645
B-CELL EXPANSION WITH NFKB AND T-CELL ANERGY; BENTA	0.00440529	0.2202645
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE II; CDG2	0.00440529	0.2202645
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3; PFIC3	0.00440529	0.2202645
ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE II	0.00440529	0.2202645
APOLIPOPROTEIN C-II DEFICIENCY	0.00440529	0.2202645
IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	0.00440529	0.2202645
GLYCOGEN STORAGE DISEASE IXC	0.00440529	0.2202645
ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY; SIDBA3	0.00440529	0.2202645
#185000 OVERHYDRATED HEREDITARY STOMATOCYTOSIS; OHS;;POTASSIUM-SODIUM DISORDER OF ERYTHROCYTE	0.00440529	0.2202645
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00440529	0.2202645
#606367 IMMUNODEFICIENCY 41 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD41;;INTERLEUKIN 2 RECEPTOR, ALPHA, DEFICIENCY OF;;IL2RA DEFICIENCY;;CD25 DEFICIENCY	0.00440529	0.2202645
SPHEROCYTOSIS, TYPE 2	0.00440529	0.2202645
PYRUVATE KINASE DEFICIENCY OF RED CELLS	0.00440529	0.2202645
PERSISTENT POLYCLONAL B-CELL LYMPHOCYTOSIS; PPBL	0.00440529	0.2202645
IMMUNODEFICIENCY 16	0.00440529	0.2202645
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.004323733	0.21618664999999998
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.004323733	0.21618664999999998
#301835 ARTS SYNDROME; ARTS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS;;ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 18; MRXS18	0.004323733	0.21618664999999998
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.004323733	0.21618664999999998
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.004323733	0.21618664999999998
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.004323733	0.21618664999999998
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.004323733	0.21618664999999998
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.004323733	0.21618664999999998
SULFOCYSTEINURIA	0.004323733	0.21618664999999998
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.004323733	0.21618664999999998
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.004323733	0.21618664999999998
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.004323733	0.21618664999999998
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.004323733	0.21618664999999998
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.004323733	0.21618664999999998
Glycosylphosphatidylinositol biosynthesis defect 18	0.004323733	0.21618664999999998
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY	0.004323733	0.21618664999999998
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.004323733	0.21618664999999998
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.004323733	0.21618664999999998
ELEJALDE DISEASE	0.004323733	0.21618664999999998
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C	0.004323733	0.21618664999999998
Cerebral creatine deficiency syndrome 2	0.004323733	0.21618664999999998
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.004323733	0.21618664999999998
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.004323733	0.21618664999999998
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.004323733	0.21618664999999998
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.004323733	0.21618664999999998
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00408163	0.2040815
ACETYLATION, SLOW	0.00408163	0.2040815
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00408163	0.2040815
PREMATURE CENTROMERE DIVISION; PCD	0.00408163	0.2040815
ICHTHYOSIS, X-LINKED	0.00408163	0.2040815
#256050 ATELOSTEOGENESIS, TYPE II; AOII;;AO2;;NEONATAL OSSEOUS DYSPLASIA IDE LA CHAPELLE DYSPLASIA, INCLUDED; DLCD, INCLUDED	0.00408163	0.2040815
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00408163	0.2040815
GLUTATHIONE REDUCTASE	0.00408163	0.2040815
NEUTROPHIL ACTIN DYSFUNCTION	0.00408163	0.2040815
NORMOKALEMIC PERIODIC PARALYSIS	0.00408163	0.2040815
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00408163	0.2040815
EHLERS-DANLOS SYNDROME, TYPE VI	0.00408163	0.2040815
FETAL IODINE DEFICIENCY DISORDER	0.00408163	0.2040815
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00408163	0.2040815
LYMPHOKINE DEFICIENCY	0.00408163	0.2040815
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00408163	0.2040815
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.00408163	0.2040815
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00408163	0.2040815
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00408163	0.2040815
MYOPATHY, SPHEROID BODY	0.00408163	0.2040815
DELETED IN AZOOSPERMIA	0.00408163	0.2040815
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.00408163	0.2040815
LIPASE DEFICIENCY, COMBINED	0.00408163	0.2040815
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00408163	0.2040815
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00408163	0.2040815
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00408163	0.2040815
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00408163	0.2040815
PENDRED SYNDROME	0.00408163	0.2040815
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.00408163	0.2040815
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00408163	0.2040815
PARAOXONASE 1	0.00408163	0.2040815
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00408163	0.2040815
PREMATURE OVARIAN FAILURE 1	0.00408163	0.2040815
OSTEOGENESIS IMPERFECTA, TYPE V	0.00408163	0.2040815
HOOFT DISEASE	0.00408163	0.2040815
HYPERPROGLUCAGONEMIA	0.00408163	0.2040815
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00408163	0.2040815
SPERMATOGENIC FAILURE 1; SPGF1	0.00408163	0.2040815
AREDYLD	0.00408163	0.2040815
MAGNESIUM, ELEVATED RED CELL	0.00408163	0.2040815
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00408163	0.2040815
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00408163	0.2040815
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00408163	0.2040815
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00408163	0.2040815
#203655 ALOPECIA UNIVERSALIS CONGENITA; ALUNC;;ATRICHIA, GENERALIZED	0.00408163	0.2040815
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00408163	0.2040815
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00408163	0.2040815
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00408163	0.2040815
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00408163	0.2040815
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00408163	0.2040815
XANTHINURIA, TYPE I	0.00408163	0.2040815
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.00408163	0.2040815
WHITE SPONGE NEVUS OF CANNON	0.00408163	0.2040815
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00408163	0.2040815
PROPERDIN DEFICIENCY, X-LINKED	0.00408163	0.2040815
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00408163	0.2040815
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00408163	0.2040815
TESTICULAR GERM CELL TUMOR; TGCT	0.00408163	0.2040815
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00408163	0.2040815
%608572 BURN-MCKEOWN SYNDROME	0.00408163	0.2040815
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00408163	0.2040815
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00408163	0.2040815
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00408163	0.2040815
CITRULLINE TRANSPORT DEFECT	0.00408163	0.2040815
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00408163	0.2040815
#301830 SPINAL MUSCULAR ATROPHY, X-LINKED 2; SMAX2;;SPINAL MUSCULAR ATROPHY, X-LINKED LETHAL INFANTILE;;SPINAL MUSCULAR ATROPHY, INFANTILE X-LINKED; XLSMA;;ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, X-LINKED;;AMC, DISTAL, X-LINKED;;ARTHROGRYPOSIS, X-LINKED, TYPE I; AMCX1	0.00408163	0.2040815
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00408163	0.2040815
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00408163	0.2040815
OVARIAN CANCER	0.00408163	0.2040815
#270300 PEELING SKIN SYNDROME 1; PSS1;;PSS;;SKIN PEELING, FAMILIAL CONTINUOUS GENERALIZED;;KERATOLYSIS EXFOLIATIVA CONGENITA;;DECIDUOUS SKIN	0.00408163	0.2040815
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00408163	0.2040815
HYPOASCORBEMIA	0.00408163	0.2040815
LACTOSE INTOLERANCE, ADULT TYPE	0.00408163	0.2040815
GLOMUVENOUS MALFORMATIONS	0.00408163	0.2040815
CARBOXYLESTERASE 1	0.00408163	0.2040815
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00408163	0.2040815
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00408163	0.2040815
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00408163	0.2040815
PROGESTERONE RESISTANCE	0.00408163	0.2040815
CALVARIAL HYPEROSTOSIS	0.00408163	0.2040815
MACULAR DYSTROPHY, CORNEAL, 1	0.00408163	0.2040815
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00408163	0.2040815
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00408163	0.2040815
OSTEOGENIC SARCOMA	0.00408163	0.2040815
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00408163	0.2040815
ETHANOLAMINOSIS	0.00408163	0.2040815
DERMATOLEUKODYSTROPHY	0.00408163	0.2040815
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00408163	0.2040815
#217095 CONOTRUNCAL HEART MALFORMATIONS; CTHMTRUNCUS ARTERIOSUS COMMUNIS, INCLUDED;;CONOTRUNCAL ANOMALY FACE SYNDROME, INCLUDED; CAFS, INCLUDED;;DOUBLE-OUTLET RIGHT VENTRICLE, INCLUDED; DORV, INCLUDED;;PERSISTENT TRUNCUS ARTERIOSUS, INCLUDED; PTA, INCLUDED;;INTERRUPTED AORTIC ARCH, INCLUDED	0.00408163	0.2040815
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00408163	0.2040815
SCHIZOPHRENIA 4	0.00408163	0.2040815
ALAND ISLAND EYE DISEASE	0.00408163	0.2040815
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00408163	0.2040815
CATECHOL-O-METHYLTRANSFERASE	0.00408163	0.2040815
ZINC, ELEVATED PLASMA	0.00408163	0.2040815
APOLIPOPROTEIN(A)	0.00408163	0.2040815
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00408163	0.2040815
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00408163	0.2040815
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.00408163	0.2040815
KERATOSIS, FAMILIAL ACTINIC	0.00408163	0.2040815
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.00408163	0.2040815
#143860 HYPERCHLORHIDROSIS, ISOLATED	0.00408163	0.2040815
CHOROIDAL OSTEOMA, BILATERAL	0.00408163	0.2040815
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00408163	0.2040815
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00408163	0.2040815
FINGERPRINT BODY MYOPATHY	0.00408163	0.2040815
PITUITARY DWARFISM IV	0.00408163	0.2040815
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00408163	0.2040815
PYGMY	0.00408163	0.2040815
ONCOCYTOMA	0.00408163	0.2040815
BEETURIA	0.00408163	0.2040815
CONE-ROD DYSTROPHY 1; CORD1	0.00408163	0.2040815
NEPHROSIALIDOSIS	0.00408163	0.2040815
SERTOLI CELL-ONLY SYNDROME	0.00408163	0.2040815
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00408163	0.2040815
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00408163	0.2040815
#609152 HYPERTHYROIDISM, NONAUTOIMMUNE;;HYPERTHYROIDISM, CONGENITAL NONAUTOIMMUNE;;HYPERTHYROIDISM, NONAUTOIMMUNE, AUTOSOMAL DOMINANT;;TOXIC THYROID HYPERPLASIA, AUTOSOMAL DOMINANT	0.00408163	0.2040815
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00408163	0.2040815
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00408163	0.2040815
TRISOMY 18-LIKE SYNDROME	0.00408163	0.2040815
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.00408163	0.2040815
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.00408163	0.2040815
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00408163	0.2040815
DERMATITIS, ATOPIC	0.00408163	0.2040815
#270960 SPERMATOGENIC FAILURE 4; SPGF4;;AZOOSPERMIA DUE TO PERTURBATIONS OF MEIOSIS;;AZOOSPERMIA WITH MATURATION ARREST;;SPERMATOGENESIS ARRESTPREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 4; RPRGL4	0.00408163	0.2040815
HEINZ BODY ANEMIAS	0.00408163	0.2040815
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00408163	0.2040815
#301200 AMELOGENESIS IMPERFECTA, TYPE IE; AI1E;;AMELOGENESIS IMPERFECTA, HYPOPLASTIC/HYPOMATURATION, X-LINKED 1;;AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, WITH SNOW-CAPPED TEETH;;AMELOGENESIS IMPERFECTA, X-LINKED 1; AIH1;;ENAMEL HYPOPLASIA, X-LINKED	0.00408163	0.2040815
GLUTATHIONURIA	0.00408163	0.2040815
SPINAL ARACHNOIDITIS	0.00408163	0.2040815
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00408163	0.2040815
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00408163	0.2040815
LUTHERAN SUPPRESSOR, X-LINKED	0.00408163	0.2040815
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00408163	0.2040815
#309548 MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE;;FRAXE MENTAL RETARDATION SYNDROME	0.00408163	0.2040815
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00408163	0.2040815
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00408163	0.2040815
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00408163	0.2040815
LARON SYNDROME	0.00408163	0.2040815
T-SUBSTANCE ANOMALY	0.00408163	0.2040815
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00408163	0.2040815
PACMAN DYSPLASIA	0.00408163	0.2040815
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.00408163	0.2040815
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00408163	0.2040815
#192600 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1;;CMH;;VENTRICULAR HYPERTROPHY, HEREDITARY;;ASYMMETRIC SEPTAL HYPERTROPHY; ASH;;HYPERTROPHIC SUBAORTIC STENOSIS, IDIOPATHIC	0.00408163	0.2040815
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00408163	0.2040815
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00408163	0.2040815
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00408163	0.2040815
257960 OCULOTRICHODYSPLASIA; OTD	0.00408163	0.2040815
#225250 HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 5; CHNG5	0.00408163	0.2040815
OCULORENOCEREBELLAR SYNDROME	0.00408163	0.2040815
XM SYSTEM	0.00408163	0.2040815
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00408163	0.2040815
ALKAPTONURIA	0.00408163	0.2040815
URATE-BINDING GLOBULIN, DECREASE IN	0.00408163	0.2040815
CARDIAC LIPIDOSIS, FAMILIAL	0.00408163	0.2040815
GONADOBLASTOMA	0.00408163	0.2040815
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00408163	0.2040815
POLYCYSTIC OVARY SYNDROME 1	0.00408163	0.2040815
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00408163	0.2040815
#608747 INSULIN-LIKE GROWTH FACTOR I DEFICIENCY;;IGF1 DEFICIENCY;;GROWTH RETARDATION WITH SENSORINEURAL DEAFNESS AND MENTAL RETARDATION	0.00408163	0.2040815
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00408163	0.2040815
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00408163	0.2040815
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.003724741	0.18623705000000002
SPINOCEREBELLAR ATAXIA 47; SCA47	0.003724741	0.18623705000000002
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.003724741	0.18623705000000002
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.003724741	0.18623705000000002
#520000 DIABETES AND DEAFNESS, MATERNALLY INHERITED; MIDD;;DIABETES-DEAFNESS SYNDROME, MATERNALLY TRANSMITTED;;BALLINGER-WALLACE SYNDROME;;DIABETES MELLITUS, TYPE II, WITH DEAFNESS;;NONINSULIN-DEPENDENT DIABETES MELLITUS WITH DEAFNESS;;NIDDM WITH DEAFNESS	0.003724741	0.18623705000000002
#603516 SPINOCEREBELLAR ATAXIA 10; SCA10	0.003724741	0.18623705000000002
ALZHEIMER DISEASE 3; AD	0.003724741	0.18623705000000002
#607136 SPINOCEREBELLAR ATAXIA 17; SCA17;;HUNTINGTON DISEASE-LIKE 4; HDL4	0.003724741	0.18623705000000002
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.003724741	0.18623705000000002
#200150 CHOREOACANTHOCYTOSIS; CHAC;;LEVINE-CRITCHLEY SYNDROME;;ACANTHOCYTOSIS WITH NEUROLOGIC DISORDER;;NEUROACANTHOCYTOSIS;;CHOREA-ACANTHOCYTOSIS	0.003724741	0.18623705000000002
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.003724741	0.18623705000000002
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.0036528719999999997	0.1826436
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.0036528719999999997	0.1826436
#275900 SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20;;TROYER SYNDROME;;SPASTIC PARAPARESIS, CHILDHOOD-ONSET, WITH DISTAL MUSCLE WASTING;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, TROYER TYPE	0.0036528719999999997	0.1826436
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.0036528719999999997	0.1826436
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.0036528719999999997	0.1826436
PEROXISOME BIOGENESIS DISORDER 5B	0.0036528719999999997	0.1826436
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.0036528719999999997	0.1826436
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.0036528719999999997	0.1826436
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.0036528719999999997	0.1826436
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.0036528719999999997	0.1826436
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.0036528719999999997	0.1826436
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.0036528719999999997	0.1826436
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00358423	0.1792115
%611252 SPASTIC PARAPLEGIA 32, AUTOSOMAL RECESSIVE; SPG32	0.00358423	0.1792115
FRONTONASAL DYSPLASIA 2; FND2	0.00358423	0.1792115
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00358423	0.1792115
FONTAINE PROGEROID SYNDROME; FPS	0.00358423	0.1792115
ANIRIDIA	0.00358423	0.1792115
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00358423	0.1792115
VAN MALDERGEM SYNDROME 2; VMLDS2	0.00358423	0.1792115
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.00358423	0.1792115
CEREBROOCULONASAL SYNDROME	0.00358423	0.1792115
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.00358423	0.1792115
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00358423	0.1792115
#182600 SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT; SPG3A;;SPG3;;STRUMPELL DISEASE;;FAMILIAL SPASTIC PARAPLEGIA, AUTOSOMAL DOMINANT, 1; FSP1	0.00358423	0.1792115
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00358423	0.1792115
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.00358423	0.1792115
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00358423	0.1792115
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00358423	0.1792115
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00358423	0.1792115
MECKEL SYNDROME, TYPE 4; MKS4	0.00358423	0.1792115
KEARNS-SAYRE SYNDROME; KSS	0.003479851	0.17399255
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.003479851	0.17399255
NEUROFIBROMATOSIS, TYPE II	0.003479851	0.17399255
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.003479851	0.17399255
KNOBLOCH SYNDROME 1; KNO1	0.003479851	0.17399255
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.003479851	0.17399255
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.003479851	0.17399255
PERRAULT SYNDROME 5; PRLTS5	0.003479851	0.17399255
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.003479851	0.17399255
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.003479851	0.17399255
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.003479851	0.17399255
DIAMINOPENTANURIA	0.003479851	0.17399255
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.003479851	0.17399255
FLYNN-AIRD SYNDROME	0.003479851	0.17399255
WAARDENBURG-SHAH SYNDROME	0.0034079819999999995	0.17039909999999997
JOUBERT SYNDROME 35; JBTS35	0.0034079819999999995	0.17039909999999997
JOUBERT SYNDROME 6	0.0034079819999999995	0.17039909999999997
JOUBERT SYNDROME 17; JBTS17	0.0034079819999999995	0.17039909999999997
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.0034079819999999995	0.17039909999999997
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.0034079819999999995	0.17039909999999997
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.0034079819999999995	0.17039909999999997
JOUBERT SYNDROME 1	0.0034079819999999995	0.17039909999999997
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.0034079819999999995	0.17039909999999997
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.0034079819999999995	0.17039909999999997
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.0034079819999999995	0.17039909999999997
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.0034079819999999995	0.17039909999999997
JOUBERT SYNDROME 8	0.0034079819999999995	0.17039909999999997
ARIMA SYNDROME	0.0034079819999999995	0.17039909999999997
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.0034079819999999995	0.17039909999999997
JOUBERT SYNDROME 33; JBTS33	0.0034079819999999995	0.17039909999999997
JOUBERT SYNDROME 25	0.0034079819999999995	0.17039909999999997
JOUBERT SYNDROME 27	0.0034079819999999995	0.17039909999999997
MECKEL SYNDROME 13; MKS13	0.0034079819999999995	0.17039909999999997
OROFACIODIGITAL SYNDROME XVI; OFD16	0.0034079819999999995	0.17039909999999997
JOUBERT SYNDROME 15	0.0034079819999999995	0.17039909999999997
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.0034079819999999995	0.17039909999999997
JOUBERT SYNDROME 28	0.0034079819999999995	0.17039909999999997
RICHARDS-RUNDLE SYNDROME; RRNS	0.0034079819999999995	0.17039909999999997
#606703 DYSKINESIA, FAMILIAL, WITH FACIAL MYOKYMIA; FDFM	0.00280899	0.1404495
CEREBELLAR ATAXIA, NEUROPATHY, AND VESTIBULAR AREFLEXIA SYNDROME; CANVAS	0.00280899	0.1404495
#613728 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 10; SCAR10	0.00280899	0.1404495
#611302 SPASTIC ATAXIA 2, AUTOSOMAL RECESSIVE; SPAX2	0.00280899	0.1404495
SPINOCEREBELLAR ATAXIA 43; SCA43	0.00280899	0.1404495
%600223 SPINOCEREBELLAR ATAXIA 4; SCA4;;SPINOCEREBELLAR ATAXIA, AUTOSOMAL DOMINANT, WITH SENSORY AXONAL NEUROPATHY	0.00280899	0.1404495
SPINOCEREBELLAR ATAXIA 44; SCA44	0.00280899	0.1404495
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.00280899	0.1404495
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00280899	0.1404495
DYSTONIA 17, TORSION, AUTOSOMAL RECESSIVE; DYT17	0.00280899	0.1404495
#118700 CHOREA, BENIGN HEREDITARY; BHC;;BCH;;HEREDITARY PROGRESSIVE CHOREA WITHOUT DEMENTIA	0.00280899	0.1404495
SPINOCEREBELLAR ATAXIA 38; SCA38	0.00280899	0.1404495
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00280899	0.1404495
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.00280899	0.1404495
SPINOCEREBELLAR ATAXIA 40; SCA40	0.00280899	0.1404495
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.00280899	0.1404495
EPISODIC ATAXIA, TYPE 7; EA7	0.00280899	0.1404495
HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	0.00280899	0.1404495
#614696 AMYOTROPHIC LATERAL SCLEROSIS 17; ALS17;;AMYOTROPHIC LATERAL SCLEROSIS, CHMP2B-RELATED	0.00280899	0.1404495
ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD	0.00280899	0.1404495
#610246 SPINOCEREBELLAR ATAXIA 28; SCA28	0.00280899	0.1404495
MAST SYNDROME	0.00280899	0.1404495
#614153 SPINOCEREBELLAR ATAXIA 36; SCA36	0.00280899	0.1404495
LEBER OPTIC ATROPHY AND DYSTONIA	0.00280899	0.1404495
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.00280899	0.1404495
HUNTINGTON DISEASE-LIKE 1	0.00280899	0.1404495
PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE EARLY-ONSET	0.00280899	0.1404495
EPISODIC ATAXIA, TYPE 1; EA1	0.00280899	0.1404495
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.00280899	0.1404495
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00280899	0.1404495
SYRINGOMYELIA, ISOLATED	0.00280899	0.1404495
WOODHOUSE-SAKATI SYNDROME	0.00280899	0.1404495
DYSTONIA 26, MYOCLONIC; DYT26	0.00280899	0.1404495
SPINOCEREBELLAR ATAXIA 26	0.00280899	0.1404495
%108650 SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7;;SPASTIC ATAXIA WITH CONGENITAL MIOSIS;;MIOSIS, CONGENITAL, WITH SPASTIC ATAXIA	0.00280899	0.1404495
#613908 SPINOCEREBELLAR ATAXIA 35; SCA35	0.00280899	0.1404495
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.00280899	0.1404495
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.00280899	0.1404495
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.00280899	0.1404495
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00280899	0.1404495
AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTEMPORAL DEMENTIA 1	0.00280899	0.1404495
#137440 GERSTMANN-STRAUSSLER DISEASE; GSD;;ENCEPHALOPATHY, SUBACUTE SPONGIFORM, GERSTMANN-STRAUSSLER TYPE;;GERSTMANN-STRAUSSLER-SCHEINKER DISEASE; GSS;;CEREBELLAR ATAXIA, PROGRESSIVE DEMENTIA, AND AMYLOID DEPOSITS IN CNS;;AMYLOIDOSIS, CEREBRAL, WITH SPONGIFORM ENCEPHALOPATHY;;PRION DEMENTIACEREBRAL AMYLOID ANGIOPATHY, PRNP-RELATED, INCLUDED	0.00280899	0.1404495
#183086 SPINOCEREBELLAR ATAXIA 6; SCA6	0.00280899	0.1404495
#608768 SPINOCEREBELLAR ATAXIA 8; SCA8	0.00280899	0.1404495
#255200 MYOPATHY, CENTRONUCLEAR, 2; CNM2;;MYOPATHY, CENTRONUCLEAR, AUTOSOMAL RECESSIVE;;MYOTUBULAR MYOPATHY, AUTOSOMAL RECESSIVE	0.00280899	0.1404495
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.00280899	0.1404495
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 24; SCAR24	0.00280899	0.1404495
#602099 AMYOTROPHIC LATERAL SCLEROSIS 5, JUVENILE; ALS5	0.00280899	0.1404495
#256850 GIANT AXONAL NEUROPATHY 1, AUTOSOMAL RECESSIVE; GAN1;;GAN	0.00280899	0.1404495
SPINOCEREBELLAR ATAXIA 2; SCA2	0.00280899	0.1404495
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.00280899	0.1404495
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4	0.00280899	0.1404495
AMYOTROPHIC LATERAL SCLEROSIS 15 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS15	0.00280899	0.1404495
EPISODIC ATAXIA, TYPE 2	0.00280899	0.1404495
AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10	0.00280899	0.1404495
ATAXIA-OCULOMOTOR APRAXIA 3; AOA3	0.00280899	0.1404495
HUNTINGTON DISEASE-LIKE 2	0.00280899	0.1404495
#614808 AMYOTROPHIC LATERAL SCLEROSIS 18; ALS18	0.00280899	0.1404495
#613954 AMYOTROPHIC LATERAL SCLEROSIS 14, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA;ALS14	0.00280899	0.1404495
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.00280899	0.1404495
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00280899	0.1404495
#253250 MULIBREY NANISM;;MUSCLE-LIVER-BRAIN-EYE NANISM;;PERICARDIAL CONSTRICTION AND GROWTH FAILURE;;PERHEENTUPA SYNDROME	0.00280899	0.1404495
HYPOPREBETALIPOPROTEINEMIA, ACANTHOCYTOSIS, RETINITIS PIGMENTOSA,AND PALLIDAL DEGENERATION	0.00280899	0.1404495
SPINOCEREBELLAR ATAXIA 27; SCA27	0.00280899	0.1404495
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.00280899	0.1404495
#118800 PAROXYSMAL NONKINESIGENIC DYSKINESIA 1; PNKD1;;PAROXYSMAL DYSTONIC CHOREOATHETOSIS; PDC;;CHOREOATHETOSIS, FAMILIAL PAROXYSMAL; FPD1;;MOUNT-REBACK SYNDROME;;CHOREOATHETOSIS, NONKINESIGENIC;;DYSTONIA 8; DYT8	0.00280899	0.1404495
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.00280899	0.1404495
SPINOCEREBELLAR ATAXIA 20	0.00280899	0.1404495
SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	0.00280899	0.1404495
MOEBIUS SYNDROME; MBS	0.00280899	0.1404495
PARKINSON DISEASE 20, EARLY-ONSET; PARK20	0.00280899	0.1404495
#608627 AMYOTROPHIC LATERAL SCLEROSIS 8; ALS8	0.00280899	0.1404495
SPINOCEREBELLAR ATAXIA 46; SCA46	0.00280899	0.1404495
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.00280899	0.1404495
SPINOCEREBELLAR ATAXIA 45; SCA45	0.00280899	0.1404495
SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	0.00280899	0.1404495
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.00280899	0.1404495
AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 24; ALS24	0.00280899	0.1404495
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26	0.00280899	0.1404495
#606070 AMYOTROPHIC LATERAL SCLEROSIS 21; ALS21;;MYOPATHY, DISTAL, 2, FORMERLY; MPD2, FORMERLY;;VOCAL CORD AND PHARYNGEAL DYSFUNCTION WITH DISTAL MYOPATHY, FORMERLY;VCPDM, FORMERLY	0.00280899	0.1404495
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.00280899	0.1404495
#258450 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS,AUTOSOMAL RECESSIVE; PEOB;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL RECESSIVE	0.00280899	0.1404495
ATAXIA-TELANGIECTASIA-LIKE DISORDER 1; ATLD1	0.00280899	0.1404495
#610250 SPASTIC PARAPLEGIA 31, AUTOSOMAL DOMINANT; SPG31	0.00280899	0.1404495
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00280899	0.1404495
TREMOR, HEREDITARY ESSENTIAL, 1	0.00280899	0.1404495
SPINOCEREBELLAR ATAXIA 12	0.00280899	0.1404495
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.00280899	0.1404495
#304700 MOHR-TRANEBJAERG SYNDROME; MTS;;DYSTONIA-DEAFNESS SYNDROME; DDS;;DEAFNESS-DYSTONIA-OPTIC ATROPHY SYNDROME; DDP;;DEAFNESS SYNDROME, PROGRESSIVE, WITH BLINDNESS, DYSTONIA, FRACTURES,AND MENTAL DEFICIENCY	0.00280899	0.1404495
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.00280899	0.1404495
SPINOCEREBELLAR ATAXIA 15	0.00280899	0.1404495
#604432 SPINOCEREBELLAR ATAXIA 11; SCA11	0.00280899	0.1404495
CEREBRAL PALSY, ATAXIC, AUTOSOMAL RECESSIVE	0.00280899	0.1404495
SPINOCEREBELLAR ATAXIA 48; SCA48	0.00280899	0.1404495
#229300 FRIEDREICH ATAXIA 1; FRDA;;FRDA1;;FAFRIEDREICH ATAXIA WITH RETAINED REFLEXES, INCLUDED; FARR, INCLUDED	0.00280899	0.1404495
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.00280899	0.1404495
#607259 SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE; SPG7	0.00280899	0.1404495
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.00280899	0.1404495
SPINOCEREBELLAR ATAXIA 13	0.00280899	0.1404495
CHIARI MALFORMATION TYPE I	0.00280899	0.1404495
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3	0.00280899	0.1404495
EPISODIC ATAXIA, TYPE 5	0.00280899	0.1404495
SPINOCEREBELLAR ATAXIA 14	0.00280899	0.1404495
OPTIC ATROPHY 2	0.00280899	0.1404495
SPASTIC PARAPLEGIA 27, AUTOSOMAL RECESSIVE	0.00280899	0.1404495
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.00280899	0.1404495
#164300 OCULOPHARYNGEAL MUSCULAR DYSTROPHY; OPMD;;MUSCULAR DYSTROPHY, OCULOPHARYNGEAL	0.00280899	0.1404495
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.00280899	0.1404495
SPINOCEREBELLAR ATAXIA 34; SCA34	0.00280899	0.1404495
DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE; DYT2	0.00280899	0.1404495
#601462 MYASTHENIC SYNDROME, CONGENITAL, SLOW-CHANNEL; SCCMS;;MYASTHENIC SYNDROME, CONGENITAL, POSTSYNAPTIC SLOW-CHANNEL;;MYASTHENIC SYNDROME, CONGENITAL, TYPE IIa; CMS2A;;CMS IIa	0.00280899	0.1404495
#613435 AMYOTROPHIC LATERAL SCLEROSIS 12; ALS12	0.00280899	0.1404495
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.00280899	0.1404495
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.00280899	0.1404495
SPASTIC PARAPLEGIA 62, AUTOSOMAL RECESSIVE	0.00280899	0.1404495
PALLIDAL DEGENERATION, PROGRESSIVE, WITH RETINITIS PIGMENTOSA	0.00280899	0.1404495
#609161 STRIATAL DEGENERATION, AUTOSOMAL DOMINANT; ADSD	0.00280899	0.1404495
PARKINSON DISEASE, LATE-ONSET; PD	0.00280899	0.1404495
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00280899	0.1404495
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.00280899	0.1404495
PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	0.0025640999999999997	0.12820499999999999
NYSTAGMUS, HEREDITARY VERTICAL	0.0025640999999999997	0.12820499999999999
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.0025640999999999997	0.12820499999999999
272600 TAPETORETINAL DEGENERATION WITH ATAXIA	0.0025640999999999997	0.12820499999999999
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.0025640999999999997	0.12820499999999999
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.0025640999999999997	0.12820499999999999
WERNICKE-KORSAKOFF SYNDROME	0.0025640999999999997	0.12820499999999999
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.0025640999999999997	0.12820499999999999
MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS	0.0025640999999999997	0.12820499999999999
NEUROPATHY, HEREDITARY SENSORY, ATYPICAL	0.0025640999999999997	0.12820499999999999
#615558 HYPOBETALIPOPROTEINEMIA, FAMILIAL, 1; FHBL1;;HYPOBETALIPOPROTEINEMIA, FAMILIAL; FHBL;;ACANTHOCYTOSIS WITH HYPOBETALIPOPROTEINEMIA;;HYPOBETALIPOPROTEINEMIA, NORMOTRIGLYCERIDEMIC	0.0025640999999999997	0.12820499999999999
ATAXIA WITH FASCICULATIONS	0.0025640999999999997	0.12820499999999999
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.0025640999999999997	0.12820499999999999
POSTERIOR COLUMN ATAXIA	0.0025640999999999997	0.12820499999999999
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.0025640999999999997	0.12820499999999999
HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	0.0025640999999999997	0.12820499999999999
OPTIC ATROPHY 1; OPA1	0.0025640999999999997	0.12820499999999999
TRYPTOPHANURIA WITH DWARFISM	0.0025640999999999997	0.12820499999999999
#535000 LEBER OPTIC ATROPHY;;LEBER HEREDITARY OPTIC NEUROPATHY; LHON	0.0025640999999999997	0.12820499999999999
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.0025640999999999997	0.12820499999999999
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.0025640999999999997	0.12820499999999999
DEMENTIA, FAMILIAL DANISH	0.0025640999999999997	0.12820499999999999
#276880 UROCANASE DEFICIENCY	0.0025640999999999997	0.12820499999999999
SPINOCEREBELLAR ATAXIA 41; SCA41	0.0025640999999999997	0.12820499999999999
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.0025640999999999997	0.12820499999999999
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.0025640999999999997	0.12820499999999999
MUSCULAR ATROPHY, ATAXIA, RETINITIS PIGMENTOSA, AND DIABETES MELLITUS	0.0025640999999999997	0.12820499999999999
KURU, SUSCEPTIBILITY TO	0.0025640999999999997	0.12820499999999999
DE SANCTIS-CACCHIONE SYNDROME	0.0025640999999999997	0.12820499999999999
JOUBERT SYNDROME 3; JBTS3	0.0025640999999999997	0.12820499999999999
SPINOCEREBELLAR ATAXIA, X-LINKED 2	0.0025640999999999997	0.12820499999999999
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.0025640999999999997	0.12820499999999999
FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURALDEAFNESS	0.0025640999999999997	0.12820499999999999
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.0025640999999999997	0.12820499999999999
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.0025640999999999997	0.12820499999999999
JOUBERT SYNDROME 5	0.0025640999999999997	0.12820499999999999
CEREBELLAR HYPOPLASIA	0.0025640999999999997	0.12820499999999999
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.0025640999999999997	0.12820499999999999
KALLMANN SYNDROME WITH SPASTIC PARAPLEGIA	0.0025640999999999997	0.12820499999999999
SPINOCEREBELLAR ATAXIA, X-LINKED 4	0.0025640999999999997	0.12820499999999999
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.0025640999999999997	0.12820499999999999
REFSUM DISEASE	0.0025640999999999997	0.12820499999999999
GILLESPIE SYNDROME; GLSP	0.0025640999999999997	0.12820499999999999
#613078 NIJMEGEN BREAKAGE SYNDROME-LIKE DISORDER; NBSLD;;NBS-LIKE DISORDER;;RAD50 DEFICIENCY;;MICROCEPHALY AND SPONTANEOUS CHROMOSOME INSTABILITY WITHOUT IMMUNODEFICIENCY	0.0025640999999999997	0.12820499999999999
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.0025640999999999997	0.12820499999999999
CEREBELLAR ATAXIA AND NEUROSENSORY DEAFNESS	0.0025640999999999997	0.12820499999999999
ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH	0.0025640999999999997	0.12820499999999999
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.0025640999999999997	0.12820499999999999
164700 OLIVOPONTOCEREBELLAR ATROPHY V; OPCA V;;OPCA WITH DEMENTIA AND EXTRAPYRAMIDAL SIGNS	0.0025640999999999997	0.12820499999999999
212835 CEREBELLAR ATAXIA AND ECTODERMAL DYSPLASIA	0.0025640999999999997	0.12820499999999999
ATONIC-ASTATIC SYNDROME OF FOERSTER	0.0025640999999999997	0.12820499999999999
Boucher-Neuhauser syndrome	0.0025640999999999997	0.12820499999999999
POLYMYOCLONUS, INFANTILE	0.0025640999999999997	0.12820499999999999
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.0025640999999999997	0.12820499999999999
245800 LAURENCE-MOON SYNDROME	0.0025640999999999997	0.12820499999999999
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.0025640999999999997	0.12820499999999999
VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF	0.0025640999999999997	0.12820499999999999
ABETALIPOPROTEINEMIA	0.0025640999999999997	0.12820499999999999
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.0025640999999999997	0.12820499999999999
MYOCLONUS, FAMILIAL CORTICAL; FCM	0.0025640999999999997	0.12820499999999999
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.0025640999999999997	0.12820499999999999
#612020 SPASTIC PARAPLEGIA 39, AUTOSOMAL RECESSIVE; SPG39;;NTE-RELATED MOTOR NEURON DISORDER; NTEMND	0.0025640999999999997	0.12820499999999999
#604187 SPASTIC PARAPLEGIA 10, AUTOSOMAL DOMINANT; SPG10;;SPASTIC PARAPLEGIA 10 WITH OR WITHOUT PERIPHERAL NEUROPATHY	0.0025640999999999997	0.12820499999999999
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.0025640999999999997	0.12820499999999999
OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	0.0025640999999999997	0.12820499999999999
ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.0025640999999999997	0.12820499999999999
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001759633	0.08798165
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.001759633	0.08798165
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001759633	0.08798165
CHROMOSOME 2q37 DELETION SYNDROME	0.001759633	0.08798165
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.001759633	0.08798165
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.001759633	0.08798165
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.001759633	0.08798165
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001759633	0.08798165
JOUBERT SYNDROME 30; JBTS30	0.001759633	0.08798165
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001759633	0.08798165
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.001759633	0.08798165
CHROMOSOME 22q13 DUPLICATION SYNDROME	0.001759633	0.08798165
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001759633	0.08798165
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.001759633	0.08798165
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001759633	0.08798165
PHACE ASSOCIATION	0.001759633	0.08798165
#614845 NEPHRONOPHTHISIS 15; NPHP15	0.001759633	0.08798165
#613657 D-2-@HYDROXYGLUTARIC ACIDURIA 2;;D2HGA2	0.001759633	0.08798165
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.001759633	0.08798165
LUSCAN-LUMISH SYNDROME; LLS	0.001759633	0.08798165
DIGEORGE SYNDROME; DGS	0.001759633	0.08798165
Muenke syndrome	0.001759633	0.08798165
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.001759633	0.08798165
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001759633	0.08798165
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001759633	0.08798165
OCULOECTODERMAL SYNDROME; OES	0.001759633	0.08798165
MENTAL RETARDATION, X-LINKED 72	0.001759633	0.08798165
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.001759633	0.08798165
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001759633	0.08798165
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001759633	0.08798165
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001759633	0.08798165
#614483 PORENCEPHALY 2; POREN2	0.001759633	0.08798165
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.001759633	0.08798165
SHUKLA-VERNON SYNDROME; SHUVER	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.001759633	0.08798165
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001759633	0.08798165
#269000 SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME	0.001759633	0.08798165
WIEACKER-WOLFF SYNDROME	0.001759633	0.08798165
CHROMOSOME 5Q12 DELETION SYNDROME	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.001759633	0.08798165
MENTAL RETARDATION, X-LINKED 103	0.001759633	0.08798165
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.001759633	0.08798165
MENTAL RETARDATION, X-LINKED 90	0.001759633	0.08798165
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001759633	0.08798165
#300831 CK SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICALMALFORMATION	0.001759633	0.08798165
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.001759633	0.08798165
#300894 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5;;BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; BPAN;;STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD;SENDA	0.001759633	0.08798165
GM2-GANGLIOSIDOSIS, AB VARIANT	0.001759633	0.08798165
GRISCELLI SYNDROME, TYPE 1	0.001759633	0.08798165
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE	0.001759633	0.08798165
WIEDEMANN-STEINER SYNDROME; WDSTS	0.001759633	0.08798165
LANDAU-KLEFFNER SYNDROME	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001759633	0.08798165
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.001759633	0.08798165
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.001759633	0.08798165
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001759633	0.08798165
#613730 HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION,AND CATARACTS; HDBSCC	0.001759633	0.08798165
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.001759633	0.08798165
GRACILE BONE DYSPLASIA; GCLEB	0.001759633	0.08798165
PALLISTER-HALL SYNDROME	0.001759633	0.08798165
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.001759633	0.08798165
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.001759633	0.08798165
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001759633	0.08798165
#300422 FG SYNDROME 4; FGS4MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT NYSTAGMUS, INCLUDED	0.001759633	0.08798165
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001759633	0.08798165
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001759633	0.08798165
#615279 CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.001759633	0.08798165
#300886 MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32	0.001759633	0.08798165
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001759633	0.08798165
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001759633	0.08798165
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.001759633	0.08798165
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.001759633	0.08798165
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001759633	0.08798165
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001759633	0.08798165
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001759633	0.08798165
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.001759633	0.08798165
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	0.001759633	0.08798165
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001759633	0.08798165
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001759633	0.08798165
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001759633	0.08798165
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001759633	0.08798165
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.001759633	0.08798165
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.001759633	0.08798165
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.001759633	0.08798165
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001759633	0.08798165
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.001759633	0.08798165
KBG SYNDROME	0.001759633	0.08798165
CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB	0.001759633	0.08798165
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.001759633	0.08798165
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.001759633	0.08798165
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001759633	0.08798165
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.001759633	0.08798165
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.001759633	0.08798165
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001759633	0.08798165
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.001759633	0.08798165
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W	0.001759633	0.08798165
MENTAL RETARDATION, X-LINKED 91; MRX91	0.001759633	0.08798165
PRADER-WILLI SYNDROME; PWS	0.001759633	0.08798165
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.001759633	0.08798165
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.001759633	0.08798165
SHASHI-PENA SYNDROME; SHAPNS	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.001759633	0.08798165
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.001759633	0.08798165
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001759633	0.08798165
#300867 KABUKI SYNDROME 2; KABUK2	0.001759633	0.08798165
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001759633	0.08798165
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001759633	0.08798165
CHROMOSOME 16p13.2 DELETION SYNDROME	0.001759633	0.08798165
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.001759633	0.08798165
Pierpont syndrome	0.001759633	0.08798165
INFANTILE LIVER FAILURE SYNDROME 1	0.001759633	0.08798165
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.001759633	0.08798165
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.001759633	0.08798165
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001759633	0.08798165
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001759633	0.08798165
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001759633	0.08798165
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	0.001759633	0.08798165
#136570 CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KBFRAGILE SITE 16p12, INCLUDED	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001759633	0.08798165
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001759633	0.08798165
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001759633	0.08798165
#613668 MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	0.001759633	0.08798165
#613180 POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.001759633	0.08798165
MENTAL RETARDATION, X-LINKED 88	0.001759633	0.08798165
MEND SYNDROME; MEND	0.001759633	0.08798165
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD	0.001759633	0.08798165
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.001759633	0.08798165
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001759633	0.08798165
IMMUNODEFICIENCY 49; IMD49	0.001759633	0.08798165
KLEEFSTRA SYNDROME 2; KLEFS2	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001759633	0.08798165
CHROMOSOME 16p13.3 DELETION SYNDROME	0.001759633	0.08798165
SCHAAF-YANG SYNDROME; SHFYNG	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.001759633	0.08798165
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.001759633	0.08798165
CATEL-MANZKE SYNDROME; CATMANS	0.001759633	0.08798165
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001759633	0.08798165
MACDERMOT-WINTER SYNDROME	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001759633	0.08798165
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.001759633	0.08798165
#611718 HYPOMAGNESEMIA 4, RENAL; HOMG4;;HYPOMAGNESEMIA, RENAL, NORMOCALCIURIC	0.001759633	0.08798165
KETOADIPICACIDURIA	0.001759633	0.08798165
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.001759633	0.08798165
TIMOTHY SYNDROME; TS	0.001759633	0.08798165
C SYNDROME	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001759633	0.08798165
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001759633	0.08798165
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.001759633	0.08798165
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001759633	0.08798165
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001759633	0.08798165
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001759633	0.08798165
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001759633	0.08798165
CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL	0.001759633	0.08798165
#614202 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15	0.001759633	0.08798165
#236250 HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATEREDUCTASE ACTIVITY;;METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY;;MTHFR DEFICIENCYMTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED	0.001759633	0.08798165
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.001759633	0.08798165
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1	0.001759633	0.08798165
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.001759633	0.08798165
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001759633	0.08798165
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.001759633	0.08798165
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001759633	0.08798165
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.001759633	0.08798165
HARTNUP DISORDER	0.001759633	0.08798165
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.001759633	0.08798165
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001759633	0.08798165
AUTISM, SUSCEPTIBILITY TO, 18	0.000915751	0.04578755
HYPER-BETA-ALANINEMIA	0.000915751	0.04578755
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000915751	0.04578755
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	0.000915751	0.04578755
#614650 COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6	0.000915751	0.04578755
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.000915751	0.04578755
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000915751	0.04578755
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.000915751	0.04578755
HHHH SYNDROME	0.000915751	0.04578755
224250 DYSMYELINATION WITH JAUNDICE	0.000915751	0.04578755
#300558 MENTAL RETARDATION, X-LINKED 30; MRX30;;MENTAL RETARDATION, X-LINKED 47; MRX47	0.000915751	0.04578755
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000915751	0.04578755
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.000915751	0.04578755
MENTAL RETARDATION, X-LINKED 100	0.000915751	0.04578755
#602541 MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC;;MUSCULAR DYSTROPHY, CONGENITAL, WITH MITOCHONDRIAL STRUCTURAL ABNORMALITIES	0.000915751	0.04578755
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000915751	0.04578755
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000915751	0.04578755
1p36 microdeletion syndrome	0.000915751	0.04578755
SECKEL SYNDROME 1; SCKL1	0.000915751	0.04578755
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000915751	0.04578755
BRANCHIOOCULOFACIAL SYNDROME	0.000915751	0.04578755
ACTH DEFICIENCY, ISOLATED; IAD	0.000915751	0.04578755
CHROMOSOME 15q13.3 MICRODELETION SYNDROME	0.000915751	0.04578755
VISCERAL STEATOSIS, CONGENITAL	0.000915751	0.04578755
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000915751	0.04578755
THREONINEMIA	0.000915751	0.04578755
TAY-SACHS DISEASE; TSD	0.000915751	0.04578755
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000915751	0.04578755
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000915751	0.04578755
RETINAL DEGENERATION AND EPILEPSY	0.000915751	0.04578755
COFFIN-LOWRY SYNDROME; CLS	0.000915751	0.04578755
GRISCELLI SYNDROME, TYPE 2; GS2	0.000915751	0.04578755
#158900 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FSHD; FMD;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1A; FSHD1A;;LANDOUZY-DEJERINE MUSCULAR DYSTROPHYFACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY, INFANTILE, INCLUDED;;FACIOSCAPULOHUMERAL DYSTROPHY WITH SENSORINEURAL HEARING LOSS ANDTORTUOSITY OF RETINAL ARTERIOLES, INCLUDED	0.000915751	0.04578755
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000915751	0.04578755
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000915751	0.04578755
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.000915751	0.04578755
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000915751	0.04578755
#187300 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER;HHT;;OSLER-RENDU-WEBER DISEASE;;ORW DISEASETELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 1, INCLUDED; HHT1, INCLUDED	0.000915751	0.04578755
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000915751	0.04578755
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.000915751	0.04578755
#248250 HYPOMAGNESEMIA 3, RENAL; HOMG3;;HYPOMAGNESEMIA, PRIMARY, DUE TO DEFECT IN RENAL TUBULAR TRANSPORTOF MAGNESIUM;;HYPOMAGNESEMIA, ISOLATED RENAL;;HYPOMAGNESEMIA, FAMILIAL, WITH HYPERCALCIURIA AND NEPHROCALCINOSISHYPERCALCIURIA, CHILDHOOD, SELF-LIMITING, INCLUDED	0.000915751	0.04578755
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000915751	0.04578755
HYPOPARATHYROIDISM, X-LINKED	0.000915751	0.04578755
OHDO SYNDROME	0.000915751	0.04578755
#300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ	0.000915751	0.04578755
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.000915751	0.04578755
PAPILLORENAL SYNDROME	0.000915751	0.04578755
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000915751	0.04578755
Wolf-Hirschhorn Syndrome	0.000915751	0.04578755
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000915751	0.04578755
KIFAFA SEIZURE DISORDER	0.000915751	0.04578755
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.000915751	0.04578755
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000915751	0.04578755
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000915751	0.04578755
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.000915751	0.04578755
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000915751	0.04578755
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE	0.000915751	0.04578755
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000915751	0.04578755
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000915751	0.04578755
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000915751	0.04578755
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000915751	0.04578755
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000915751	0.04578755
#310600 NORRIE DISEASE; ND;;ATROPHIA BULBORUM HEREDITARIA;;EPISKOPI BLINDNESS	0.000915751	0.04578755
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000915751	0.04578755
#612580 MENTAL RETARDATION, AUTOSOMAL DOMINANT 3; MRD3	0.000915751	0.04578755
MENTAL RETARDATION, X-LINKED 1	0.000915751	0.04578755
#244460 KENNY-CAFFEY SYNDROME, TYPE 1; KCS1;;KCS;;KENNY-CAFFEY SYNDROME, AUTOSOMAL RECESSIVE	0.000915751	0.04578755
PALLISTER-KILLIAN SYNDROME	0.000915751	0.04578755
TENORIO SYNDROME; TNORS	0.000915751	0.04578755
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.000915751	0.04578755
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000915751	0.04578755
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000915751	0.04578755
2q33.1 deletion syndrome	0.000915751	0.04578755
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000915751	0.04578755
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.000915751	0.04578755
STURGE-WEBER SYNDROME	0.000915751	0.04578755
#605375 EPILEPSY, NOCTURNAL FRONTAL LOBE, 3; ENFL3	0.000915751	0.04578755
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000915751	0.04578755
PERRAULT SYNDROME 3	0.000915751	0.04578755
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.000915751	0.04578755
CROUZON SYNDROME	0.000915751	0.04578755
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.000915751	0.04578755
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000915751	0.04578755
PHENYLKETONURIA	0.000915751	0.04578755
HYPERPROLINEMIA, TYPE II	0.000915751	0.04578755
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000915751	0.04578755
#615752 POLYMICROGYRIA, BILATERAL PERISYLVIAN, AUTOSOMAL RECESSIVE; BPPR ;;PMGR	0.000915751	0.04578755
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000915751	0.04578755
#614923 BRANCHED-CHAIN KETOACID DEHYDROGENASE KINASE DEFICIENCY; BCKDKD;;BCKDK DEFICIENCY	0.000915751	0.04578755
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000915751	0.04578755
DARIER-WHITE DISEASE; DAR	0.000915751	0.04578755
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000915751	0.04578755
PARIETAL FORAMINA	0.000915751	0.04578755
#611755 LEBER CONGENITAL AMAUROSIS 10; LCA10	0.000915751	0.04578755
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000915751	0.04578755
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000915751	0.04578755
HYPOMAGNESEMIA 2, RENAL	0.000915751	0.04578755
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000915751	0.04578755
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.000915751	0.04578755
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000915751	0.04578755
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000915751	0.04578755
#236600 HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE 1; HYC1;;HYDROCEPHALY;;VENTRICULOMEGALY	0.000915751	0.04578755
RAMON SYNDROME	0.000915751	0.04578755
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000915751	0.04578755
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000915751	0.04578755
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000915751	0.04578755
#202200 GLUCOCORTICOID DEFICIENCY 1; GCCD1;;FAMILIAL GLUCOCORTICOID DEFICIENCY 1; FGD1;;ADRENAL UNRESPONSIVENESS TO ACTH;;ACTH RESISTANCE	0.000915751	0.04578755
HYPOPHOSPHATASIA, CHILDHOOD	0.000915751	0.04578755
#610768 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im; CDG1M;;CDG Im; CDGIm;;DOLICHOL KINASE DEFICIENCY;;DK1 DEFICIENCY	0.000915751	0.04578755
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000915751	0.04578755
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000915751	0.04578755
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000915751	0.04578755
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000915751	0.04578755
#612285 JOUBERT SYNDROME 9; JBTS9JOUBERT SYNDROME 9/15, DIGENIC, INCLUDED	0.000915751	0.04578755
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000915751	0.04578755
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000915751	0.04578755
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000915751	0.04578755
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000915751	0.04578755
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000915751	0.04578755
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.000915751	0.04578755
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.000915751	0.04578755
RETINITIS PIGMENTOSA 59; RP59	0.000915751	0.04578755
GURRIERI SYNDROME	0.000915751	0.04578755
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000915751	0.04578755
MENTAL RETARDATION, X-LINKED 14	0.000915751	0.04578755
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000915751	0.04578755
PACHYGYRIA, FRONTOTEMPORAL	0.000915751	0.04578755
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000915751	0.04578755
#300143 MENTAL RETARDATION, X-LINKED 21; MRX21;;MENTAL RETARDATION, X-LINKED 34; MRX34	0.000915751	0.04578755
#614399 MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET;EMARDDMYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET,MILD VARIANT, INCLUDED	0.000915751	0.04578755
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000915751	0.04578755
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000915751	0.04578755
#223360 DOPAMINE BETA-HYDROXYLASE DEFICIENCY, CONGENITAL;;NOREPINEPHRINE DEFICIENCY;;NORADRENALINE DEFICIENCY	0.000915751	0.04578755
#119540 CLEFT PALATE, ISOLATED; CPI;;CLEFT PALATE; CPCLEFT PALATE, ISOLATED, AND MENTAL RETARDATION, INCLUDED	0.000915751	0.04578755
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000915751	0.04578755
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.000915751	0.04578755
FILIPPI SYNDROME; FLPIS	0.000915751	0.04578755
KLEEFSTRA SYNDROME	0.000915751	0.04578755
SUDDEN CARDIAC FAILURE, INFANTILE	0.000915751	0.04578755
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000915751	0.04578755
INCONTINENTIA PIGMENTI; IP	0.000915751	0.04578755
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000915751	0.04578755
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000915751	0.04578755
#300049 HETEROTOPIA, PERIVENTRICULAR, X-LINKED DOMINANT;;HETEROTOPIA, FAMILIAL NODULAR;;PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1;;NODULAR HETEROTOPIA, BILATERAL PERIVENTRICULAR; NHBP; BPNHHETEROTOPIA, PERIVENTRICULAR NODULAR, WITH FRONTOMETAPHYSEAL DYSPLASIA,INCLUDED	0.000915751	0.04578755
HUNTINGTON DISEASE; HD	0.000915751	0.04578755
POTOCKI-SHAFFER SYNDROME	0.000915751	0.04578755
MENTAL RETARDATION, FRA12A TYPE	0.000915751	0.04578755
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000915751	0.04578755
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000915751	0.04578755
SJOGREN-LARSSON SYNDROME; SLS	0.000915751	0.04578755
#116860 CEREBRAL CAVERNOUS MALFORMATIONS; CCM;;CAVERNOUS ANGIOMA, FAMILIAL;;CAVERNOUS ANGIOMATOUS MALFORMATIONS; CAM;;CEREBRAL CAPILLARY MALFORMATIONSCEREBRAL CAVERNOUS MALFORMATIONS 1, INCLUDED; CCM1, INCLUDED;;CAVERNOUS MALFORMATIONS OF CNS AND RETINA, INCLUDED;;HYPERKERATOTIC CUTANEOUS CAPILLARY-VENOUS MALFORMATIONS ASSOCIATEDWITH CEREBRAL CAPILLARY MALFORMATIONS, INCLUDED	0.000915751	0.04578755
#240900 HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY; HIHGHH	0.000915751	0.04578755
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.000915751	0.04578755
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.000915751	0.04578755
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000915751	0.04578755
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000915751	0.04578755
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000915751	0.04578755
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000915751	0.04578755
MICROPHTHALMIA, SYNDROMIC 1	0.000915751	0.04578755
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000915751	0.04578755
MECKEL SYNDROME, TYPE 10; MKS10	0.000915751	0.04578755
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000915751	0.04578755
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000915751	0.04578755
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000915751	0.04578755
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.000915751	0.04578755
AYME-GRIPP SYNDROME; AYGRP	0.000915751	0.04578755
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000915751	0.04578755
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000915751	0.04578755
CRANIOSYNOSTOSIS 2	0.000915751	0.04578755
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.000915751	0.04578755
COFFIN-SIRIS SYNDROME 7; CSS7	0.000843882	0.0421941
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000843882	0.0421941
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000843882	0.0421941
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000843882	0.0421941
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000843882	0.0421941
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000843882	0.0421941
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000843882	0.0421941
NOONAN SYNDROME 6; NS6	0.000843882	0.0421941
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000843882	0.0421941
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000843882	0.0421941
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000843882	0.0421941
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000843882	0.0421941
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.000843882	0.0421941
#227810 FANCONI-BICKEL SYNDROME; FBS;;HEPATORENAL GLYCOGENOSIS WITH RENAL FANCONI SYNDROME;;HEPATIC GLYCOGENOSIS WITH FANCONI NEPHROPATHY;;HEPATIC GLYCOGENOSIS WITH AMINO ACIDURIA AND GLUCOSURIA;;FANCONI SYNDROME WITH INTESTINAL MALABSORPTION AND GALACTOSE INTOLERANCE;;PSEUDO-PHLORIZIN DIABETES;;GLYCOGENOSIS, FANCONI TYPE;;GLYCOGEN STORAGE DISEASE XI	0.000843882	0.0421941
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.000843882	0.0421941
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000843882	0.0421941
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000843882	0.0421941
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000843882	0.0421941
CREE MENTAL RETARDATION SYNDROME	0.000843882	0.0421941
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000843882	0.0421941
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000843882	0.0421941
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000843882	0.0421941
HYDROCEPHALUS, NORMAL-PRESSURE	0.000843882	0.0421941
#613603 CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME	0.000843882	0.0421941
HYPOTONIA-CYSTINURIA SYNDROME	0.000843882	0.0421941
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000843882	0.0421941
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.000843882	0.0421941
Jawad syndrome	0.000843882	0.0421941
AL-RAQAD SYNDROME; ARS	0.000843882	0.0421941
OROFACIODIGITAL SYNDROME IX; OFD9	0.000843882	0.0421941
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000843882	0.0421941
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000843882	0.0421941
#612626 CHROMOSOME 15q26-qter DELETION SYNDROME;;DRAYER SYNDROME	0.000843882	0.0421941
TOWNES-BROCKS SYNDROME 1; TBS1	0.000843882	0.0421941
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G	0.000843882	0.0421941
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000843882	0.0421941
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000843882	0.0421941
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000843882	0.0421941
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000843882	0.0421941
RAINE SYNDROME	0.000843882	0.0421941
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000843882	0.0421941
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.000843882	0.0421941
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000843882	0.0421941
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000843882	0.0421941
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.000843882	0.0421941
#609425 CHROMOSOME 3q29 DELETION SYNDROME;;MICRODELETION 3q29 SYNDROME	0.000843882	0.0421941
#614701 CORNELIA DE LANGE SYNDROME 4; CDLS4	0.000843882	0.0421941
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000843882	0.0421941
STEEL SYNDROME; STLS	0.000843882	0.0421941
DIAMOND-BLACKFAN ANEMIA 5	0.000843882	0.0421941
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000843882	0.0421941
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000843882	0.0421941
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000843882	0.0421941
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000843882	0.0421941
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000843882	0.0421941
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000843882	0.0421941
NOONAN SYNDROME 9; NS9	0.000843882	0.0421941
BARDET-BIEDL SYNDROME 14; BBS14	0.000843882	0.0421941
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000843882	0.0421941
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.000843882	0.0421941
Cerebral creatine deficiency syndrome 3	0.000843882	0.0421941
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000843882	0.0421941
#615432 SPECIFIC LANGUAGE IMPAIRMENT 5; SLI5	0.000843882	0.0421941
#615278 CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2	0.000843882	0.0421941
#610915 OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8;;OI, TYPE VIII	0.000843882	0.0421941
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000843882	0.0421941
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000843882	0.0421941
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.000843882	0.0421941
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000843882	0.0421941
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.000843882	0.0421941
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.000843882	0.0421941
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000843882	0.0421941
ALAZAMI-YUAN SYNDROME	0.000843882	0.0421941
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000843882	0.0421941
#608443 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3; MRT3	0.000843882	0.0421941
JOUBERT SYNDROME 26	0.000843882	0.0421941
PEROXISOME BIOGENESIS DISORDER 10B	0.000843882	0.0421941
NOONAN SYNDROME 2; NS2	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.000843882	0.0421941
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000843882	0.0421941
#604804 MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3	0.000843882	0.0421941
Temtamy preaxial brachydactyly syndrome	0.000843882	0.0421941
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000843882	0.0421941
#268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS;;COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;;COVESDEM SYNDROME, FORMERLYROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OFPHALANGES AND METACARPALS/METATARSALS, INCLUDED;;ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY,INCLUDED	0.000843882	0.0421941
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000843882	0.0421941
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000843882	0.0421941
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1; CEMCOX1	0.000843882	0.0421941
#609054 FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ	0.000843882	0.0421941
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000843882	0.0421941
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.000843882	0.0421941
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.000843882	0.0421941
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.000843882	0.0421941
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.000843882	0.0421941
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000843882	0.0421941
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000843882	0.0421941
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.000843882	0.0421941
MENTAL RETARDATION, X-LINKED 99	0.000843882	0.0421941
CHROMOSOME 16Q22 DELETION SYNDROME	0.000843882	0.0421941
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000843882	0.0421941
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000843882	0.0421941
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000843882	0.0421941
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000843882	0.0421941
AU-KLINE SYNDROME; AUKS	0.000843882	0.0421941
SWEENEY-COX SYNDROME; SWCOS	0.000843882	0.0421941
CEREBELLOFACIODENTAL SYNDROME	0.000843882	0.0421941
#615541 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39	0.000843882	0.0421941
DIAPHANOSPONDYLODYSOSTOSIS	0.000843882	0.0421941
COHEN-GIBSON SYNDROME; COGIS	0.000843882	0.0421941
CURRARINO SYNDROME	0.000843882	0.0421941
#615401 IMMUNODEFICIENCY 8; IMD8	0.000843882	0.0421941
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.000843882	0.0421941
#615583 VERHEIJ SYNDROME; VRJS;;CHROMOSOME 8q24.3 DELETION SYNDROME	0.000843882	0.0421941
CHAR SYNDROME	0.000843882	0.0421941
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000843882	0.0421941
BARDET-BIEDL SYNDROME 13; BBS13	0.000843882	0.0421941
DESBUQUOIS DYSPLASIA 2; DBQD2	0.000843882	0.0421941
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000843882	0.0421941
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000843882	0.0421941
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.000843882	0.0421941
CHROMOSOME 17P13.1 DELETION SYNDROME	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000843882	0.0421941
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000843882	0.0421941
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000843882	0.0421941
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000843882	0.0421941
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.000843882	0.0421941
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000843882	0.0421941
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000843882	0.0421941
AUSTRALIA ANTIGEN	0.000843882	0.0421941
Aarskog-Scott syndrome	0.000843882	0.0421941
SECKEL SYNDROME 9; SCKL9	0.000843882	0.0421941
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000843882	0.0421941
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000843882	0.0421941
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000843882	0.0421941
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000843882	0.0421941
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000843882	0.0421941
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000843882	0.0421941
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000843882	0.0421941
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.000843882	0.0421941
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.000843882	0.0421941
NETHERTON SYNDROME; NETH	0.000843882	0.0421941
RITSCHER-SCHINZEL SYNDROME 1	0.000843882	0.0421941
#610168 LOEYS-DIETZ SYNDROME 2; LDS2;;AORTIC ANEURYSM, FAMILIAL THORACIC 3; AAT3;;MARFAN SYNDROME, TYPE II, FORMERLY	0.000843882	0.0421941
CULLER-JONES SYNDROME; CJS	0.000843882	0.0421941
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000843882	0.0421941
Bardet-Biedl syndrome 2	0.000843882	0.0421941
RAHMAN SYNDROME	0.000843882	0.0421941
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000843882	0.0421941
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000843882	0.0421941
NEPHRONOPHTHISIS 11; NPHP11	0.000843882	0.0421941
JOUBERT SYNDROME 24	0.000843882	0.0421941
#613641 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B; CMTRIB;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE B; RI-CMTB	0.000843882	0.0421941
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000843882	0.0421941
NOONAN SYNDROME 3; NS3	0.000843882	0.0421941
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000843882	0.0421941
%300712 CRANIOFACIOSKELETAL SYNDROME	0.000843882	0.0421941
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000843882	0.0421941
Mental retardation, autosomal dominant 21	0.000843882	0.0421941
RETINITIS PIGMENTOSA 80; RP80	0.000843882	0.0421941
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000843882	0.0421941
#300123 MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISMMENTAL RETARDATION, X-LINKED, WITH ISOLATED GROWTH HORMONE DEFICIENCY,INCLUDED; MRGH, INCLUDED	0.000843882	0.0421941
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000843882	0.0421941
OROTIC ACIDURIA	0.000843882	0.0421941
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000843882	0.0421941
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.000843882	0.0421941
CHROMOSOME 15q25 DELETION SYNDROME	0.000843882	0.0421941
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.000843882	0.0421941
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.000843882	0.0421941
CHROMOSOME 15Q14 DELETION SYNDROME	0.000843882	0.0421941
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000843882	0.0421941
HOLOPROSENCEPHALY 3; HPE3	0.000843882	0.0421941
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000843882	0.0421941
THANATOPHORIC DYSPLASIA, TYPE I	0.000843882	0.0421941
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000843882	0.0421941
SAUL-WILSON SYNDROME; SWILS	0.000843882	0.0421941
WARSAW BREAKAGE SYNDROME; WABS	0.000843882	0.0421941
FRIAS SYNDROME	0.000843882	0.0421941
ROSSELLI-GULIENETTI SYNDROME	0.000843882	0.0421941
CHROMOSOME 18P DELETION SYNDROME	0.000843882	0.0421941
#614970 JOUBERT SYNDROME 20; JBTS20	0.000843882	0.0421941
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000843882	0.0421941
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000843882	0.0421941
BARDET-BIEDL SYNDROME 3; BBS3	0.000843882	0.0421941
SENIOR-LOKEN SYNDROME 9	0.000843882	0.0421941
#613076 MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARINGLOSS, AND DEVELOPMENTAL DELAY;;MYOPATHY WITH CATARACT AND COMBINED RESPIRATORY CHAIN DEFICIENCY;;MITOCHONDRIAL COMPLEX DEFICIENCY, COMBINED	0.000843882	0.0421941
#614728 SECKEL SYNDROME 6; SCKL6	0.000843882	0.0421941
#614732 INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIACONGENITA, AND GENITAL ANOMALIES;;IMAGE SYNDROME	0.000843882	0.0421941
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000843882	0.0421941
MEIER-GORLIN SYNDROME 7	0.000843882	0.0421941
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000843882	0.0421941
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.000843882	0.0421941
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000843882	0.0421941
HOLOPROSENCEPHALY 5; HPE5	0.000843882	0.0421941
CHROMOSOME 4q21 DELETION SYNDROME	0.000843882	0.0421941
#613752 HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000843882	0.0421941
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000843882	0.0421941
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.000843882	0.0421941
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.000843882	0.0421941
PEROXISOME BIOGENESIS DISORDER 3B	0.000843882	0.0421941
#614582 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9	0.000843882	0.0421941
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000843882	0.0421941
SECKEL SYNDROME 8; SCKL8	0.000843882	0.0421941
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.000843882	0.0421941
#614976 CARPENTER SYNDROME 2; CRPT2	0.000843882	0.0421941
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000843882	0.0421941
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000843882	0.0421941
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.000843882	0.0421941
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000843882	0.0421941
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000843882	0.0421941
HYPERTRYPTOPHANEMIA; HYPTRP	0.000843882	0.0421941
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000843882	0.0421941
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000843882	0.0421941
TONNE-KALSCHEUER SYNDROME; TOKAS	0.000843882	0.0421941
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.000843882	0.0421941
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.000843882	0.0421941
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000843882	0.0421941
#614213 NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C	0.000843882	0.0421941
LOWRY-MACLEAN SYNDROME	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000843882	0.0421941
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.000843882	0.0421941
#615665 JOUBERT SYNDROME 22; JBTS22	0.000843882	0.0421941
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.000843882	0.0421941
3MC SYNDROME 2	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000843882	0.0421941
#615066 OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14 ;;OI, TYPE XIV	0.000843882	0.0421941
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000843882	0.0421941
CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME	0.000843882	0.0421941
CHOPS SYNDROME; CHOPS	0.000843882	0.0421941
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.000843882	0.0421941
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000843882	0.0421941
Leukotriene C4 synthase deficiency	0.000843882	0.0421941
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000843882	0.0421941
CDAGS SYNDROME	0.000843882	0.0421941
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000843882	0.0421941
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.000843882	0.0421941
CHROMOSOME 9P DELETION SYNDROME	0.000843882	0.0421941
MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000843882	0.0421941
#615314 CRANIOSYNOSTOSIS 3; CRS3	0.000843882	0.0421941
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000843882	0.0421941
BARATELA-SCOTT SYNDROME	0.000843882	0.0421941
ADAMS-OLIVER SYNDROME 3; AOS3	0.000843882	0.0421941
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000843882	0.0421941
#180700 ROBINOW SYNDROME, AUTOSOMAL DOMINANT; DRS;;ROBINOW DWARFISM;;FETAL FACE SYNDROME;;ACRAL DYSOSTOSIS WITH FACIAL AND GENITAL ABNORMALITIES	0.000843882	0.0421941
#614873 PEROXISOME BIOGENESIS DISORDER 7B; PBD7B	0.000843882	0.0421941
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000843882	0.0421941
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000843882	0.0421941
OROFACIODIGITAL SYNDROME VI	0.000843882	0.0421941
#615220 OSTEOGENESIS IMPERFECTA, TYPE XV; OI15;;OI, TYPE XV	0.000843882	0.0421941
#303110 CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION;;CHROMOSOME Xq21 DELETION SYNDROME	0.000843882	0.0421941
CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL	0.000843882	0.0421941
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000843882	0.0421941
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000843882	0.0421941
FRONTOOCULAR SYNDROME	0.000843882	0.0421941
